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Administrative health data is under-used as a research tool for palliative care research in 
Ireland. The overarching aim of this thesis was to explore the potential of population based 
cancer registry data linked to hospital episode data and death certificate data to examine 
palliative and end-of-life care (PEoLC) for cancer patients, in Ireland.  Research objectives 
include using the available linked data to identify vulnerable subgroups in need of palliative 
care, to identify and compare characteristics of those who receive palliative with those who do 
not and to explore the relationship between receiving palliative care and place of death. The 
knowledge gained was extrapolated to other non-cancer health and social care data collections 
to evaluate the potential and challenges of these data for PEoLC research and so develop 




A population based  study of lung cancer decedents found  those  patients who  die  within 30 
days of diagnosis (short-term survivors) were older, (aged 80 years and over), had  more 
comorbid disease and were more likely to present through the emergency department than those 
who survived longer. These characteristics are available at diagnosis and could be used to guide 
decisions on early assessment for palliative care for lung cancer patients at admission. Short-
term survivors are more likely to die in hospital so reporting place of death by survival time 
may be useful to evaluate interventions to reduce deaths in acute hospitals. 
 
A second study compared the characteristics and place of death of cancer patients receiving 
specialist palliative care in acute hospitals with those who do not. Almost two thirds of cancer 
patients who attended a cancer centre in 2016 and died in 2016 had an inpatient palliative care 
encounter. They were younger, less likely to be married, and more likely to be from a deprived 
area. Having accounted for sociodemographic factors, there was evidence of regional variation 
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in receiving palliative care. Place of death differed by palliative care encounter, 45% of those 
who were seen by the palliative care team died in hospital, 33% died in a hospice and 18% died 
at home. Of those who had no record of a palliative care encounter 50% died in hospital, 16% 
died in hospice and 28% died at home. 
 
These studies demonstrate that Irish administrative health data can be used for PEoLC research 
however a thorough advance knowledge of the datasets to be used is critical. For each data set, 
information on how the data are organised (data models) and what data are collected (data 
dictionaries) are required.  Knowledge of what is missing within each dataset is as important 
as knowing what is available. These considerations inform most aspects of study planning, 
design and implementation and were used to evaluate the potential of other national and social 
care data collections for PEoLC research. Efforts to identify and control for bias, both known 
and unknown are a particular concern when using administrative health data for research.  
 
This thesis contributes to population based PEoLC research in Ireland and to the international 
body of work that uses administrative health care and social care data for PEoLC research. It 
can inform future use of Irish health data for population based research and has identified 
several avenues for further research. It is hoped the thesis findings will give impetus to ongoing 
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Chapter 1: Introduction 
 
 Palliative care  
 
The World Health Organisation (WHO) defines palliative care  “as an approach that improves 
the quality of life of persons and their families facing the problems associated with life-
threatening illness, through the prevention and relief of suffering by means of early 
identification and impeccable assessment and treatment of pain and other problems, physical, 
psychosocial and spiritual”  (World Health Organization, 2020). WHO states “palliative care 
provides relief from pain and other distressing symptoms, affirms and enhances life, integrates 
the psychological and spiritual aspects of patient care and offers a support system to help 
patients and their families. It is applicable early in the course of illness, in conjunction with 
other therapies that are intended to prolong life, such as chemotherapy or radiation therapy, 
and it includes investigations needed to better understand and manage distressing clinical 
complications. Palliative care uses a team approach to address the needs of persons and their 
families, including bereavement counselling, if indicated”. 
 
In Ireland, the National Clinical Programme for Palliative Care (NCPPC) have developed a 
Palliative Care Model of Care for the organisation of care for people with life-limiting or life-
threatening conditions (National Clinical Programme for Palliative Care, 2019). The model of 
care recommends palliative care services should be structured in three levels of increasing 
specialisation: 
Level 1: Provided in any location or setting by all healthcare professionals as part of their role 
and using a palliative care approach. A palliative care approach aims to promote both physical 
and psychosocial wellbeing. It is a vital and integral part of all clinical practice, whatever the 
illness or its stage, informed by a knowledge and practice of palliative care principles. 
Level 2: Provided in any location, using a palliative care approach by healthcare professionals 
who have additional knowledge of palliative care principles and use this as part of their role.  
Level 3: Provided by healthcare professionals who work solely in palliative care, and who 
have extensive knowledge and skills in this specialty. Specialist palliative care services are 
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provided by an inter-disciplinary team, under the direction of a consultant physician in 
palliative medicine. 
End of life care is the term used to describe care that is provided during the period when death 
is imminent, and life expectancy is limited to a short number of hours or days (The National 
Clinical Programme for Palliative Care, 2016). The term has been used to describe the last 12 
months of life however NCPPC does not use the term in this way. Hospice care is a ‘term that 
may be used to describe both a place of care (i.e. institution) and a philosophy of care, which 
may be applied in a wide range of care settings’ and is often used interchangeably with 
‘palliative care’. Hospice care aims to improve the lives of people whose illness is no longer 
curable. It strives to help people to live as fully as possible to the end and provides support to 
families. It also extends into bereavement care.  Hospice care can be provided in a hospice, at 
home, in a hospital or in a nursing home.    
Palliative care provision is underfunded in most developed countries (O’Dowd, 2015; Meier et 
al., 2017; Canada, 2018). There is an associated lack of high quality research in palliative  and 
end-of-life care (PEoLC), partly  due to lack of funding (Halpern, 2015; Higginson, 2016) but 
also related to sensitivities around the subject of death and  dying (Fischer et al., 2012; Chen 
E. K., et al., 2014). A key challenge relates to the study population where it is difficult to recruit 
and retain subjects. This is compounded by ethical concerns for vulnerable patients who are 
often seriously ill as well as methodological concerns including loss to follow up, recall bias 
or difficulties measuring  endpoints such as pain or symptom burden (Chen E. K., et al., 2014). 
 Administrative health data 
 
Some of the challenges for PEoLC research can be addressed using routine data, which is 
defined as ‘non-targeted data obtained from ongoing data collection systems associated with 
health and social services’ (‘Routine Data’, 2020). Routine data typically include health event 
data such as birth and death registration, disease registries e.g. cancer registries, health surveys 
and health activity data that can include information on hospital admissions (Public Health 
Action Support Team, 2010). Administrative health data reflect the structure and organisation 
of the health systems from which they derive. The terms ‘routine data’, ‘administrative health 
care data’, ‘health care utilization data’, and ‘administrative claims data’ are used throughout 
the literature. The term ‘administrative health data’ is used throughout this thesis to mean 




The use of administrative health data for research purposes is an area of growing interest and 
several  papers have described the challenges and opportunities associated with it (Gavrielov-
Yusim & Friger, 2014; Bradley et al., 2010; Bohensky et al., 2010).  More recently, its  use as 
a research tool for PEoLC research is an area of increasing international interest (Davies et al., 
2016; Maetens et al., 2016; Tanuseputro, 2017).   
 
Davies et al described  a number of initiatives that use routine data for PEolC research in 
England and elsewhere (Davies et al., 2016). Three priorities for future used of routine data 
were identified:  i) safe and ethical access to data; ii) improved data linkage; and iii) improved 
PEoLC data collections.    In Belgium, Maetens et al identified and described the steps  to 
access,  interrogate and link seven population level databases  for   end-of-life research  
(Maetens et al., 2016) while in Ontario,  Tanuseputro et al used a  range of routine data sources 
to examine the delivery of palliative care across acute care, outpatient clinics, and home care 
health sectors at the population level (Tanuseputro et al., 2017). Both Ontario and Belgium 
have almost universal health care coverage so that health insurance databases are generally 
population based where each individual is uniquely identified. In England, the  National Health 
Service (NHS) is a publically funded (single payer) health care system that uses an NHS 
number as a unique patient identifier (Boyd et al., 2018).  These studies demonstrate the 
potential of administrative health data for PEoLC research but also that the organisation of a 
healthcare system impacts what data are available and how it can leveraged.  
 
 The Irish health service 
 
Unlike most European countries, Ireland has a mixed public private health care system where 
publically funded health care is managed by the Health Service Executive (HSE) and funded 
through the tax system (Connolly & Wren, 2019). Those on lower incomes (means tested) are 
entitled to medical cards which permits free public health services. Individuals without medical 
cards are entitled to subsidised public hospital services and prescription medicines, but pay the 
full cost of general practitioner (GP) and other primary care services (Connolly & Wren, 2019).  
GPs are not directly employed by the government.  
There are three types of hospitals in Ireland  i) public hospitals which are owned and funded 
by the HSE, ii) voluntary public hospitals,  most of whose income comes  from the State but 
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can be privately owned and managed and iii) private hospitals that receive no state funding. 
The public health system is provided through HSE and voluntary hospitals, but these can also 
provide private medical services. On admittance to a public (or voluntary) hospital, patients 
choose to be treated on a public or private basis by their consultant. Private hospitals operate 
independently of the State health services and the cost of care must be paid either directly or 
through private health insurance (Citizensinformation.ie, 2018).  In 2017, 33% of the 
population had a medical card and approximately 43% of the population are covered by private 
health insurance (Department of Health, 2018) 
 
 Structural issues in healthcare organisation and delivery 
The mixed public, voluntary and private health system, ad-hoc development of data collections 
and lack of unique patient identifier has resulted in an information infrastructure that does not 
link easily across service providers leading to duplication, fragmentation and increased 
workload.  Patients cannot be easily tracked from hospital to community based care leading to 
large gaps and silos of underused data (Health Information and Quality Authority, 2013). Gaps 
in data exist particularly from the primary and community care sector as well as from   
outpatient clinics and emergency department attendances that don’t result in hospital 
admission. The lack of community and social care data is particularly relevant for PEoLC as a 
considerable amount of palliative care is delivered in the community. Similarly how data are 
managed and accessed across providers, many of whom are not part of the HSE, is not well 
defined. Private hospitals do not contribute to the HSE hospital admissions data collection so 
that studies based on HSE data cannot be generalised to the whole population.   Data models 
describing how the data are stored and organised and/or data dictionaries describing what data 
are collected are often not available.  
 Thesis rationale  
 
The starting point for this thesis was access to   population based cancer registry data linked to 





 The cancer registry  
The National Cancer Registry Ireland, established in 1994, collects population based data on 
cancer incidence, treatment and survival in Ireland. Population based cancer registration is 
complex (Tyczynski & Démaret, 2003), to maximise value it is important to ensure all cancer 
cases are captured and that the data are as complete as possible. In Ireland, this is achieved by  
active data collection from hospital based medical records, pathology laboratories and general 
practitioners, supplemented by  the interrogation of administrative health datasets including 
hospital episode data and death certificate data.  This process creates a potentially useful but 
underutilised research resource in the form of a linked health dataset that is, population based 
cancer registry data linked to hospital episode data and death certificate data.  
 
Ireland has a rapidly aging population and the proportion aged over 65 years has increased by 
over 19% between 2011 and 2016 (Central Statistics Office, 2019b).  The impact of an aging 
population  on the need for forward planning  of palliative care services in Ireland has been 
recognised for serious illnesses (May et al., 2020) including cancer (National Cancer Registry 
Ireland, 2019a).  Cancer accounts for about 30% of all deaths per year in Ireland (Kane et al., 
2015) and this is likely to increase as the population ages.  Population based cancer registry 
data linked to hospital episode data and death certificate data has been used for research (Kelly 
et al., 2012, 2013; McDevitt et al., 2013) but to-date its use for PEoLC research has been limited 
(Ó Céilleachair et al., 2011; Sharp et al., 2010).   
 
 Research aims and objectives 
The overarching objective of this thesis is to explore the potential and challenges of using 
administrative health data for PEoLC in Ireland, more specifically in cancer patients using 
population based cancer registry data linked to hospital episode data and death certificate data.  
Informed by the international experience of using administrative health data for PEoLC 
research and with detailed knowledge of the available linked datasets, the research aims to   
• Identify cancer subgroups in need of palliative care. 
• Identify receipt of palliative care. 
• Compare the characteristics of those who receive palliative care in acute public 
hospitals and those who do not. 
• Explore the relationship between receiving palliative care and place of death. 
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• Extrapolate the knowledge gained to other health and social care data collections to 
evaluate the potential and challenges of these data for PEoLC research. 
• Develop guidelines for using Irish administrative health and social care data for PEoLC 
research to maximise its potential as a research tool while identifying the limitations of 
its use. 
 
This research should provide an added impetus to recent initiatives to improve the research 
potential of Ireland’s health and social data collections (eHealth Ireland, 2018; Houses of the 
Oireachtas, 2017; Moran et al., 2016).  
 
 Thesis outline 
 
The remaining chapters of the thesis are as follows: 
 
Chapter 2 reviews the literature on the use of administrative health data for PEoLC research 
nationally and internationally. Chapter 3 provides information on the setting of the Irish health 
service and the development of palliative care services in Ireland. The permission received to 
use the data for research is described along with a detailed description of the administrative 
health datasets used and how the data are linked. The remainder of the chapter describes the 
methodology for each of the three studies undertaken including, where appropriate, the 
statistical methods used for data analyses. The results chapters are presented as published 
articles (Chapter 4 and 5) and an article under review (Chapter 6). The articles are presented 
with references given at the end of each chapter, formatted as published in the journals. Chapter 
4 describes using administrative health data to identify indicators for early assessment for 
palliative care in lung cancer patients. Chapter 5 examines receipt of specialist palliative care 
in acute hospitals and place of death. Chapter 6 draws together the knowledge gained from 
using Irish administrative health data for PEoLC research. It documents in detail the strengths 
and weaknesses of available administrative health datasets as well as identifying where gaps 
occur. Chapter 7 draws together the findings from this thesis and summarises the potential and 
challenges of linked administrative health data for PEoLC research in Ireland and opportunities 




Chapter 2: Literature review 
 
The purpose of this literature review is to critically review how administrative health data are 
used internationally for PEoLC research.  It will examine which data have been utilised for this 
purpose, identify common themes across the studies undertaken and identify differences in how 
the data has been used across regions. This in turn will provide insight on how administrative 
health data can be used for PEoLC research in Ireland and contribute to the international body 




 Peer reviewed literature 
The criteria for the literature review including concepts used, development of the search 
strategy, the databases searched and the inclusion criteria are given in Table 2.1. Because the 
primary data sources for this thesis are population based cancer registration data linked to 
administrative health data, there was a particular focus on cancer patients.  The search criteria 
returned a large volume of material which was further categorised to those using population 
based data and those using administrative health data from just one or a few health care centres.  
The population based material was reviewed in the first instance to identify relevant papers and 
from these further relevant studies were retrieved from the bibliographies. This iterative or 
‘snowball’ methodology identified three key authors who have used administrative health data 
for PEoLC research at a national level. A number of common themes emerged from these and 
are described below.  Of particular relevance to the thesis aims and objectives was  how 
administrative health data  could be used to  i) identify the need for palliative care, ii) identify 
the delivery of palliative care and iii) prognosticate patient outcomes. Using the same snowball 
methodology all the literature was re-examined to identify how this was done. Throughout the 
literature review process, data syntheses from systematic reviews were prioritised over reviews 
of individual papers. The results from the two distinct phases of the literature review are 
described separately below. The literature review was first conducted in 2015 and repeated in 









 Grey literature 
In addition to the peer-reviewed literature search, a broad search via search engine (Google) 
for relevant reports and outputs from government departments, health service providers, 
research institutes, university departments and charities involved in the provision of PEoLC 
was undertaken. The bibliographies of reports identified as relevant were also checked for any 





Exploration and  
Development  
Concept 1 Concept 2 Concept 3 Concept 4 
 MeSH MeSH   
 Cancer ‘end of life’ administrative ‘healthcare 
utilization’ 
 Neoplasm ‘end-of-life’ ‘routine data’ ‘healthcare 
utilisation’ 
 Tumour terminal - - 
 Tumor palliative - - 
  hospice   




AND  ( ‘End of 
life’ OR end-of-
life OR  ‘terminal 











Databases MEDLINE CINAHL EMBASE  
Fields searched Title and 
abstract 
Title and abstract Title and 
abstract 
Inclusion criteria Range: 2000-2020  English Language; Human;  All 





Recent studies indicate the  use of administrative health  data for PEoLC research is an area of 
increasing importance with examples   from the United Kingdom (Davies et al., 2016), Belgium 
(Maetens et al., 2016)  and Ontario, Canada (Tanuseputro et al., 2017). Their work builds on 
an established international body of literature and identifies a set of recurring themes that need 
to be addressed at a national/regional level in order to leverage administrative health data.  
These authors, and authors they cited, were examined first and used as a roadmap to guide the 
remainder of this review. 
 
 Using administrative health data for PEoLC research 
Davies et al (2016) described  a series of workshops whose aim was to  highlight  valuable 
examples of how administrative health data was used  for PEoLC research in the U.K. (Davies 
et al., 2016). Data sources used included population based death certificate data, hospital 
activity data and primary care data mainly from general practitioners (GPs).  The national 
hospital activity data set, Hospital Episode Statistics, covers all National Health Service (NHS) 
hospitals in England  (Hospital Episode Statistics (HES), 2020). The Clinical Practice Research 
Datalink is the largest available collection of primary care data, containing longitudinal medical 
records on a sample of around 10% of the UK population. Cancer registry data was noted as a 
national resource for PEoLC but no examples using cancer data were described.  Although not 
strictly administrative health data, the usefulness of large nationally representative surveys to 
examine variation between groups and evaluate policy was highlighted. The authors drew 
attention to the lack of social care data and listed examples where locally collected data were 
used to fill the gaps. Three priorities for the continued use of administrative health data were 
indicated. These included safe and ethical access to the data, improved data linkage, and the 
need for more palliative and end of life care specific data.   
 
 In Belgium, exploring a similar theme, Maetens et al examined  which full-population 
databases  provided valid information about end-of-life care,  the  procedures in place  to use 
these databases, and what was needed to integrate separate databases (Maetens et al., 2016). 
The study aim was to retrieve healthcare use data for all decedents for the two years prior to 
their death. Health insurance is legally mandatory in Belgium, so that reimbursement data of 
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all legal residents are available from a single agency that manages all healthcare insurers’ data. 
In total seven databases were identified including three health insurance databases which do 
not have disease specific information; the Belgian cancer registry database which records all 
incidence of cancer; national death certificate data  providing  cause of death information; a 
national census database providing information on household composition, educational 
attainment and other socio-economic information and  augmented by a second national fiscal 
database with additional socio-economic data. Although hospital activity data were available, 
they were not used as they only captured hospitalized patients.  Instead, cause of death and 
clinical data abstracted from health care claims data were deemed sufficient to derive individual 
level data across the entire Belgian population.  The authors described the procedures necessary 
to access the data where two types of approval were needed for every database: i) internal 
approval from database administrator organizations and ii) approval from the relevant Belgian 
Privacy Commission bodies. As of  2018, the Belgian Privacy commission has been replaced 
by the Belgian Data Protection Authority with increased regulatory power  so that the 
requirements for GDPR can be properly enforced (De Smedt, 2017). The process of data 
linkage was undertaken by trusted third parties to guarantee data privacy. Data linkage was 
predominantly deterministic based on a common social security identifier across all data 
sources except for death certificate data. Here, data were linked using date of birth, sex, and 
municipality of residence.   
 
In Ontario Canada, Tanuseputro et al (Tanuseputro et al., 2017)  used linked  administrative 
health data to examine the delivery of palliative care at the population level across all health 
sectors  for all decedents over a two year period in Ontario. Ontario has almost universal health 
care coverage which  includes  cover for  all residents for costs associated with acute care 
hospitalizations, physician visits, emergency room visits, long-term care, home care, and 
complex continuing care as well as medications for those over 65 years and for those receiving 
social assistance (Tanuseputro et al., 2015).  The study population was identified from a 
population based health insurance database where   encrypted health card numbers were used 
as unique identifiers to link across various administrative databases. Data are held and linked 
by ICES formerly known as the Institute for Clinical and Evaluative Sciences (Schull et al., 
2020). ICES has a special designation under Ontario’s Personal Health Information Protection 
Act, granted by the Information and Privacy Commissioner of Ontario  which means health 
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information custodians can disclose personal health information to ICES without consent 
(ICES, 2020).   
 
 
These three studies demonstrate the potential of administrative health data for PEoLC research 
but also highlight how the organisation of a healthcare system impacts what data are available 
and how it can leveraged. Both Ontario and Belgium have almost universal health care 
coverage so that health insurance databases are generally population based and each individual 
is uniquely identified. This facilitates not only data linkage across databases but also facilitates 
the de-identification of individuals and anonymisation of the data. The level of health insurance 
coverage dictates what information is available. In Ontario, population based data are available 
across a wide range of out-patient services including physician home visits, home care and 
long-term care services.  Both Maetens (Belgium) and Tanuseputro (Ontario) note that non-
covered and out-of-pocket medical costs are likely to be missing in their datasets. England’s 
NHS is a population based  publically funded (single payer) health care system that uses an 
NHS number as a unique patient identifier (Boyd et al., 2018) and so  data linkage should be 
possible. However while infrastructures to link and share health data exist in the UK,  many 
practical and legal obstacles remain (Mourby et al., 2019). Davies highlighted the need for 
improved data linkage through trusted third parties along with the establishment of a legal basis 
for the collection, linkage and use of data.   
 
The themes common to these studies include identifying the available data, how that data can 
be safely and ethically accessed, safeguarding patient privacy, linking data across available 
datasets and finally recognising the inherent opportunities and  limitations of how the data can 
be used. 
 
 Literature review outline 
Tanuseputro describes three ways in which linked administrative health data can be used to 
improve palliative care delivery (Tanuseputro, 2017)  These are i) identifying the need for 
palliative care, ii) identifying the delivery of palliative care and iii) prognostication of patient 
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outcomes including mortality, hospitalisation and institutionalisation so that those who need 
palliative care are identified and receive it. 
 
The overarching objective of this thesis is to explore the potential and challenges of using 
administrative health data for PEoLC in Ireland.  The thesis aims are mainly focussed on cancer 
patients because of the availability and access to population based cancer registry data linked 
at the person level to hospital episode data and death certificate data. The first two thesis 
objectives  i) to identify cancer subgroups in need of palliative care and ii) to identify receipt 
of palliative care align closely with the uses of administrative data described by Tanuseputro.   
 
Identifying the need for palliative care is examined in section 2.3. Internationally, studies that 
estimate the population need for palliative care rely predominantly on death certificate data. 
Studies focusing on the palliative care needs of the individual rely on a wider range of data 
sources and are concerned with capturing information on the patient experience in a predefined 
time period before death. This literature review focussed on studies that used  measures derived 
from administrative health data that include death certificate data (cause and place of death), 
claims data (for chemotherapy billing, intensive care unit  and hospice admission information) 
and hospital episode data (information on admission type, discharge location, clinical diagnosis 
and/or death in acute care setting). Subgroup analysis by a range of characteristics that can 
include combinations of age, disease type, method of presentation and place of death have been 
used as markers of  appropriate or inappropriate care at end of life. 
 
Section 2.4 is concerned with identifying receipt of palliative care. The extent to which 
palliative care receipt can be identified from administrative health data relies not only on  how 
healthcare is structured and funded within a country but also the care setting  e.g. hospital, 
home, hospice and/or the community. This section examines how palliative care receipt has 
been identified in different jurisdictions and in different care settings. The characteristics of 




A more detailed examination of the relationship between patient characteristics, receipt of 
palliative care, place of care and place of death is given in section 2.5.  Factors contributing to 
regional variation in place of death are considered including the role of healthcare organisation 
and policy. 
 
Section 2.6 examines how linked administrative health data has been used internationally for 
prognostication of patient outcomes (mortality, hospitalisation and institutionalisation) so that 
those who need palliative care are identified and receive it. This was the   third use of  linked 
administrative health data identified by Tanuseputro to improve palliative care delivery 
(Tanuseputro, 2017).   Section 2.7 reviews the literature around PEoLC research in Ireland with 
a particular emphasis on studies that have used administrative health data. The last section 2.8 
summarises the findings and outlines the research gap this thesis addresses. 
 
 
 Identifying the need for palliative care  
  
 The need for palliative care at a population level 
Identifying the need for palliative care at the population level has been researched extensively. 
Death certificate data either on its own or in conjunction with additional sources underpins this 
research and relies on the principle of quantifying at the population level mortality from 
diseases with an associated palliative care need. Death certificate data uses International 
Statistical Classification of Diseases and Related Health Problems–10th Revision (ICD-10) 
(World Health Organization, 2004) codes to record an underlying and contributory cause of 
death. Global estimates on the need for palliative care are based  primarily  on the ICD codes 
recorded on death certificate mortality data for diseases requiring palliative care, adjusted by 
estimated symptom  prevalence for each disease category (Connor et al., 2014; Murtagh et al., 
2014).   The methodology  was first described by Higginson (Higginson, 1997) and 
modifications of the methodology have been used to generate population based estimates.  
 
In Australia,  Rosenwax  et al  used mortality data linked to hospital admissions data to generate 
a minimal, an intermediate (based on all deaths hospitalised with the same condition certified 
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on the death certificate), and a maximal estimate of need (more disease categories included)  
(Rosenwax et al., 2005). In Spain,  Gómez-Batiste  et al used mortality data and either a flat 
rate percentage of 75% for all diseases and all deaths (Gómez-Batiste et al., 2012) or more 
recently directly measured prevalence of disease in chronically ill patients (Gómez-Batiste et 
al., 2014).  Murtagh et al   reviewed these methods and made a number of  refinements 
including  i) reviewing and updating the disease classification codes used in the models, ii) 
examining  in more detail the role of the main and contributory  causes of death and iii) 
considering  the pattern of hospitalisations in the year before death (Murtagh et al., 2014). 
Diseases identified as  having  a palliative care need include malignant neoplasm, heart disease 
including cerebrovascular disease, renal disease, liver disease, respiratory disease, 
neurodegenerative disease  that include Alzheimer’s, dementia and senility and HIV/AIDS. 
The methodologies were then compared by estimating the population need for palliative care 
using all deaths in England between 2006 and 2008. The refined method estimated a minimum 
of 63% of all deaths may need palliative care compared to just 37% using the Rosenwax 
method.  Some of the differences are due to the inclusion of extra disease categories e.g. chronic 
heart disease and stroke and the expansion of others such as Alzheimer’s to include other 
dementias.  
 
In Germany, Scholten et al used the Murtagh and Rosenwax methodology to estimate palliative 
care need but did not have access to hospital episode data (Scholten et al., 2016). The  
Rosenwax method was used to  compare the population based need for palliative care  across 
14 countries by Pivodic et al using 2008  death certificate  data from each country  (Pivodic et 
al., 2016). The relationship between place of death, cause of death, sociodemographic variables 
and health care characteristics for diseases which are indicative of palliative care need was 
investigated. These included cancer, heart/renal/liver failure, chronic obstructive pulmonary 
disease, diseases of the nervous system and HIV/AIDS.  
 
Morin et al estimated  the need for palliative care across 12 countries using three  estimation 
methods, i) Rosenwax et al,  ii) the Murtagh et al and  one other  (Morin et al., 2017). 
Irrespective of methodology used, the authors found home and nursing home were the two 
places of deaths with the highest prevalence of palliative care needs although it is not clear if 




Brameld et al highlights  that estimates produced often depend on the data sources used as  
there can be differences in the way data are recorded across data sources (Brameld et al., 2017). 
There is variation within diseases on how accurately they are recorded. For example,  
neoplasms are generally recorded across all data sources while  COPD, renal disease and heart 
disease are underreported in death certificate data (Murtagh et al., 2014) but are  more   
common in hospital episode data.  Age and sex variations exist by data source and by disease 
condition, so that use of different administrative data sources can give varying results for the 
estimate of the size of the population in need of palliative care and the frequency of conditions 
needing palliative care. For example, the Brameld study population used death certificate data 
for people who died in Western Australia in 2009 and 2010 aged 20 years or older, linked to 
hospital episode data. It reported that between 43% and 73% of the 23,852 people who died 
had a condition potentially amenable to palliative care, depending on the information source(s) 
used. 
 
These studies highlight the importance of death certificate data for service planning for 
palliative care needs at the population level. 
 
 Identifying the need of palliative care at the individual level   
Death in an acute care setting was first identified as a quality measure for end of life care by 
Earle et al in 2003 (Earle et al., 2003).  Using a mixture of literature review, focus groups and 
expert panel opinion, the authors identified and evaluated  candidate quality performance 
measures that could  be derived from administrative data to profile  cancer care near the end of 
life (Earle et al., 2003). Three concepts of poor quality of care were identified: i) the initiation 
of new anticancer therapies or continuation of ongoing treatments very near death, ii) a high 
number of emergency room visits, inpatient hospital admissions, and days spent in the ICU 
near the end of life, and iii) a high proportion of patients never referred to hospice or only 
referred in the last few days of life, or death in an acute-care setting. These indicators relied on 
access to a variety of data sources including death certificate data as described above, claims 
data and hospital episode data. Based on this early work by Earle, numerous studies worldwide 
have used these measures to examine end of life care. These fall into two main categories: i) 
studies of the intensity of end of life care and ii) studies of healthcare utilisation at end of life. 
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The studies are informative because they seek to identify patients who may have received 
inappropriate care near death using administrative health data. Two systematic reviews 
examine most of this work, the first focusses on  the intensity of care (Luta et al., 2015)  and  
the second on healthcare utilisation (Langton et al., 2014)  at end of life. 
 
Luta et al  summarised  the features, characteristics of  use and reported validity of measures 
across 58 studies investigating intensity of end of life care (Luta et al., 2015). Measures of 
intensity were defined as all quantifiable measures describing the type and intensity of medical 
care administered during the last year of life. Hospitalisations (44 studies), intensive care unit 
(ICU) admissions (39 studies) and chemotherapy use (27 studies) were the most commonly 
reported measures.  Less than half (24 of the 58) of the studies reviewed were specifically 
concerned with measuring intensity of care,  the remaining studies measured a variety of related 
measures including healthcare utilisation at the end of life, variation in care across different 
settings at end of life, population and time trends and the quality of end of life care. The time 
frames examined for intensity of care ranged from 48 hours to 12 months.  Only four studies 
reported any information on validation of the measures used.  Nearly all the studies used 
administrative data and the majority were in patients aged 65 years or over. The vast majority 
of studies were from North America (45 studies), with 8 from Europe, 4 from Asia and 1 from 
Australia. In the review the authors identified a number of limitations including a lack of 
agreement on the definition for intensity of end of life care, a lack of validation for the measures 
used and of most relevance to this thesis, little agreement on the end of life timeframe. Most 
studies were concerned with cancer patients (31 studies) but differences in survival and 
therefore end-of-life   timeframe by disease and/or cancer subtype were not considered.  
 
Langton et al  reviewed 78 studies published between 1990 and 2011, that examined  end of 
life resource utilisation and cost in cancer care (Langton et al., 2014). Of these, 14 were part of 
the  2015 systematic review  by Luta et al (Luta et al., 2015). The study population comprised 
over 3.7 million adult cancer decedents with solid tumours. Resource utilisation included 
diagnostic tests, hospital admissions, emergency department visits, ICU use, and medications 
including chemotherapy, surgery and palliative care services such as hospice and community 
care.  A number of studies (n = 15) examined resource use in terms of quality indicators of end 
of life which were generally classified as ‘aggressive’ or ‘palliative’. The majority were 
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focussed on care delivered in the last month of life.  Across all studies the most common end 
of life period was 6 to 9 months (49 studies) but ranged from 3 days to 3 years. The majority 
of the studies originated in North America (55 studies) with 10 from Europe, 8 from Asia and 
5 from Australia. The study population in 54 studies was decedents with any solid tumour 
cancer diagnosis (categorised using ICD codes). Decedents were identified from cancer 
registries (32 studies), administrative health claims (17 studies), death certificate data (10 
studies), health insurance databases (4 studies) with the remainder from a combination of 
sources. In 50 studies, the decedents died from cancer. The most common resource utilisation 
measures were hospital admissions, ICU use and emergency department attendance. The 
review found an increase in service use as death approached, with hospital costs highest. 
Fifteen studies using quality of care indicators showed approximately 38% of cancer patient 
received chemotherapy or life sustaining treatments in the last month of life and up to 66% did 
not receive palliative care services (hospice or community care).  Quality indicators for 
palliative care included hospice care, pain relief (opioids), and primary and community care at 
the end-of-life. 
 
In Ontario Canada, Tanuseputro et al used population based administrative databases linked to 
death certificate data for all deaths from April 2010 – March 2013 inclusive (n= 264, 755 
deaths),  to examine health care use and cost in the last year of life across several healthcare 
sectors (Tanuseputro et al., 2015).  These included inpatient, outpatient, long term and home 
care sectors. About 75% of decedents had inpatient care, 25% used long-term care and 60% 
used home care. Costs rose sharply in the last 120 days prior to death primarily for inpatient 
care.  
 
Bekelman et al conducted a  retrospective cohort study comparing site of death (acute care 
hospital), health care utilisation (hospitalizations in acute care hospitals, admissions to ICUs, 
emergency department visits, chemotherapy episodes)  and hospital expenditures (from claims 
data,  either commercial or governmental)  in  persons dying of cancer from seven developed 
countries (Belgium, Canada, England, Germany, the Netherlands, Norway, and the United 
States) in 2010 (Bekelman et al., 2016).  Health care utilisation and hospital expenditure was 
examined during the 180 day and 30 day period before death. Separate analyses were conducted 
for i) decedents from all countries in those aged 65 year over, ii)  for all ages in  all countries 
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excluding the United States and iii) for all decedents with lung cancer aged 65 years or older. 
The data sources for this study included claims data, hospital episode data, cancer registry data 
and death certificate data. Death rates in acute hospitals ranged from 52% in Canada to just 
over 20% in the United States across the seven developed countries for decedents with any 
cancer aged 65 years and over. End-of-life care was more hospital-centric in Belgium, Canada, 
England, Germany, and Norway than in the Netherlands or the United States.  
 
 
These studies highlight several limitations that need to be considered when using 
administrative health data for PEolC research. The lack of consensus on the end-of-life time 
frame reported  for all diseases (Langton et al., 2014; Luta et al., 2015) is unsurprising  given 
the variation of survival times both across all diseases and by cancer subtypes (Cancer Survival 
Statistics, 2015). Some addressed this issue by doing a subgroup analysis by cancer type e.g.  
lung cancer patients (Bekelman et al., 2016). Although a number of studies had access to cancer 
registry data, none reported survival times or attempted to characterise end-of-life timeframes 
by cancer type. Looking forward from an event such as a cancer diagnosis (i.e. using  date of 
incidence from cancer registry data) may be more informative  than looking back from death,  
particularly for cancers with poor survival such as lung cancer (Cancer Survival Statistics, 
2015). Langton et al stressed the importance of understanding features of individual health 
systems and study populations when making comparisons across health systems (Langton et 
al., 2014).  
 
 Palliative care need in vulnerable subgroups 
Certain palliative care subpopulations have been identified as having less frequent access to 
specialist palliative care (Currow et al., 2008). These include the elderly, those in rural and 
remote areas, members of indigenous communities, people from non-English speaking 
backgrounds, people from lower socioeconomic backgrounds and those without caregivers. In 
a critical review of 10 studies from  the USA, Canada, France, Australia and New Zealand, 
Wong et al  highlighted an  absence of evidence regarding the palliative care requirements of 
older patients particularly those presenting to emergency departments, with a  call for more 
research to help improve service provision (Wong et al., 2014). Eight of the studies used a 
clinical diagnosis to identify patients with palliative care needs. Disease categories included 
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cancer, neurological diseases (Alzheimer’s, Parkinson’s and motor neurone), cardiopulmonary 
diseases including congestive heart failure and chronic obstructive pulmonary disease, organ 
failures (renal and liver), end stage liver disease and diseases of the immune system including 
HIV and AIDS. These are similar to those identified previously (Murtagh et al., 2014). 
 
 In Scotland, Brewster et al used  cancer registry records linked to hospital discharge and death 
records to explore the characteristics of patients dying within 30 days of being diagnosed with 
breast or colorectal cancer  in Scotland during 2003-2007  (Brewster et al., 2011). Being elderly 
and one or more emergency admission in the 30 days either before or after diagnosis were most 
strongly associated with dying within 30 days of diagnosis. Similarly McPhail et al  used cancer 
registry data  linked to hospital episode data and  death certificate data  to identify  cancer 
patients diagnosed via emergency presentation for all newly diagnosed cancers in England 
between 2006 and 2008  (McPhail et al., 2013).  Emergency presentation was predictive of 
short-term mortality in cancer patients even when age, stage, and co-morbidity were accounted 
for.  Although similarly linked datasets are available in Ireland no such studies have been done. 
Using administrative health data to identify receipt of palliative care and thus compare 
characteristics of those who have and have not received palliative care is another way in which 
vulnerable subgroups might be identified.  
 
 Identifying receipt of palliative care  
 
A value of administrative health data for PEoLC research lies in the ability to determine that 
palliative care has been received. Internationally studies that used administrative health data to 
identify receipt of palliative care are mostly from health regions with  universal health care 
systems and rely on billing codes in claims data e.g. Ontario (Jang et al., 2015; Tanuseputro et 
al., 2017), Belgium (Maetens et al., 2016)  and Taiwan (Chang et al., 2016).  
 
 Health insurance data  
Using linked data from several population databases from Ontario,  Jang et al  investigated the 
association between receipt of palliative care and  aggressive end of life care  in patients with 
advanced pancreatic cancer (Jang et al., 2015).   Physician billing data using Ontario Health 
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Insurance Plan (OHIP) database were used to identify receipt of palliative care consultation 
based on the use of a palliative care billing code (Ontario Medical Association, 2014).  Just 
over 52.3% of n = 5381 patients   received a palliative care consultation which was associated 
with lower odds of aggressive care.  
 
Using a similar methodology Tanuseputro et al identified the delivery of palliative care from a 
documented range of billing and diagnostic codes used to capture aspects of palliative care 
delivery from a variety of data sources.  These  included the OHIP database, the Canadian 
Institute for Health Information Discharge Abstract Database, the National Ambulatory Care 
Reporting System, Home Care Database, long-term care facilities  and Complex Continuing 
Care systems (Tanuseputro et al., 2017).  The study population comprised all decedents in 
Ontario, Canada, from 1 April 2010 to 31 March 2012 (n = 177,817). Across all health sectors, 
just over 50% (n= 92,276) decedents had at least one record of palliative care in the last year 
of life and 84.9% received palliative care in acute hospitals. The authors acknowledge 
underreporting of palliative care is a limitation in all population-level administrative data but 
also that it represents one of the few methods to examine palliative care at the population level. 
Suggested reasons for under coding of palliative care in administrative data include a lack of 
awareness of palliative care billing codes so that regular visit codes are used instead. This is 
particularly true of nursing homes where patients are frail and approaching end-of-life but this 
care is seen as general health care and not coded accurately. Also the diversity of palliative 
care delivery models across multiple disciplines means the true extent of palliative and end-of-
life care delivery is difficult to define and capture using administrative data alone (Hsu & 
Tanuseputro, 2017). 
 
Palliative care is legally recognised as a right in  Belgium where a highly organised  palliative 
care system is underpinned by a legal framework (Keirse et al., 2009). Palliative care networks 
exist in all provinces in Belgium. Financial measures include the provision of a palliative care 
flat fee paid to the individual which covers additional costs for home care while procedures 
performed by general practitioners, nurses and physical therapists providing palliative care are 
also covered. Two types of palliative care facilities have been set up in hospitals. These include 
a small palliative care unit (providing approximately 400 beds for the whole country), and 
mobile teams who provide specific support to end-of-life patients who are hospitalised in other 
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departments. A similar palliative function has been created in nursing care facilities. The 
databases used by Maetens et al to investigate end-of-life care at the population level in 
Belgium  (Maetens et al., 2016)  included three  health insurance databases, cancer registry 
data, national census data, death certificate data as well as  national fiscal and education data.  
The authors stressed the need for adequate validation processes when using the data but noted 
services not covered by insurers are not included in the data; for example, there is no individual 
reimbursement for mobile hospital palliative care teams.  
 
 
Taiwan has a universal health care system that ensures patients have free access to any health 
care system and provider they choose. Health care systems are reimbursed for services 
provided, and co-payment is waived for patients with recognized major diseases, including 
malignancy.  By linking data from National Register of Deaths Database, Cancer Registration 
 System database, and National Health Insurance claims database, population based data are 
available for study. Inpatient palliative care qualifies for reimbursement and enrolment in 
hospice services has been used as a marker for palliative care receipt (Chang et al., 2016; 
Chiang et al., 2017; Wang et al., 2016). Claims data are validated by the  Bureau of National 
Health Insurance by randomly interviewing and reviewing the charts of one claimant for every 
100 ambulatory care claims and one for every 20 inpatient claims. A number of studies using 
these administrative data have been included in the review by  Luta et al (Tang et al., 2009) 
and Langton et al (Tang et al., 2010, 2010, 2011).  Recent  studies using this population level 
data  investigate  the differences between inpatient palliative care and acute hospital care for 
inpatients with pancreatic cancer(Wang et al., 2016), examining the readmission rates and  
experiences of patients who have received in-patient palliative care (Chang et al., 2016) and an 
examination of the effect of hospice care on quality of end-of-life care for patients with 
advanced cancer in Taiwan between 2002 and 2011 (Chiang et al., 2017). 
 
 Hospital based palliative care  
Several studies from Australia used a consultation or care with the hospital based palliative 
care services from hospital episode data to identify receipt of specialist palliative care, 
(Sundararajan et al., 2014; Philip et al., 2015; Rosenwax et al., 2016). In Victoria Australia, 
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Sundararajan et al   used linked hospital, emergency department and death data to examine the 
association between symptom burden and palliative care receipt (i.e.  referral to a palliative 
care program or a palliative care consultation) from first hospitalisation until death in 
glioblastoma patients  (Sundararajan et al., 2014). The datasets were linked by the Victoria 
Department of Health and data quality was checked by a series of internal logic checks and 
manual review of randomly selected case groups. Patients with high symptom burden were 
more likely to receive palliative care and those who did were less likely to die in hospital. In  
related work, Philip et al investigated the timing of palliative care for metastatic small cell lung 
cancer patients (Philip et al., 2015) and found  patients had late engagement with palliative 
care.  In both studies palliative care was defined as consultation or care with the hospital based 
palliative care service and used the 8th edition of the  Australian Classification of Health 
Intervention Codes (Australian Classification of Health Interventions (ACHI) 8th Edition, 
2016).  
 
Rosenwax et al used de-identified and linked extraction of death records, hospital morbidity 
records and community-based care to examine who had access to specialist palliative care in 
hospital or the community in Western Australia (WA) in the last year of life ((Rosenwax et al., 
2016)). Specialist palliative care was defined as receiving specific community-based or 
hospital-based palliative care. Community-based care data was defined as care provided by a 
single not-for-profit organisation that provides over 90% of all in-home health care and 100% 
of in-home palliative care in WA. Hospital-based palliative care in WA is classified as care in 
a hospital palliative care unit, in a designated palliative care program or under the principal 
clinical management of a palliative care physician, or when the clinical intent of care is 
palliation. Hospital-based palliative care was identified from hospital morbidity records where 
the episode of care was coded as palliative. In WA, the care type of an episode of care is 
determined by the medical practitioner responsible for the management of the patient care 
(Department of Health, Government of Western Australia, 2018). Currently there are 10 care 
types one of which is palliative care.  
 
 Death in an in hospice setting 
Death in a hospice setting  has also been used as a marker for receipt of palliative care 




 Characteristics of those who receive palliative care 
The 2017 population based study of PEoLC in Ontario decedents  across all healthcare setting 
by Tanusupetro et al found being female, middle-aged, living in wealthier and urban 
neighbourhoods, having cancer, and less multi-morbidity were all associated with higher odds 
of palliative care (Tanuseputro et al., 2017). Most palliative care (84.9%) was delivered in acute 
care hospitals and half of all palliative care was initiated in the last two months of life. A second 
study using the same data sources examined access to palliative care by disease trajectory. 
Three trajectories based on cause of death were considered i) terminal illness typical of cancer 
(high function with acute decline), ii) organ failure typical of heart and lung disease (high-
medium function with acute intermitted exacerbations and partial recovery) iii) frailty typical 
of dementia (low function and gradual decline). Terminal illness decedents were more likely 
to receive any palliative care in the 12 months before death than organ failure or frailty 
decedents. Across all settings, 88% of those with terminal illness received palliative care and 
terminal illness decedents (76%) were twice as likely to receive palliative care, as hospital 
inpatients, than the other trajectories (Seow et al., 2018).  
 
The 2016 Rosenwax study investigating receipt of  palliative care in hospital or the community  
in the last year of life in Western Australia identified n = 12817 deaths in 2009 and 2010  from 
cancer, heart failure, renal failure, liver failure, chronic obstructive pulmonary disease, 
Alzheimer’s disease, motor neurone disease, Parkinson’s disease, Huntington’s disease and/or 
HIV/AIDS. (Rosenwax et al., 2016).  The majority (69 %; n = 4928) of decedents with cancer 
accessed palliative care during the last year of life, while only 14 % (n = 729) of decedents with 
non-cancer conditions accessed specialist palliative care.  
 
A detailed examination of inpatient hospice deaths in England using death certificate data 
showed just over 5% of all adult hospice decedents between 1993 and 2012 had a non-cancer 
diagnosis although the likelihood of non-cancer conditions increased over the time period. The 
study also found inpatient hospice death was more likely among decedents living in less 




Coupland et al used cancer registry data linked to death certificate data to examine  ethnic 
variation in place of death (Coupland et al., 2011). The study population included all lung, 
colorectal, breast and prostate cancer patient from South East England who died between 1998 
and 2006. Only patients dying in a hospice could be identified as having received specialist 
palliative care and Asian patients were significantly less likely than White patients to die in a 
hospice.   
 
Using the data infrastructure described previously (Maetens et al., 2016), De Schreye et al 
conducted a population-level retrospective observational study of all cancer decedents in 
Belgium in 2012 (n =26 400) to assess end-of-life care and risk factors for exposure to care (De 
Schreye et al., 2017).  Almost half (47%) of the decedents received specialist palliative care 
(defined as admission to a hospital palliative care unit or receiving multidisciplinary home 
care) while 17% had palliative care initiated in the last fourteen days of life. 
 
These studies indicate cancer patients are more likely to receive palliative care than non-cancer 
patients and this  is partly  due to the predictability of patient decline and the history of hospice 
care for cancer patients  (Seow et al., 2018; Sleeman et al., 2016).   However the relationship 
between patient characteristics and receipt of palliative care are complex.  The disease type and 
associated trajectory often determines the place of care, for example dementia patients are 
normally cared for in a long-term care setting.  Place of care can determine the availability of 
PEoLC which in turn relies on the healthcare model (structure, organisation, funding) and 
healthcare policy. By definition, place of death is the final place of care and has been widely 
used as an indicator of how palliative care is organized and provided. Section 1.5 examines the 
factors affecting place of death. 
 
 Factors affecting place of death 
 
In a literature review of 58 studies of  terminally ill cancer patients, Gomes et al found that the 
network of factors related to where patients die was complicated (Gomes & Higginson, 2006).  
Three groups of factors were found to be important: those related to the individual, the illness 
and the environment. Individual-related factors included sociodemographic characteristics 
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(education, social class and income) and patient’s preference for place of death. In terms of 
illness there was consistently strong evidence that patients with non-solid tumours were more 
likely to die in hospital, while those with a long illness trajectory and low functional status 
were more likely to die at home. The authors suggest the long illness trajectory might facilitate 
patient preference for a home death. Environment-related factors included healthcare input 
(e.g. home care, hospital and hospice bed availability, and hospital admissions), social support 
(e.g. a patient’s living arrangements and social support network) as well as macrosocial factors 
(historical trends, health care policy, and cultural factors). Factors related to the environment 
(healthcare input and social support) were considered the most important.   
 
Costa et al examined the evidence base to assess which factors  are associated with place of 
death (Costa, 2014). The study examined two systematic reviews including the Gomes review 
and 29 observational studies from Canada, Asia, Europe, the United States, Mexico and New 
Zealand. Study participants were adults diagnosed with an advanced, life-limiting condition 
who were not expected to improve.  Outcomes of interest included home death, hospital deaths, 
nursing home deaths, inpatient palliative care unit deaths and inpatient hospice deaths. 
Determinants of place of death included type of disease, hospital admission, functional status, 
pain, palliative care in place of residence, availability of beds, patient or family preference for 
place of death, marital status or living arrangements and characteristics of the caregiver. The 
study found the determinants varied depending on the place of death and the type of disease 
with cancer patients more likely to die at home.  The availability of palliative care at any 
location improved the chances of dying at that location, but earlier referral (one month or more 
before death) reduced the likelihood of hospital deaths.   
 
 
  Individual level factors affecting place of death 
A study of all cancer deaths in England from 1993-2010  found hospital the most common 
place of death throughout the study period (Gao et al., 2013). Patients with haematological 
cancers, not partnered and aged over 75 years were less likely to die at home or in hospice. 
Cancer type and marital status were most strongly associated with place of death. Patients from 
less deprived areas were more likely to die at home or in a hospice relative to those from more 
deprived areas. The study did not provide information on patient preference for place of death. 
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A study based on death certificate data of 20 710 cancer deaths in 2012 in Sweden found 
hospital the most common place of death for cancer patients where 50.9% of deaths occurred 
(Öhlén et al., 2017). Death at home was most common for upper gastrointestinal cancer (25.6% 
died at home) and least common for haematological cancers (15.2% died at home).  Individuals 
living at home or in nursing homes who were married were less likely to die in hospital.  
 
 
 Palliative care and place of death 
The evidence base for the effect of palliative care on subsequent place of death from 
administrative health data is limited. In a systematic review, Costa et al found the availability 
of palliative care at any location improved the chances of dying at that location, but earlier 
referral reduced the likelihood of hospital deaths (Costa, 2014).  Patient preference for home 
death and advance care directives for nursing homes were important factors for death at those 
locations, suggesting access to palliative care allowed for patient and/or family preferences to 
be taken into account.   A cancer diagnosis and a longer time between referral to palliative care 
and death increased the likelihood of inpatient hospice death.  
 
 Using data from a London-based electronic palliative care register, Orlovic et al examined 
determinants of dying in hospital in a retrospective observational cohort study  of 21,231 
individuals aged 18 or older who had died between March 2011 and July 2019 with  a recorded 
place of death (Orlovic et al., 2020).   Electronic palliative care registers are designed to record 
and share with relevant care providers a patient’s preferences around place of death and 
resuscitation.  Frail individuals and those with long-term diseases such as cancer had a higher 
likelihood of dying out of hospital relative to those with heart or respiratory disease, however 
documented end of life preference was most strongly associated with subsequent place of 
death. The likelihood of dying in hospital was higher in patients who did not have a documented 
preference for the place of death (OR = 1.43, 95% CI 1.26–1.62, p<0.001). Individuals who 
were “not for resuscitation” had a 57% lower chance of dying in hospital while those with a 
documented preference for symptomatic treatment were 64% less likely to die in hospital 





Chen et al  report that specialist palliative care may modify  the effect of socioeconomic status 
(SES) on place of death in a narrative synthesis of nine observational studies from Spain, 
United States, Japan, Canada and New Zealand  (Chen H., et al., 2016). Two of the seven 
studies found statistically significant differences in place of death by SES. The first study used 
retrospective administrative data from a hospice in New Zealand for 1268 patients of whom 
82% had cancer, 72% were aged 65 years and older and 82% were European. All received 
home, outpatient and/or inpatient palliative care. Having a community service card was used 
as a crude marker of lower SES and was associated with increased odds of death in an acute 
hospital rather than at home. The second study used an administrative dataset from a hospice 
provider that operated 26 hospice programmes in eight states in the United States. Of 61,063 
patients, 64.2% had cancer, 70.2% were White and 77.7% were aged 65 years and over. SES 
was categorised based on income. Patients received either standard home based specialist 
palliative care or more intensive needs based palliative care. The study showed the odds of 
non-home death increased as median annual household income decreased in those receiving 
standard care  but no significant difference across income levels for those receiving more 
intensive needs based care.  
 
 Regional variation in place of death 
The 2018  atlas of variation for palliative and end of life care in England (Public Health 
England, 2018) reported regional variation for all 29 indicators of palliative care need. The 
indicators cover three domains  i) the need for palliative and end of life care with 10 indicators, 
ii)  the role of hospitals in palliative and end of life care with 7 indicators, and iii) palliative 
and end of life care in the community setting with 11 indicators. Cancer care indicators included 
variation in the proportion of all people who died in 2015 with an underlying cause of cancer 
(need for palliative and end of life care domain), and variation in the proportion of all people 
that died in a hospice in 2015 with a recorded cause of death as cancer (palliative and end of 
life care in the community domain). The indicators for end-of-life-care in hospitals include 
deaths in a hospital, hospital admissions in last 90 days, 3 or more emergency admissions in 
last 90 days, admissions ending in death that lasted 8 days or longer, recognition of dying, 
communication about dying, holistic needs assessment and provision of face-to-face specialist 
palliative care. For every indicator there was geographical variation across England. The only 
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direct measure of specialist palliative i.e. provision of face-to-face specialist palliative care  
was derived from Royal College of Physicians (RCP) ‘End of life care audit – dying in hospital’ 
(Royal College of Physicians, 2016).   Palliative care in the community indicators were derived 
mostly by analysis of place of death (care homes and hospice), general practitioner disease 
registers and examination of service levels e.g. number of care home beds in the community.  
 
A study of all adult deaths (aged 25 years and over)  in England in 2014 (Gao et al., 2019) 
found  health service type (adult inpatient hospice, hospitals, general practitioner and care 
homes)  and capacity (ratio of service facilities to user population, counts of services types 
within functional areas,) were the strongest predictors of the area-level variation in place of 
death.  Service location, that is the distance from the residential address of the deceased to the 
nearest care facility, showed consistent effects on place of death. Overall, the increased 
distance to a specific  institutional care setting was associated with a reduced chance of dying 
in that care setting,  particularly for care home and hospice deaths. Data were derived from a 
variety of sources that included NHS England, Hospice UK, Hospice Aid UK website and the 
Care Quality Commission website.   The study identified large gaps in data, for example there 
was no master list of hospices in England nor a central facility to collect national data on 
hospice capacity. The study highlighted the need to develop systems to collect robust national 
data on palliative and end-of-life care services to enable evidence-based service commission, 
planning, design and delivery. 
 
 
In  Sweden Öhlén et al reported large variations in the place of death between the different 
healthcare regions in the country (Öhlén et al., 2017). The authors suggest the cross-regional 
variation may be due to differences in healthcare organisation leading to variation in the 





  Healthcare organisation, policy and place of death 
Cohen et al compared the place of death of people with cancer (ICD-10 codes C00-C97) using 
2008 death certificate data  from 14 countries: Belgium, Canada (excluding Quebec), Czech 
Republic, England, Wales, France, Hungary, Italy, Mexico, the Netherlands, New Zealand, 
South Korea, Andalusia in Spain (data from  2010) and USA (data from  2007), (Cohen et al., 
2015). The study reported between 12% (South Korea) and 57% (Mexico) of cancer deaths 
occurred at home, and between 26% (the Netherlands and New Zealand) and 87% (South 
Korea) of cancer deaths occurred in hospital. Cancer type (solid tumour) and being married 
were most consistently associated with home deaths across countries. The authors noted large 
country specific variations may be due in part to differences in health care resources, how the 
health care system is organised as well as cultural and social differences including health care 
policy specific to end-of-life care. Using the same data, a  related 2016 study by Pivodic et al  
found  for a number of diseases  indicative of the need for palliative care, between 13% 
(Canada) and 53% (Mexico) of people died at home and between 25% (the Netherlands) and 
85% (South Korea) died in hospital (Pivodic et al., 2016). Differences between countries in 
home versus hospital death were only partly explained by the factors examined so that place of 
death was not entirely attributable to sociodemographic characteristics, cause of death or 
availability of healthcare resources. The authors suggested a country’s palliative and end-of-
life care policies may influence where people die.   
 
  Prognostication of patient outcomes 
 
Using administrative health data for prognostication of patient outcomes is well established 
with the development of the Charlson index of comorbidity (Charlson et al., 1987) and the 
Elixhauser index (Elixhauser et al., 1998). The comorbidities included in the Charlson index 
had been defined based on clinical data but have been translated into ICD codes used by 
administrative data such as hospital episode data (Quan et al., 2011). The Charlson index was 
designed to predict one-year mortality while  Elixhauser was designed  to predict  length of 
stay, hospital charges, and in-hospital death (Sharabiani et al., 2012).  Hsu et al used 
administrative health home care data from Ontario Canada to develop a mortality risk algorithm 
to predict survival time for community-dwelling older adults who may be nearing the end of 
life  (Hsu et al., 2016).   
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The use of machine learning (ML) to improve palliative and end of life care using health 
administrative data is an area of growing interest. In a rapid review of published studies that 
use ML to improve palliative care, three studies were  included in the final assessment (Storick 
et al., 2019).  The data sources of the three studies included were US Medicare data (two 
studies) and data from electronic health records (EHR) from a six–hospital network in 
Minnesota. Outcomes of interest were survival, quality of life, place of death, costs, and receipt 
of high-intensity treatment near end of life.  Depending on the data source, predictors included 
demographic data, ICD codes, chronic conditions, functional status, vital signs, blood count, 
and metabolic panel data.  The review found ML approaches are powerful in predicting 12 
month mortality in older and/or hospitalised adults and superior to traditional logistic 
regression but only when sufficient data (particularly physiological and biochemical data) are 
available.   
 
 PEoLC research in Ireland using administrative health data 
 
Two  systematic reviews of PEoLC research on the island of Ireland have also been carried out   
(McIlfatrick S. et al., 2018; McIlfatrick S. & Murphy, 2013).  
 
The 2013 review identified 151 studies from 2002 to 2012 of which 66 were quantitative, 58 
were qualitative, 27 used mixed methods and 6 were systematic reviews. Of the quantitative 
studies, only two were population based. These  were from the National Cancer Registry 
Ireland and examined  trends in place of death for colorectal cancer ( n= 10175 deaths, 1994-
2004)  (Céilleachair et al., 2010)  and lung cancer (n= 18078 deaths, 1995-2005) (Sharp et al., 
2010)   using cancer registry data linked to national death certificate  data (hospital episode 
data were not used). In both cases, the number of deaths in hospital was unchanged over the 
study period (49% of colorectal deaths and 52.5% of lung deaths). For colorectal cancer 
decedents, hospice deaths rose between 1994 and 2003 while home deaths decreased but only 
in regions with inpatient hospice services. For lung cancer decedents hospital deaths were more 
common in areas without a hospice. A third quantitative study was a retrospective case review 
of n= 695 adult patients with cancer which examined reasons for death in acute hospitals in 
Northern Ireland. The study participants who died  between July and December 2007  in  16 
acute hospitals were  identified  through the Northern Irish Cancer Registry (Blaney et al., 
2011). Three main reasons for acute hospital deaths were identified:  i)  over one quarter of 
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patients were diagnosed with cancer during their last hospital admission and were found to be 
older and sicker than the rest of the sample, and without a partner, ii) patients were very ill with 
over three quarters admitted as an emergency, requiring medical attention as a result of cancer-
related and urgent physical symptom and iii) despite over one third of patients specifically 
requesting discharge to their usual residence, hospice or other hospital, this was not achieved. 
This led the authors to conclude that late diagnosis of cancer is a problem which requires further 
research.  
 
The follow-up systematic review covered the period from May 2012 to April 2017 and 
identified 117 studies  representing a 100% increase in palliative care research on the island of 
Ireland compared to the ten year period up to 2012 (McIlfatrick S. et al., 2018). The dominant 
research theme was a focus on specific groups, services, and settings.  The most common 
conditions included cancer (12 studies), dementia (12 studies) and Parkinson’s disease (6 
studies).  Hospice care was the theme for five studies and five studies focused on coordinating 
care across services. Research gaps around community based palliative care and out of hours’ 
palliative care were identified.   
 
Only three studies included in the review used administrative health data. The first (Kane et 
al., 2015) used death certificate data from the Central Statistics Office for the period 2007 – 
2011 (n = 141 807 deaths) to estimate the potential population with generalist and/or specialist 
palliative care needs in Ireland  using the methodology described  by Murtagh et al (Murtagh 
et al., 2014).  Over the study period, 82% of deaths from diseases identified as having a 
palliative care need were in decedents aged 65 years and over thus indicating an increased need 
for palliative care in Ireland given the rapidly aging population. As only the underlying cause 
of death was available from the dataset, a minimal estimate of need for palliative care was 
produced. 
 
 The second study was a  national audit  of End-of-Life Care in Hospitals in Ireland  carried 
out in 2008/9 (McKeown et al., 2015).  It was based on a sample of 1,000 deaths with data 
collected from nurses, doctors and relatives who spent the most time with the patient during 
the last week of life. The audit is a representative sample of 10% of acute hospital deaths and 
29% of community hospital deaths in Ireland in 2008/9. The study showed significant 
32 
 
differences in how care outcomes, including pain, were assessed by nurses, doctors and 
relatives. This audit informed the development of a set of  Quality Standards for End-of-Life 
Care (Donovan, 2010)  in Irish hospitals by the Hospice Friendly Hospitals  programme which 
was initiated by the Irish Hospice Foundation  in May 2007.  
 
The third study  used individual-level patient records from the National Cancer Registry Ireland 
(NCRI) linked to prescription dispensing records from the HSE Primary Care Reimbursement 
Services (PCRS) pharmacy claims database  to describe the changes in statin initiation and 
continuation prior to death in patients with breast or colorectal cancer in the five years prior to 
death (Smith et al., 2017).  In patients with reduced life expectancy, there may be a substantial 
increase in pharmacotherapeutic burden. Statin use in these patients may be limited and should 
be considered for discontinuation. The study population were patients diagnosed with stages 
I–III, invasive breast (ICD-10 C50) or colorectal cancer (ICD-10 C18-C20), between 1 January 
2001 and 31 December 2009 who had   continuous eligibility for a means tested medical card 
starting at least 1 year prior to diagnosis. It was concluded that a significant proportion of 
patients will cease statin treatment in the months prior to a colorectal or breast cancer death. 
However, the number of patients initiating statin use did not differ between those who died of 
their cancer and those who did not.  
 
 
The Irish Longitudinal Study on Ageing (TILDA) is a prospective nationally representative 
study of community dwelling adults, aged 50 years and over resident in the Republic of Ireland. 
(Kenny et al., 2010). The first wave of data collection surveyed a nationally representative 
sample of over 8500 people beginning in  October  2009 with  a further four  waves of data 
collection in 2012, 2014, 2016 and 2018.  Using TILDA data,  May et al completed 375 end-
of-life interviews with family members of TILDA participants who died  between Wave 1 
(2009) and Wave 3 (2014) (May et al., 2017)  Nearly half (46%) of all decedents died in 
hospital, 27% at home, 11% in hospice and 10% in a nursing home. The study found 
characteristics other than illness burden, such as domestic living situation, may drive healthcare 




May et al used cause of death from death certificate data and Irish population census projections 
(2016-2046) to estimate numbers of people dying from a disease with a palliative care need in 
Ireland to 2046. Further analysis combined these data with TILDA data to estimate to the year 
2046 the numbers of people aged 50 years and over living and dying with diseases with a 
palliative care need.  This analysis was used to estimate disability burden, pain prevalence and 
health care utilisation among people aged 50 years and over living and dying with diseases 
with a palliative care need. The authors report that prevalence of palliative care need will almost 
double over the next 30 years as the population ages. An 84% increase in people dying  from 
a disease  with a palliative care need  and an  89% increase in those aged 50 years and over, 
not in the last year of life with a relevant diagnosis,  are predicted by 2046  (May et al., 2020). 
 
In a further study Ward et al  linked death registration data with individual level records of 
TILDA decedents matching on name, address and month  and year of birth (Ward et al., 2020).  
Over nine years of follow-up, 779 (9.1%) TILDA participants died (37% from cancer, 32.9% 
from diseases of the circulatory system, 14.4% from diseases of the respiratory system with the 
remaining 15.8% were attributed to all other causes).  Mortality rates were higher among less 
educated participants, manual occupation social class groups, and those with lower average 
annual household incomes. The authors emphasise the potential of   linked data to contribute 
to an understanding of the social, behavioural, economic, and health antecedents to mortality 




Internationally identifying the need for palliative care at the population level relies primarily 
on the ICD codes recorded on death certificates for diseases requiring palliative care, adjusted 
by estimated symptom  prevalence for each disease category(Connor et al., 2014; Murtagh et 
al., 2014). Diseases recognised as having a palliative care need  include malignant neoplasm, 
heart disease including cerebrovascular disease, renal disease, liver disease, respiratory disease, 
neurodegenerative disease  that include Alzheimer’s, dementia and senility and 




Identifying the need for palliative care at the individual level relies on deriving indicators of 
quality and intensity of  care received  at end of life from a variety of administrative health data  
using methods first described by Earle et al  in 2003 (Earle et al., 2003). This methodology has 
been used extensively to investigate end of life care. The populations studied, the measures 
used and the end-of-life timeframes vary  widely depending on the specific study objectives 
and data sources available (Langton et al., 2014; Luta et al., 2015). There is an absence of 
evidence regarding the palliative care needs of older patients and/or those presenting to 
emergency departments (Wong et al., 2014) although  older age (Brewster et al., 2011) and 
emergency presentation (McPhail et al., 2013) have been shown to be  predictive of  short-term 
mortality in cancer patients. Although several studies investigating the quality and intensity of 
care received at end of life in cancer patients had access to cancer registry data, none reported  
or characterised end-of-life  care by survival time (Langton et al., 2014; Luta et al., 2015). 
 
The structure and organisation of a healthcare system determines what administrative health 
data are collected. Jurisdictions  with mandatory universal health insurance including Belgium  
(Maetens et al., 2016) and Ontario (Tanuseputro, 2017; Tanuseputro et al., 2017)  are best 
placed to identify receipt of  palliative care  at the population level across healthcare settings. 
Elsewhere receipt of palliative care has been identified from hospital episode data   (Philip et 
al., 2015; Rosenwax et al., 2016; Sundararajan et al., 2014) or by a palliative care service 
provider e.g. inpatient hospice  (Coupland et al., 2011; Sleeman et al., 2016).  Cancer patients 
are more likely to receive palliative care than non-cancer patients in Ontario (Seow et al., 2018; 
Tanuseputro et al., 2017), in Western Australia (Rosenwax et al., 2016) and in  England 
(Sleeman et al., 2016). As well as having cancer,  Tanusupetro reported  being female, middle-
aged, living in wealthier and urban neighbourhoods  and having  less multi-morbidity were all 
associated with higher odds of palliative care in Ontario (Tanuseputro et al., 2017) while 
Sleeman found inpatient hospice death was more likely among decedents living in less deprived 
areas (Sleeman et al., 2016). Using death in hospice  as a marker for palliative care receipt, 
Coupland et al  found some evidence of ethnic variation in dying in a hospice (Coupland et al., 
2011).  The relationship between patient characteristics and receipt of palliative care are 
complex.  The disease type and associated trajectory often determines the place of care (for 
example dementia patients are normally cared for in a long-term care setting).  Place of care 
can determine the availability of PEoLC which in turn relies on the healthcare model (structure, 




 By definition, place of death is the final place of care and has been widely used as an indicator 
of how palliative care is organized and provided. Hospital is the most common place of death 
for cancer patients in England (Gao et al., 2013) and Sweden (Öhlén et al., 2017).  In Ireland 
46% of all deaths in those aged 50 years and over were in hospital (May et al., 2017), and 
specifically  49% of colorectal deaths between  1994-2004 (Céilleachair et al., 2010) and 52.5% 
of lung deaths between 1995-2005 (Sharp et al., 2010)  occurred in hospital. Individual level 
factors that affect place of death in cancer patients include cancer subgroup (solid tumour v 
haematological cancer), marital status, age and deprivation. The availability of palliative care 
at any location improved the chances of dying at that location, and earlier referral reduced the 
likelihood of hospital deaths (Costa, 2014). Orlovic et al showed a documented end of life 
preference is strongly  associated with subsequent place of death (Orlovic et al., 2020). 
Regional  differences in service provision  (Gao et al., 2014; Öhlén et al., 2017) as well as 
national differences in   health care resources, health care system  organisation,  cultural and 
social differences that include health care policy specific to end-of-life care are also important  
(Cohen et al., 2015; Pivodic et al., 2016).  
 
  
 The gap in an Irish context 
Increasingly Irish health administrative data are being used to investigate PEoLC.  While 
population level estimates on the need for palliative care have been examined in detail (Kane 
et al., 2015; May et al., 2020), information on  the need for palliative care need at the individual 
level is lacking. Internationally, patients with cancer are more likely to receive palliative care 
than those diagnosed with  non-cancer diseases  (Seow et al., 2018; Hsu & Tanuseputro, 2017; 
Rosenwax et al., 2016; Sleeman et al., 2016) but there is dearth of studies that examine end of 
life care in cancer patients who die shortly after diagnosis.  All registered cancers in Ireland  
record a  date of incidence so that   in conjunction with death certificate data  the survival times 
for  subgroups of cancer patients can be determined (e.g. lung, prostate, colorectal and breast). 
Differences, if any, in the characteristics of patients who die shortly after diagnosis can be 





Identifying receipt of palliative care from administrative health data relies to a large extent on 
the data sources available. Prior to 2005 approximately half of all lung and colorectal cancer 
deaths occurred in hospital (Ó Céilleachair et al., 2011; Sharp et al., 2010) while  more recent 
data (May et al., 2017) suggest the proportion of hospital deaths has not decreased  in those 
aged 50 years and older. Hospital episode data linked to cancer registry and death certificate 
data presents an opportunity to determine whether the delivery of specialist palliative care to 
cancer patients in acute hospitals in Ireland can be identified.  This would allow differences in 
the characteristics of those receiving specialist palliative care with those who don’t to be 
examined in more detail including subsequent place of death. The role of structural factors that 
affect place of death  (for example the availability and capacity of inpatient hospice (Gao et al., 
2019)) could be examined in an Irish context for the first time. 
 
 
To realise the potential of administrative health data for PEoLC research in Ireland, a thorough 
knowledge of how health care is organised, funded and delivered is necessary so that the most 
relevant sources of health administrative data for PEoLC research can be identified. The merits 
of each dataset in terms of the population it represents, the data available and equally important 
what is missing is required. By identifying and documenting the potential and challenges of 
administrative data for PEoLC research in cancer patients the knowledge gained can be 
extrapolated to other non-cancer health and social care data collections. 
 
Chapter 3 presents the methods used to explore these gaps in the literature and address the aims 
of this thesis.  
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Chapter 3: Methods 
 
In this chapter I lay out the materials and methods of my thesis.  Section 3.1 summarises the 
Irish health context in which this research took place. This includes a description of the current 
public health service in Ireland and a brief overview of how that system evolved. This is 
followed by a description of the milestones in the development of palliative care services in 
Ireland.  Section 3.2 briefly describes each of the three datasets used in the thesis studies 
followed by a description of the approval necessary to use the data (section 3.3).  Section 3.4 
describes the theories underpinning data linkage and the methodology used to link the data.  
The remainder of the chapter describes the studies undertaken using the linked health, in total 
three studies are described.  The first aims to identify indicators for early assessment for 
palliative care in lung cancer patients, (section 3.5). The second study explored differences 
between cancer patients who did and did not receive specialist palliative care in acute hospitals, 
(section 3.6).  For each, a detailed description of the study design and participants, data 
definitions, outcome measure and statistical methods are given. The third study (section 3.7) 
examines the potential of currently available administrative health and social care data for 
PEoLC research in Ireland. It describes how the organisation of the health care system affects 
what data are available and the implications when using administrative health and social care 
data for PEoLC research, particularly in the context of ongoing health service reforms and 
recent changes to data privacy laws. 
 
 The Irish Health Service  
 
As described previously, Ireland has a mixed public private health care system where publically 
funded health care is managed by the HSE and funded through the tax system. Those on lower 
incomes (means tested) are entitled to medical cards which permits free public health services 
under the General Medical Scheme (GMS). Individuals without medical cards are entitled to 
subsidized public hospital services and prescription medicines, but pay the full cost of GP and 
other primary care services (Connolly & Wren, 2019). Those not eligible for a medical card 
may be entitled to a GP visit card, which is also means tested but with a higher income 
threshold. A GP visit card exempts the holder from GP charges; currently the card is available 
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to everyone aged over 70 and under 6 without an income test. GPs are not directly employed 
by the government.  
 
There are three type of hospitals in Ireland  i) public hospitals which are owned and funded by 
the HSE, ii) voluntary public hospitals,  most of whose income comes  from the State and iii) 
private hospitals that receive no state funding.  Voluntary public hospitals are sometimes 
owned by private bodies, for example, religious orders or are incorporated by charter or statute 
and run by boards often appointed by the Minister for Health. Most of these hospitals also 
provide private medical services but they must be able to distinguish between public and 
private care. On admittance to a public (or voluntary) hospital, patients choose to be treated by 
their consultant on a public or private basis. Private hospitals operate independently of the State 
health services and the cost of care must be paid either directly or through private health 
insurance (Citizensinformation.ie, 2018). In 2017, 33% of the population had a medical card 
and 10% had a GP visit card while approximately 43% of the population  are covered by private 
health insurance  (Department of Health, 2018).  
 
 
3.1.1. History of the Public Health Service 
Health service reform started in 2005 with the beginning of several reorganisations and 
configurations of the Irish health service. The HSE replaced  eight health boards that had 
existed for more than 30 years previously (Department of Health and Children, 2001a; 
Department of Health and Children (DOHC) et al., 2003). This coincided with the 2004 
National Health Information Strategy (Department of Health and Children (DOHC), 2004) 
which  instigated a coordinated health information strategy that included  the establishment of 
Health Information and Quality Authority (HIQA).  
 
HIQA is an independent body that evaluates the quality of the information available on health 
and social care and makes  recommendations to improve quality, minimise inconsistencies and 
fill gaps where data are not available (Health Information and Quality Authority, 2013, 2017a). 
HIQA advocates eight guiding principles for organisations collecting data that include 
formalised governance arrangements, facilitating appropriate access to the data to optimise its 
benefits, continuous monitoring/improvements of data quality and effective information 
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governance procedures.  Standards for data quality include the use of data dictionaries, 
classification systems and clinical terminologies (Health Information and Quality Authority, 
2013).  HIQA produces a catalogue of national health and social care data collections using a 
standardised template to describe existing data collections (Health Information and Quality 
Authority, 2017b). National health and social care data collections are defined as  national 
repositories of routinely collected health and social care data, including administrative sources, 
censuses, surveys and national patient registries in the Republic of Ireland (Health Information 
and Quality Authority, 2017b).   
 
 
The National Cancer Control Programme (NCCP) was established in 2007 and is responsible 
for overseeing national services for treatment of cancer(Health Service Executive, 2018c). An 
early priority was the establishment of designated cancer centres for surgery, so that nearly all 
cancer surgery currently takes place in these centres. The NCCP ensures designated centres for 
individual tumour types have adequate case volume, expertise and concentration of specialist 
skills.  
 
In  2015,  voluntary hospitals and HSE public acute hospitals were reorganised into seven  
hospital groups  (Hospital Groups - List and Contact Details, 2018). The hospital groups 
coordinate services between the different hospitals within the group and are linked with 
academic institutions. In addition,  nine  geographically distinct  community health 
organisations (CHO’s) were established (Health Service Executive, 2018b). The purpose of the 
CHO is to facilitate integrated care within community services, between the community and 
hospital services and with wider public service organisations e.g. local authorities, Child & 
Family Agency, education and local voluntary organisations.  Each CHO serves   a population 
of approximately 450,000-500,000 people. 
 
3.1.2. Palliative care delivery in Ireland 
The National Advisory Committee on Palliative Care (NACPC) was established in 1999 to 
report on palliative care services in Ireland. The report published in 2001 found there was 
limited information available on palliative care services in Ireland but that wide variation in 
the type, level and funding of services was apparent in each health board (Department of Health 
and Children, 2001b). It was noted demand for palliative care services would increase given 
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Ireland’s ageing population and a projected doubling of the population aged 65 years and over 
by 2031.  The report recommended there should be at least one specialist palliative care 
inpatient unit in each health board region, that all acute general hospitals should have a 
specialist palliative care service and that specialist palliative care services should be available 
to all people living in the community in all health board regions. Other recommendations 
included the need for increased education, training and research in specialist palliative care and 
a requirement to develop standards for all dimensions of service provision (structure, process 
and outcome of care) including a national minimum data set to standardise information on all 
patients using specialist palliative care services.  The importance of effective communication 
with patients and their families, within the hospital services, within community services as well 
as between hospital and community health care professionals was highlighted. An immediate 
recommendation was to conduct a needs assessment for specialist palliative care services in 
each health board region to include the views of major stakeholders, including service 
providers, service users and purchasers/planners. The NACPC report described the 
development of a comprehensive specialist palliative care service that was adopted as official 
policy by the Department of Health. 
 
Based on the  needs assessment reports produced by the individual health boards following the 
NACPC recommendation,  the  IHF  undertook a study of  service activity and staffing levels 
for palliative care in Ireland in  2004  (Irish hospice Foundation, 2006). The Baseline Study 
reported large regional differences in the development of palliative care services where in some 
areas, service development was on target to match the model outlined by the NACPC while in 
others the basic elements required for hospice/specialist palliative care services were not in 
place. Service organisation, staffing levels, palliative care team composition and funding 
models varied significantly by health board region so that in 2004 several health board regions 
required significant service planning and development to achieve the service levels outlined in 
the NACPC report. 
 
The National Clinical Programme for Palliative Care (NCPPC), established in 2010, marked 
the beginning of a nationally integrated approach to the management and organisation of 
palliative care services in Ireland. The NCPPC aims   to provide appropriate levels of palliative 
care to those in need, irrespective of the care setting or diagnosis (Health Service Executive, 
2018a). Current national NCPPC policy recommends a ratio of 8 to 10 specialist palliative care 
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beds per 100,000 population (National Clinical Programme for Palliative Care, 2019), 
however, in  2015, no CHO had the recommended ratio.  
 
Historically the development of palliative care services in Ireland was ad-hoc and largely 
driven by local demand. The Irish Hospice Foundation, established in 1986, along with  other 
voluntary and charitable bodies, played a significant role advocating for and developing local 
palliative care services and resources (O’ Morain, 2006). As of 2020, there are 10 adult in-
patient hospice units providing specialist palliative care in Ireland (Appendix B).The Irish 
Association for Palliative Care is an all-island body established in 1993 to promote palliative 
care through opportunities for networking, education, publications and representation on 
national bodies. It is a multidisciplinary membership organisation for those involved in the 
provision of palliative care in Ireland (Irish Association for Palliative Care, 2020) . The All 
Ireland Institute of Hospice & Palliative Care is a collaborative of hospices, health and social 
care organisations and universities on the island of Ireland. Its objective is to  promote  
education, research and  best practice to improve the palliative care experience of people with 
life limiting conditions and their families (Wescott, 2020) 
 
 The datasets 
 
3.2.1. Cancer registry data 
The NCRI is a publicly appointed body, established in 1991 by Statutory Instrument and funded 
primarily by the Department of Health1. It actively collects information on all cancer cases 
occurring in Ireland since 1994.  The registry identifies, collects, classifies, records, stores and 
analyses information relating to each newly diagnosed individual cancer patient and to each 
tumour that occurs. It also reports on the incidence and prevalence of cancer and related 
tumours in Ireland, facilitates the use of the data in approved research and in the planning and 
management of services.  
 
                                                 
1 For relevant legislation see S.I. No. 19/1991 The National Cancer Registry (Establishment) 
Order, 1991 S.I. No. 293/1996: The National Cancer Registry (Establishment) Order, 1991 




Most registrations are based on ‘active’ data collection whereby trained Cancer Data Registrars 
(CDRs), based in hospitals around the country, access a range of data sources to identify all 
new cancer cases and register all relevant patient, tumour and treatment details. Hospital 
pathology reports provided to the NCRI shortly after diagnosis comprise the bulk of the data 
on approximately 85% of all new cases. Approximately 50% of pathology reports are processed 
electronically and followed up by the CDRs. The other 50% are registered  manually by CDRs. 
Information on non-microscopically diagnosed cases is registered mainly from other hospital 
sources, principally the Hospital Inpatient Enquiry system  as well as records from radiology 
and oncology departments, medical charts, and hospital cancer databases. Most cases (≥ 95%) 
are initially registered in this way. Hospital systems and/or medical notes are accessed to 
provide information on clinical staging and treatment.  
 
The main non-hospital source of case information is death certificate data. The NCRI is 
provided with all death certificates from the Central Statistics Office (CSO). All cases initially 
notified by death certificate are followed up with the hospital of death or the certifying doctor 
and most cases are subsequently found in other data sources. These are registered as active 
cases. Between 2009 and 2016 less than 1% of cases remain classified as notified by death 
certificate only (DCO), in keeping with international norms. Follow up of patients is passive, 
where cancer cases are linked to death certificate information provided regularly by the Central 
Statistics Office and the General Registers Office. In 2018, the censor date (the date to which 
all patients are followed up) is 31st December 2016. Although case data from pathology reports 
is registered almost immediately after diagnosis, data from other sources can take longer to 
obtain. This, together with essential case checking and data quality assurance, means that the 
NCRI normally produces definitive statistics for case data a minimum of 2 to 3 years following 
the end of year of diagnosis.   
 
Incident cases are coded according to the third edition of the International Classification of 
Diseases for Oncology (ICD-O3) (Fritz, 2013). Before analysis, data is audited using 
international audit protocols from the International Association for Research on Cancer 
(IARC). Case data are recoded to the equivalent International Classification of Diseases version 
10  (World Health Organization, 2011) and results are presented according to the single or 




Completeness for 2010 incidence of all invasive cancers excluding NMSC was estimated at 
97.2% within five years of incidence. For the four cancers with the highest incidence, colorectal 
cancer, lung cancer, female breast cancer and prostate cancer, five-year completeness was 
estimated at 99.0%, 98.7%, 99.3% and 96.2% respectively (National Cancer Registry, 2020).  
For certain cancer sites, the NCRI can provide reliable figures within six months of year of 
incidence e.g.  99% of breast, 95% of colorectal and 94% of prostate cancers are usually 
microscopically verified and are therefore registered within a couple of months. However up 
to 20% of lung and 38% of pancreatic cancers are diagnosed clinically and it may take longer 
to register these cancers. While the number of cases for certain sites may be available at an 
early stage, complete information on treatments and staging are obtained from the medical 
records of the patients. This type of information will normally only be made available 2 to 3 
years after the year of incidence, in keeping with international norms.  The NCRI continuously 
assesses electronic data sources within hospitals such as cancer databases and radiotherapy 
databases as a data source for cancer registration.  
The address of each cancer patient at the time of diagnosis is recorded by the NCRI. The 
address is stored as house name, house number, four address lines and county code.  Currently 
eircodes , the Irish postcode system  launched in Ireland in 2017, are not routinely captured by 
the NCRI (Eircode, 2015). Each address captured by NCRI is geocoded and subsequently 
assigned to an electoral division (ED) and former health board region but not to a CHO. 
Electoral divisions  are the smallest legally defined administrative areas in the State (Central 
Statistics Office, 2019a). 
A data model, data dictionary and minimum dataset are currently being developed. Information 
on the data collected are available at (Data Fields We Collect | National Cancer Registry 
Ireland, 2020)  (Appendix C). 
 
 Hospital episode data 
The Hospital In-Patient Enquiry system (HIPE) was established in 1971.  It collects 
demographic, clinical and administrative data on discharges from, and deaths in, all acute 
public hospitals nationally. HIPE is the only source of morbidity statistics available nationally 
for acute hospital services in Ireland. The Healthcare Pricing Office (HPO) has overseen the 
administration and management of HIPE since January 1st, 2014. HPO is responsible for 
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overseeing all functions associated with the operation of HIPE including the development and 
support of the data collection and reporting software, training of coders and data quality audit, 
reporting, and responding to requests for information. 
 
The patient medical record chart is the primary source of HIPE data. In 2016, the 8th Edition 
of ICD10-AM/ACHI/ACS (Healthcare Pricing Office (HPO), 2016) was  used  to code  all 
discharges in Ireland. Trained clinical coders translate the medical terminology to the alpha-
numeric codes recorded in HIPE using strictly defined protocols. Additional documentation 
used for coding an episode of care includes nursing notes, consultation reports, progress notes, 
operative reports, pre- and post-operative reports and pathology reports. The entire chart is 
used to extract the conditions and procedures to capture all relevant details of the patient and 
their health care encounter.  Data items collected include 
• Medical Record Number 
• Dates of Admission and Discharge 
• Day case indicator 
• Admission Type: booked or emergency 
• Discharge Destination: home, transfer, self-discharge or death 
• Sex 
• Marital / Civil Status 
• Area of Residence (coded by city and county) 
• Diagnoses: Principal and up to 29 additional secondary diagnoses 
• Procedures: Principal and up to 19 additional secondary procedures 
HIPE began collecting Eircode data in January 2018 (Healthcare Pricing Office, Health Service 
Executive, 2018).   
 
All HIPE discharges with cancer diagnoses i.e. ICD codes C00-D49 in any of the diagnoses 
fields are provided electronically to a dedicated server at the NCRI four times each year 
(January, April, July and October) by prior arrangement. The data are routinely linked to NCRI 
data on average twice a year.  Allowing for delays, HIPE data for the preceding year are 




The diagnostic codes in HIPE include a code for palliative care. The Irish coding standards in 
use  for HIPE coding in 2016 recommended that the diagnostic code Z51.5 Encounter for 
Palliative Care  should be assigned  as an additional diagnosis code when the intent of care at 
admission is 'for palliation', or if at any time during the admission the intent of care becomes 
'for palliation', and the care provided to the patient meets the definition above (Healthcare 
Pricing Office (HPO), 2016) page 21. Further clarification stated the code Z51.5 Encounter for 
Palliative Care is to be coded when there is documentation that the patient has been seen by 
(or attended to) by the palliative care team as the phrase ‘for palliation’ may not be used.  HIPE 
also provides a discharge destination code that records 15 discharge destinations including 
discharge to hospice - not in the HIPE hospital listing. There were 53 public acute and 
voluntary hospitals participating in the HIPE scheme in 2016, and in 2016 just under 84% of 
discharges were public patients (Healthcare Pricing Office, 2017). Public/private status relates 
to whether the patient saw the consultant on a private or public basis. It does not relate to the 
type of bed occupied nor is it an indicator of possession of private health insurance.  There are 
22 private hospitals in Ireland and these do not contribute to HIPE. These are listed in Appendix 
D.  
 
 Death certificate data 
It is legally required that every death in Ireland is notified to the state within three months of 
death2. The Department of Social Protection, CSO  and  General Register Office (GRO) collect 
and record date of death information including 
- Date of death  
- Address of residence  (house name, house number, address lines 1-4, county)  
- Place of death (house name, house  number, address lines 1-4, county) 
- Cause of death  
- Occupation of deceased 
- Age of deceased  
- Sex of deceased  
- Marital Status of deceased 
The main cause of death is  coded by the CSO using International Classification of Diseases 
version 10 (World Health Organization, 2011) while the underlying cause of death is provided 
                                                 
2  See The Vital Statistics Act 1952 and  Section 73 of the Civil Registration Act 2004 
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as text. Death certificate data is received electronically using a file transfer protocol each 
quarter by request from the NCRI and matched to NCRI data. There is no data dictionary 
available for death certificate data.   
The death events publication services (DEPS) is a service that provides information on death 
events to public sector bodies. This information contains details on all deaths notified to the 
GRO.  DEPS was developed so that notification of all registered deaths could be made available 
automatically and electronically to all relevant public sector agencies, allowing subscribing 
agencies including the NCRI to identify those persons on their registers who are deceased. It 
is updated weekly and improves the timeliness of data acquisition. Deaths are published on a 
weekly basis in a comma separated values file available for download. 
 
 Study approval 
 
The NCRI has permission under the Health (Provision of Information) Act 1997 to collect and 
hold data on all persons diagnosed with cancer in Ireland without requiring individual consent. 
The use of that data for approved research is covered by the Statutory Instrument which 
established the Registry Board in 1991.  Written permission to use the data sources for this 
thesis was obtained from NCRI management in April 2015 (Appendix E). Further permission 
for the continued use of the data was granted by the NCRI Data Research Application 
Committee in December 2018, following enactment of the 2018 Data Protection Act, 
(Appendix E).  All datasets were de-identified prior to analysis 
 Data Linkage 
 
3.4.1. Overview 
Data recorded at the level of an individual (for example NCRI data) should not have duplicate 
records, that is every individual diagnosed with cancer should be recorded only once in the 
cancer registry database. Similarly unique events such as death should only be captured once 
so that each individual should have only one death certificate record. HIPE records hospital 
episode events so an individual can have many episodes over time and across hospitals. 




The level at which data is captured determines the frequency of events to be recorded and 
therefore data volume. Data captured over time and location are more sensitive to events that 
jeopardise data quality for example staff changes or technical issues that compromise data 
quality or prevent data transfer.  Data quality and volume also affects the data linking process. 
3.4.2. Types of linkage  
There are two  main types of data linkage (Dusetzina et al., 2014). The first is deterministic 
linkage where a pair of records are matched based on whether the record pair agree or disagree 
on a given set of identifiers. Agreement is assessed as a discrete “all-or-nothing” outcome. 
Deterministic linkage relies on the existence of one or a set of common unique health identifiers 
across the datasets to be matched.  The use of individual health identifiers (IHI)  was introduced 
by the Health Identifiers Act 2014 (Health Identifiers Act 2014, 2014) in Ireland however IHIs 
are not yet available in the NCRI, HIPE  or death certificate datasets.  
In the absence of  IHI’s  across the datasets to be matched, linking  requires probabilistic 
matching techniques (Fellegi & Sunter, 1969). Probabilistic matching techniques rely less on 
the need for common valid identifiers in the datasets to be matched and because data are 
matched on a range of variables, it is more robust to changes in data quality and availability 
over time.   
 
3.4.3. Probabilistic matching theory  
Probability theory is used to assess the likelihood of a correct match between two data records. 
Given the values in for example first name, last name, birth date, and address, what is the 
likelihood that these are a match? Probabilistic matching uses three underlying concepts: (1). 
m-probability - the probability of a variable agreeing in a correctly matched pair expressed as 
1 minus the error rate of the variable in the data set, (2) u-probability - the probability of a 
variable agreeing in an unmatched pair, that is agreeing by chance and, (3) weights - based 
upon the m and u values. Each variable and value has an agreement and disagreement weight 
associated with it. The number and frequency of values for each variable is used to determine 
the variable weights. In practice, variables that have a large range of values for example, a 
social security number, have a high m-probability weighting when they match across two 
datasets. Variables that have restricted range of values, e.g. gender recorded as ‘Male’, and 
‘Female’,   have a low u- probability when they agree across two datasets and a higher u-
probability weighting when they don’t. For matching purposes, a record pair that match on 
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social security number across two datasets is likely to be the same person. A record pair that 
match on gender is not very informative whereas not matching on gender suggests the records 
pertain to two different people. 
 
3.4.4. Data standardisation 
Data is recorded or captured in various formats in different systems and data items may be 
missing or contain errors.  The first step in data matching is data cleaning and standardisation. 
Poor quality data for example missing, inaccurate, or incomplete variables can result in missed 
or incorrect matches.  A pre-processing phase that aims to clean and standardise the data is 
therefore essential in every linkage process. Data sets may also contain duplicate entries, in 
which case a data set may need to be de-duplicated before linkage with other datasets. Common 
standardisation techniques include 
- Reformatting values, for example all date values formatted to dd/mm/yyyy 
- Removing punctuation, for example hyphens, apostrophes, full stops and  blank spaces 
- Removing common codes used for missing and/or uninformative data for example 
‘UNKNOWN’ in text fields.  
- Removing commonly used abbreviations for example Ct with Court, Rd with Road etc. 
- Phonetic encoding of alphabetic variable (such as a surname) to resolve differences in 
spelling e.g. ‘Browne’ and ‘Brown’. Common phonetic algorithms used in record 
linkage  are Soundex (Soundex System, 2016)  and NYSIIS  (Identification & System, 
1967) 
- Name and/or address standardisation where a name or address is broken down into 
individual components. For example an address can be broken down into its 
constituents such as street number, street name and street type. 
-  Resolving diminutive or nicknames using look up tables  for example replacing 
‘Bobby’ with ‘Robert’ 
- Removing or investigating  inconsistent data for example a female recorded with 
prostate cancer 
The process of standardisation is generally governed by rules and refined over time as expert 






Blocking reduces the number of record to record comparisons by sorting the two datasets to be 
matched on a common variable(s). Comparisons are made between records with the same 
values for the blocking variable. Common examples include blocking on Surname alone or 
Surname and date-of-birth.  Blocking reduces the number of comparisons to be made and 
considerably increases the efficiency of the matching process. This facilitates matching large 
volumes of data. Choice of blocking variable depends on expert knowledge of the datasets to 
be compared. Normal practice is to use the most reliable combination of blocking variables.  
 Checking for data anomalies 
All datasets used in the matching process are different, even those from the same provider over 
time, so each matching project has to be tailored to the data available. In all cases, the 
parameters for established matching routines are continually assessed and revised in light of 
the changes in the source matching datasets. In this context, the expert knowledge built up over 
time is applied to each matching project. Checks to mitigate data anomalies include: 
• Full investigation of   each dataset to identify best blocking  variables 
- Block on most reliable variables first 
- Careful  choice of blocking variables in each pass 
• Full utilisation of fuzzy logic capabilities of probabilistic matching to mitigate against 
minor spelling errors, juxta-positioned characters etc. 
• Full exploitation of the capacity to set weights to increase levels of user review of 
possible matches based on experience of data quality 
• Consider reviewing  matches after each pass 
• Exploit all available data sources  to verify individual records, that is validity checking 
across data sources 
• Look for opportunities to identify subsets of data where 100%  matching  would be 
expected (gold standard)  and use these to estimate reliability of matching 
• Look for guidance on numbers expected to match for each project based on previous 
experience 
• Record limitations/weakness of individual matching projects 
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 NCRI data linkage 
The NCRI uses a standalone probabilistic matching software, Automatch (Matchware 
Technologies, Inc., Silver Spring, MD, USA) to routinely link registry data to HIPE and death 
certificate data. HIPE data are matched using medical record number, hospital ID and date of 
admission and/or discharge as the primary blocking variables. Others include surname, date of 
birth and patient address.  HIPE records for which no match are found are actively followed up 
by CDRs to ensure no cancer cases are missed. Death certificate data are primarily matched to 
NCRI data using surname, first name, sex, date of birth and date of death as the blocking 
variables.  
Automatch allows for up to 8 passes in each project where each pass contains one set of 
blocking variables.  Normal practice is to use the most reliable combination of blocking 
variables in the first pass.  Automatch parameters can be set to allow user review after each 
pass within a run or at the end of a run on completion of all 8 passes. 
 
 Study 1 
 
3.5.1.  Design 
The first study used a retrospective cohort design to compare the characteristics of newly 
diagnosed lung cancer patients dying within 30 days of diagnosis with those who survived 
longer. The NCRI dataset was used as the primary data source, and the study sought to exploit 
the availability of acute hospital data to examine the characteristics and care experience of lung 
cancer patients from diagnosis to death.  To identify indicators for early palliative care 
assessment we distinguished between characteristics available at diagnosis (age, gender, 
smoking status, marital status, comorbid disease, admission type, tumour stage and histology) 
from those available post diagnosis (tumour directed treatment, diagnosis episode discharge 
code and cause of death (lung cancer/other)).  The variables chosen were guided by the data 
available and the literature review.  
Lung cancer remains the most common cancer worldwide and was the cause of over 1.6 million 
deaths in 2012. In Europe 12.1% of all  incident cancers in 2012 were lung cancer and it 
accounted for 20.1% of all cancer deaths (Ferlay et al., 2015). Typically lung cancer is 
characterised by short survival times, often attributed to  late diagnosis (Coleman et al., 2011; 
Thomson & Forman, 2009). The UK and Ireland have  the  poorest  one-  and five- year  relative 
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survival rates for lung cancer in  Northern Europe (Francisci et al., 2015). Characterisation of 
lung cancer patients who die shortly after diagnosis aligns with the thesis aim of exploring the 
potential of administrative health data linked at the individual level to identify the need for 
palliative care in vulnerable subgroups.  
 
3.5.2. Setting/participants 
All incident lung cancer patients (ICD-O3:C34)(Fritz, 2013), who were diagnosed in  Ireland 
between 2005 and 2012 and who died before 01-01-2014 were identified from the NCRI.  In 
2016, the censor date (the date to which all patients are followed up) was 31st December 2014. 
3.5.3. Data definitions 
The variables used in this, their source and how they were derived are shown in table 3.1. 
The diagnosis episode was the inpatient episode during which the lung cancer diagnosis was 
made. For a small proportion of patients (10%), the diagnosis date didn’t occur during an 
inpatient episode so the episode occurring in the interval from 7 days before to 14 days after 
the lung cancer diagnosis date was used.  
HIPE records episode admissions as either emergency or elective. Emergency admissions 
occur when a patient requires immediate care and treatment as a result of a severe, life 
threatening or potentially disabling condition with the patient generally admitted through the 
Emergency Department. Elective admissions occur when the patient’s condition permits 
adequate time to schedule the availability of suitable services to the patient (Hipe Unit, Health 
& Information Division, 2013).   
 
A co-morbidity score for each patient, based on the updated Charlson index (Quan et al., 2011) 
was derived from all diagnoses recorded in HIPE for the diagnosis episode. The Charlson 
comorbidity index (CCI) predicts the one-year mortality for a patient who may have a range of 
17 comorbid conditions. Each condition is assigned a score of 1, 2, 3, or 6, depending on the 
risk of dying associated with each one. Scores are summed to provide a total score to predict 
mortality.    For every episode, HIPE records a discharge code describing where the patient 
was discharged to, including categories for home, nursing home, died with and without post 
mortem and transfer to another hospital.  For this analysis we classified discharge code to 









Variable  Data 
Source  
Comments 
Age  NCRI  Age at diagnosis by age-group < 60 years, 60-69, 70-79,aged 80 and over 
Gender NCRI Male, Female 
Marital status NCRI Married, Other 
Smoker status NCRI Ever smoker , Never smoker, Unknown 
Date of diagnosis  NCRI The date of diagnosis is taken as the date of incidence which is selected from 
a hierarchy of dates in the following order,  the  date of first histological 
confirmation of malignancy or in the absence  of histological confirmation, 
the date of first treatment (excluding “seen but not treated”), followed by  the 
date  of admission to hospital because of the malignancy(National Cancer 
Registry, 2012; Tyczynski & Démaret, 2003). 
Stage NCRI Stage at diagnosis is defined according to American Joint Committee on 
Cancer (AJCC) summary staging and recorded by NCRI and were manually 
recoded to 4 groups - Stage 0/I/II, Stage III, Stage IV, Un-staged 
Histology NCRI Histological groupings were manually recoded based on the International 
Agency for Research on Cancer classification  (Egevad L et al., 2007) 
Tumour directed  
treatment 
NCRI Treatment data are classified to a yes/no category for any tumour-directed 




HIPE Manually derived using date of diagnosis and HIPE admission and discharge 
dates. The diagnosis episode was the episode where the lung cancer diagnosis 
was made or the first episode occurring in the interval from 7 days before to 
14 days after the lung cancer diagnosis. 





HIPE Manually derived  co-morbidity score for each patient, based on the updated 
Charlson index(Quan et al., 2011)from all diagnoses recorded in HIPE for the 
index diagnosis episode. Patients were classified to three comorbidity 
categories ‘None’, ‘1’ and ‘>1’ based on their Charlson score.   The lung 
cancer diagnosis was disregarded when calculating the co-morbidity score. 
Discharge code HIPE Manually recoded to Death or Other for the index  diagnosis episode discharge 
code  
Place of death Death 
certificate  
Manually derived from first line of place of death address, manually coded to 
Hospital, Home, Hospice, Nursing Home, Unknown and No death certificate  
Cause of death Death 
certificate 





Used to determine survival time as the number of days from date of diagnosis 




3.5.4. Outcome variable 
To identify early indicators for palliative care assessment, patients were classified to those who 
died within 30 days of diagnosis (short term survivors) and those who survived more than 30 
days. The 30 day cut-off was chosen for a number of reasons: i) 30 day mortality   has been 
used previously as an indicator of early mortality  for newly diagnosed  breast or colorectal 
cancer patients in Scotland (Brewster et al., 2011) and to  assess  factors affecting 30-day 
mortality in a national patient population of  lung and breast cancer patients receiving systemic 
anti-cancer therapy (Wallington et al., 2016),  ii) it aligns with the  study objective of 
identifying patient cohorts who might benefit from early assessment for palliative care as these 
patients are  unlikely to have gained survival benefits of  treatment,  iii) lung cancer is 
characterised by short survival times and in this  study just over 20% of patients died within 30 
days of diagnosis providing a natural cut point for this analysis and iv) it is easily derived  from 
cancer registry  data and can facilitate comparisons across  health systems.   
 
 
3.5.5. Statistical Analysis  
Chi-squared tests for independence were used to test for significant associations between 
categorical variables i.e. patient demographic variables  present at diagnosis (age, gender, 
smoking status and marital status); clinical variables at diagnosis (stage, histology and any 
comorbidities); characteristics of the diagnosis episode (admission type i.e. elective or 
emergency and whether death occurred in hospital during the diagnosis episode); post 
diagnostic characteristics including receipt of any tumour-directed treatment, cause of death 
and place of death; and survival time (≤ 30 days, > 30 days)  using a 5% level of significance. 
Cramer’s V was used as a measure of the strength of the association with nominal variables. 
Somers’ D was used as a measure of the strength of the association between ordinal 
independent variables and stratified survival time.  
 
Multivariable logistic regression analysis was used to predict death within 30 days of diagnosis 
(yes, no).   The model was fitted in a two stage process; the first stage examined the impact of 
patient characteristics immediately available at presentation. Next, the impact of clinical 
variables (e.g. histology and staging of tumour) were assessed by adding these to the model. 
Model goodness-of-fit was checked using the Hosmer and Lemeshow test (Hosmer et al., 
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1997). The  R statistical package was used for data preparation and analyses (R Core Team, 
2013), (Appendix F).  
 
 Study 2  
 
3.6.1. Design 
The second study was a retrospective cohort study where the exposure variable was receipt of 
palliative care and the outcome variable was place of death. The objectives of our study were 
to i) identify cancer patients who received specialist palliative care in acute hospitals in Ireland 
ii) to compare characteristics of patients receiving specialist palliative care with those who 
don’t and iii) compare place of death for these two groups.  
These  study objectives align  with the thesis aim to determine whether administrative health 
data linked at the individual level can be used to i) identify receipt of palliative care  , ii) 
describe who receives and does not receive palliative care in acute public hospitals and iii)  
determine if  receipt of palliative care affects place of death. A key part of this study was 
validation of the Z51.5 Encounter for Palliative Care code use in HIPE, (Appendix G).   
 
 Data sources 
The data sources for this study were the National Cancer Registry Ireland (NCRI), the hospital 
inpatient enquiry (HIPE) database from the Economic and Social Research Institute (ESRI) 
and death certificate (DC) data from the Central Statistics Office (CSO).  These have been 
described previously in section 3.2.  
3.6.3. Validation dataset - Specialist Palliative Care Minimum Data Set  
Specialist palliative care is delivered by the HSE along with a number of voluntary service 
providers working in partnership under Service Level Agreements. Specialist palliative care 
teams provide care in acute hospitals, community settings and specialist inpatient units 
(hospices) across the country.  All services are required to return monthly data to a national 
office. In 2016  metrics were  collected by four specialist palliative care services, inpatient units 
(IPU), community (homecare) services, day care services and acute hospitals (Weafer & Toft, 
2017).  These data constitute the HSE Specialist Palliative Care Minimum Data Set (SPC-
MDS). MDS data is generally submitted by specialist palliative care services and collated and 




Data collection from acute hospitals fully commenced in 2016 and each acute hospital provides 
monthly aggregate counts of in-patient new referrals to the specialist palliative care team. New 
referrals are further categorised to cancer and non-cancer   by the treating clinician who decides 
which disease is prompting the referral to end of life care.  
 
3.6.4. Study participants 
The study population included patients with incident invasive cancer  (ICD-O C00-C97),  
(Fritz, 2013) excluding non-melanoma skin cancer, diagnosed from 1994-2016 inclusive, who 
attended one of  eight adult cancer centres in 2016 and died in 2016. The study population was 
restricted to patients who attended a designated cancer centre in 2016 because i) cancer centres 
meet required standards so that all the patients have had access to similar standards of care 
including specialist palliative care, ii) acute public hospitals began providing numbers of 
patients referred for specialist palliative care to the national SPC-MDS in 2016 and these 
numbers were used in a validation study and iii) specialist palliative care bed capacity is 
quantified by CHO regions which were established in 2015. 
 
3.6.5. Data definitions 
The variables used in this, their source and how they were derived are shown in table 3.2. 
 
3.6.6. Statistical Methods 
Validation study for encounter for palliative care 
The number of cancer patients who had at least one indicator of palliative care recorded in their 
2016 HIPE hospital data was counted for each of the eight adult cancer centres. This was 
compared to an aggregate count of new specialist palliative care referrals for cancer patients in 
the SPC-MDS in 2016 by hospital.   
Comparison of study participants with cancer deaths in 2016 
The demographic and clinical characteristics of the decedents in our study were compared to 
all  2016 cancer deaths  using data from the CSO  Vital Statistics Annual Report 2016 (Central 




Table 3.2 Study 2 data definitions 
Variable  Data 
Source  
Comments 
Age at death NCRI  Age categories were chosen to match those used in the  CSO Vital 
Statistics Annual Report 2016 (Central Statistics Office, 2019c) 
Gender NCRI Male, Female 
Marital status NCRI Married, Other 
Smoker status NCRI Ever smoker , Never smoker, Unknown 
Deprivation  NCRI Address  at diagnosis was used to assign a deprivation score using the 
Pobal HP deprivation index (Haase & Pratschke, 2017). The index 
measures the relative affluence or socio-economic disadvantage of a 
geographical area using information collected on education, 
unemployment and other socioeconomic factors from the 2016 Census 
of Population 
Tumour group NCRI Tumour grouping  were chosen to match those used in the  CSO Vital 
Statistics Annual Report 2016 (Central Statistics Office, 2019c) 
Former health 
board region 






palliative care.   
HIPE  Used as an indicator for palliative care receipt. Coding Standards for 
HIPE state “Palliative care should be assigned (as an additional 
diagnosis code) when the intent of care at admission is 'for palliation', 
or if at any time during the admission the intent of care becomes 'for 
palliation', and the care provided to the patient meets the definition 
above.” Palliative care is to be coded when there is documentation that 
the patient has been seen by the palliative care team  (Healthcare 





hospice – not in 
HIPE listing 
HIPE  Used as an indicator for palliative care receipt. The HIPE discharge 
code describes the patient destination on discharge. Categories include 
home, nursing home, transfer to another hospital, and transfer to 
hospice and died.  
Encounter for 
palliative care  
Derived Manually derived from HIPE data. Patients were categorised to two 
groups: Encounter for palliative care (yes, no) based on having at least 
one indicator for palliative care in their HIPE data for any acute public 






Used to determine age at death. 
Place of death Death 
certificate/ 
DEPS  
Manually derived from first line of place of death address. Manually 
coded to Hospital, Home, Hospice, Nursing Home and Community 
care.  Community care included nursing homes and other long-term 





Comparison of characteristics and place of death by encounter for palliative care  
Descriptive statistics are provided for categorical demographic and clinical variables for each 
group: encounter for palliative care (yes, no). Chi squared tests examined the association 
between categorical variables. Logistic regression analysis examined the association of 
sociodemographic factors and former health board region with palliative care encounter group. 
The choice of variables used in the model were guided by the available data and the literature, 
and in particular the population based framework described by Gao et al  (Gao et al., 2018).  
Age, gender, marital status, smoking status, deprivation index, former health board region, and 
age at death were included in the model. Odds ratios (OR) and 95% confidence intervals (95% 
CI) are reported. Tumour groups were excluded from the model because of specialisation at 
certain cancer centres, so that tumour group is related to geographic region. Model goodness-
of-fit was assessed using Hosmer and Lemeshow test (Hosmer et al., 1997). Place of death was 
examined by palliative care encounter group. Data preparation and analyses were carried out 
using  R Studio, Version 1.0.143 (RStudio Team, 2016), (Appendix F). 
 
 Study 3  
 
Study 3 synthesises the knowledge gained from the initial two studies. By using existing 
available linked data in an Irish context the potential and challenges of administrative data for 
PEoLC research in cancer patients are identified and documented. The knowledge gained is 
extrapolated to other non-cancer health and social care data collections so that the potential and   
challenges of using health data for PEoLC research, given the existing information 
infrastructure, the ongoing health service reconfigurations and recent changes to data 
protection laws are better understood. 
 
The objectives for this study are i) to identify administrative health data available that may be 
useful for PEoLC research ii) to describe both the challenges and opportunities using these data 
for PEoLC based on our experiences to-date using administrative health data and iii) to describe 
how recent initiatives to improve the health information environment and changes to data 
protection laws will impact future use of administrative health and social care data in Ireland. 
Specifically we explore data validation, governance and protection and considerations for data 




3.7.1. Identifying potential datasets for PEoLC research 
A  recognised list of diseases with associated  palliative care needs (table 3.3) based on a 
methodology by Murtagh et al (Murtagh et al., 2014) was cross-referenced with the latest 
HIQA catalogue of national health and social care data collections to identify datasets that may 
have potential as a resource for PEoLC research in Ireland (Health Information and Quality 
Authority, 2017b).  Based on previous experience using cancer registry data, death certificate, 
hospital episode data and other datasets for research, we describe features of the datasets, 
including how the data are stored and organised (i.e. the data model) that affect how the datasets 
are used.  These considerations will inform the use of administrative health and social care data 
collections both in Ireland and elsewhere. 
 
 
Table 3.3 Conditions amenable to palliative care and their International Classification of 
Disease codes (ICD-10) 
 
Condition ICD-10 codes* 
Malignant neoplasm  C00-C97 
Heart disease, including cerebrovascular 
disease 
I00-I52, I60-I69 
Renal disease N17, N18, N28, I12, I13 
Liver disease K70-K77 
Respiratory disease, J06-J18, J20-J22, J40-J47 & J96 
Neurodegenerative disease G10, G20, G35, G122, G903, G231 
Alzheimer’s, dementia and senility F01, F03, G30, R54 
HIV/AIDS B20-B24 
 
Source: (Murtagh et al., 2014) 




The results from these studies are presented in the following chapters as published articles 




Chapter 4:   Indicators for early assessment of palliative care in lung 
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Chapter 4 is the Results chapters for the thesis from Study 1. It is presented as a published 







Analysing linked, routinely collected data may be useful to identify characteristics of patients 
with suspected lung cancer who could benefit from early assessment for palliative care. The 
aim of this study was to compare characteristics of newly diagnosed lung cancer patients dying 
within 30 days of diagnosis (short term survivors) with those surviving more than 30 days. To 
identify indicators for early palliative care assessment we distinguished between characteristics 
available at diagnosis (age, gender, smoking status, marital status, comorbid disease, admission 
type, tumour stage and histology) from those available post diagnosis. A second aim was to 
examine the association between receiving any tumour-directed treatment, place of death and 
survival time. 
Methods 
A retrospective observational population based study comparing lung cancer patients who died 
within 30 days of diagnosis (short term survivors) with those who survived longer using Chi-
squared tests and logistic regression.  Incident lung cancer (ICD-03:C34) patients diagnosed 
2005-2012 inclusive who died before 01-01-2014 (n=14,228) were identified from the National 
Cancer Registry of Ireland linked to death certificate data and acute hospital episode data.  
Results 
One in five newly diagnosed lung cancer patients died within 30 days of diagnosis. After 
adjusting for stage and histology, death within 30 days was higher in patients who were aged 
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80 years or older (adjusted OR 2.46; 95%CI 2.05-3.96; p<0.001), patients with emergency 
admissions at diagnosis (adjusted OR 2.96; 95%CI 2.61-3.37; p<0.001) and patients with any 
comorbidities at diagnosis (adjusted OR 1.32 95%CI 1.19-1.46; p<0.001). Overall, 75% of 
those who died within 30 days died in hospital compared to 43% of longer term survivors.   
 
Conclusions 
We have shown a high proportion of lung cancer patients who die within 30 days of diagnosis 
are older, have comorbidities and are admitted through the emergency department. These 
characteristics, available at diagnosis, may be useful prognostic factors to guide decisions on 
early assessment for palliative care for lung cancer patients. Patients who die shortly after 
diagnosis are more likely to die in hospital so reporting place of death by survival time may be 













Worldwide, lung cancer remains the most common cancer and was the cause of over 1.6 million 
deaths in 2012. In Europe 12.1% of all  incident cancers in 2012 were lung cancer and it 
accounted for 20.1% of all cancer deaths [1]. Typically lung cancer is characterised by short 
survival times, often attributed to late diagnosis [2, 3]. The UK and Ireland have  the  poorest  
one-  and five- year  relative survival rates for lung cancer in  Northern Europe [4]. In  the UK  
just over one  third of patients survive more than one year following a  lung cancer diagnosis 
(2010-2011) [5].  
 
 
Most patients with advanced cancer die in hospital [6] although a review of 210 studies from 
33 countries  found  most people would prefer to die at home [7].  Bekelman et al. reported 
death rates in acute hospitals ranging from 54% in Canada to just over 20% in the United Sates 
for lung cancer decedents over 65 years of age in  2010 across 6 developed countries [8]. Early 
palliative care in  patients with metastatic non-small-cell lung cancer has been found to improve 
survival times and lead to less aggressive care at end of life compared to patients receiving 
standard care [9].  It also improves patients understanding of their prognosis which may lead 
to more informed  choices near end of life [10]. 
 
Identifying those in need of early assessment for palliative care involves understanding 
prognostic factors of survival i.e. factors measured before treatment that have an impact on a 
patient’s outcome ‘‘independently’’ of received or general class of treatment (Paesmans, 2012). 
In the case of lung cancer clinical stage and functional status are  two important prognostic 
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factors for survival while age and gender are, to a lesser extent, also important [11].  The 
potential of using linked routine health data for prognostication has increasingly been 
recognised [12]. Data from multiple sources (registries, death certificates, hospital and 
community-based healthcare records) can be used retrospectively to identify those with unique 
needs or at risk of poorer outcomes  [13–16].  
 
The aim of this study was to use linked routine data to compare characteristics of newly 
diagnosed lung cancer patients dying within 30 days of diagnosis (short term survivors] with 
those surviving more than 30 days. To identify indicators for early palliative care assessment 
we distinguished between characteristics available at diagnosis (age, gender, smoking status, 
marital status, comorbid disease, admission type, tumour stage and histology) from those 
available post diagnosis. A second aim was to examine the association between receiving any 
tumour-directed treatment, place of death and survival time. 
 Methodology 
 
 Data definitions 
Information collected by the registry is coded and classified according to international 
guidelines including international classification of diseases (ICD) codes, definitions of 
incidence and how multiple tumours are handled [18]. The date of diagnosis is taken as the 
date of incidence which  is selected from a hierarchy of dates in the following order,  the  date 
of first histological confirmation of malignancy or in the absence  of histological confirmation, 
the date of first treatment (excluding “seen but not treated”), followed by  the date  of admission 
to hospital because of the malignancy [18, 19].  Stage at diagnosis was defined according to 
American Joint Committee on Cancer (AJCC) summary staging [20]. Histological groupings 
were based on the International Agency for Research on Cancer classification [21].  Treatment 
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data were classified to a yes/no category for any tumour-directed surgery, chemotherapy or 
radiotherapy received within one year of diagnosis.  
 
The diagnosis episode was the inpatient episode during which the lung cancer diagnosis was 
made. For a small proportion of patients (10%) the diagnosis date didn’t occur during an 
inpatient episode so the episode occurring in the interval from 7 days before to 14 days after 
the lung cancer diagnosis date was used. HIPE records episode admissions as either emergency 
or elective. Emergency admissions occur when a patient requires immediate care and treatment 
as a result of a severe, life threatening or potentially disabling condition with the patient 
generally admitted through the Emergency Department. Elective admissions occur when the 
patient’s condition permits adequate time to schedule the availability of suitable services to the 
patient [22].  A co-morbidity score for each patient, based on the updated Charlson index [23] 
was derived from all diagnoses recorded in HIPE for the diagnosis episode. The Charlson 
comorbidity index (CCI) predicts the one-year mortality for a patient who may have a range of 
17 comorbid conditions. Each condition is assigned a score of 1, 2, 3, or 6, depending on the 
risk of dying associated with each one. Scores are summed to provide a total score to predict 
mortality.   Patients were classified to three comorbidity categories ‘None’, ‘1’ and ‘>1’ based 
on their Charlson score. The lung cancer diagnosis was disregarded when calculating the co-
morbidity score.  For every episode, HIPE records a discharge code describing where the 
patient was discharged to, including categories for home, nursing home, died with and without 
post mortem and transfer to another hospital.  For this analysis we classified discharge code to 
‘Death’ and ‘Other’. 
 Outcome variable 
To identify early indicators for palliative care assessment, patients were classified to those who 
died within 30 days of diagnosis (short term survivors) and those who survived more than 30 
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days. We chose the 30 day cut-off for a number of reasons i.) 30 day mortality   has been used 
previously as an indicator of early mortality  for newly diagnosed  breast or colorectal cancer 
patients in Scotland [25] and to  assess  factors affecting 30-day mortality in a national patient 
population of  lung and breast cancer patients receiving systemic anti-cancer therapy [26],  ii.) 
it aligns with our study objective of identifying patient cohorts who might benefit from early 
assessment for palliative care as these patients are  unlikely to have gained survival benefits of  
treatment,  iii.) lung cancer is characterised by short survival times and in our study just over 
20% of patients died within 30 days of diagnosis providing a natural cut point for this analysis 
and iv.) it is easily derived  from routine data and can facilitate comparisons across  health 
systems.   
 
The association between receiving any tumour-directed treatment, place of death and survival 
time as a continuous variable was explored graphically. 
 
 Setting/participants 
All incident lung cancer patients (ICD-O3:C34) [24], who were diagnosed in  Ireland between 
2005 and 2012 and who died before 01-01-2014 were identified from the NCRI. These records 
were linked to HIPE and death certificate data. 
 
 Statistical Analysis  
Chi-squared tests for independence were used to test for significant associations between 
categorical variables i.e. patient demographic variables  present at diagnosis (age, gender, 
smoking status and marital status); clinical variables at diagnosis (stage, histology and any 
comorbidities); characteristics of the diagnosis episode (admission type i.e. elective or 
emergency and whether death occurred in hospital during the diagnosis episode); post 
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diagnostic characteristics including receipt of any tumour-directed treatment, cause of death 
and place of death; and survival time (≤ 30 days, > 30 days)  using a 5% level of significance. 
Cramer’s V was used as a measure of the strength of the association with nominal variables. 
Somers’ D was used as a measure of the strength of the association between ordinal 
independent variables and stratified survival time.  
 
Multivariable logistic regression analysis was used to predict death within 30 days of diagnosis 
(yes, no).   The model was fitted in a two stage process; the first stage examined the impact of 
patient characteristics immediately available at presentation. Next, the impact of clinical 
variables (e.g. histology and staging of tumour) were assessed by adding these to the model. 
Model goodness-of-fit was checked using the Hosmer and Lemeshow test [27]. The  R 




Of the 16638 incident lung cancer patients diagnosed between 2005-2012 inclusive, 14228 
(85.5%) died before 01-01-2014.  Of these, 383 cases were notified from death certificate data 
only and due to insufficient data are excluded from the analysis, leaving 13845 cases in the 
final dataset.  Median survival time was 137 days with an interquartile range (IQR) of 44-339 
days.   
 
Almost one in five (n=2595, 18.7%) newly diagnosed lung cancer patients died within 30 days 
of diagnosis. Table 4.1 shows the characteristics of the short term survivors compared to those 
who lived more than thirty days. The strongest association with short term survival were 
emergency admission at diagnosis, comorbidities at diagnosis, tumour histology and tumour 
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stage.  Compared with longer-term survivors, short term survivors were more likely to be 
admitted as emergencies at diagnosis (84% versus 52%), they were more likely to have 
comorbidities at diagnosis (18% versus 13% had a Charlson score of 1 and 19% versus 12% 
scored > 1), and were less likely to have their tumour characterised (37% versus 15% were 
histologically unspecified and 18% versus 11% were unstaged).  Table 4.2 shows the results 
of the multivariable logistic regression analysis adjusted for characteristics available at the 
diagnosis episode. These include gender, marital status and comorbidities present at diagnosis. 
Older patients (OR 2.72; 95%CI 2.29-3.24; p<0.001), those with emergency admissions at 
diagnosis (OR 3.92; 95%CI 3.47-4.44; p<0.001) and those with comorbid disease at diagnosis 
were significantly more likely to die within 30 days of diagnosis; the odds increased from  1.23 
( 95%CI 1.08-1.41; p= 0.002 ) among  patients with a CCI score of 1 to 1.41 (95%CI 1.23-
1.62; p<0.001 ) among  patients with a CCI > 1.  Table 4.3 shows the results of the regression 
analysis adjusted for the clinical variables stage and histology. After adjusting for stage and 
histological type, older age (adjusted OR 2.46; 95%CI 2.05-2.96; p<0.001) emergency 
admission at diagnosis (adjusted OR 2.96; 95%CI 2.61-3.37; p<0.001) and comorbid disease 
were still strongly associated with death within 30 days of diagnosis; the adjusted odds 
increased from  1.32 ( 95%CI 1.15-1.52; p<0.001) among  patients with a CCI score of 1 to 
1.44 (95%CI 1.25-1.65; p<0.001 ) among  patients with a CCI > 1.   
 
Table 4.4 describes treatment received post diagnosis, the discharge code for the diagnosis 
episode, the place of death and the cause of death by survival category.  Only 16% of the short 
term survivors received tumour directed treatment post diagnosis compared to 72% of the 
longer term survivors. Increasing survival time was associated with a steady increase in the 




The proportion dying in hospital decreased as survival time increased to 90 days but tended to 
remain stable after 90 days survival (Figure 4.1b). Overall 75% of the short term survivors died 
in hospital compared to 43% of longer term survivors. The proportion recorded as dying from 
lung cancer was similar in both groups - 89% short term survivors and 90% longer term 




One in five newly diagnosed lung cancer patients in our study died within 30 days of diagnosis 
and one quarter died within 44 days. Given the very short survival times, indicators for early 
assessment for palliative care are important to facilitate ongoing management and end of life 
care. We identified that older patients (aged 80 years and over), with any comorbid disease, 
who have emergency admissions at diagnosis are more likely to die within 30 days following 
diagnosis than younger patients, without comorbidities and admitted electively.  
 
 Survival time  
Our study aimed to identify indicators for early assessment for palliative care using routine 
linked data to compare characteristics of short- and longer term survivors. Survival time is 
affected by many factors including patient age, functional status, tumour stage at diagnosis and 
the treatment modalities available to treat disease. The relationships between these factors are 
complex; treatment plans are optimised to the individual and patients well enough to receive 
curative treatment will derive a survival benefit from that treatment. Patients who die shortly 
after diagnosis may  have had too little time for adequate  assessment  and appropriate care 
plans (curative or palliative)  to be put in place however,  this group has not been well 
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characterised at the population level. We are aware of only one population based study 
characterising short term survivors [25]. We have shown patients surviving longer are more 
likely to receive tumour-directed treatment which is associated with survival benefit, the 
proportion of patients receiving treatment increased steadily with increasing survival time.  
 
Retrospective studies of cancer care often use look-back periods from death of six or twelve 
months [29].  Survival times vary considerably by cancer type and stratification by survival 
time from diagnosis could be more informative than look-back studies (using defined periods 
of time before death). For example  when examining the care received at end of life, aggressive 
care may be completely appropriate in the early stages of treatment shortly after a cancer 
diagnosis however this information can be lost in look-back studies if survival time is not 
reported.  Reporting survival time provides an added context to evaluate the care patients 
receive at end of life. As we have shown it can highlight opportunities to improve that care for 
patient subgroups, for example patients who die very soon after diagnosis.  
 Indicators for palliative care 
Age and emergency admission 
 In a critical review of 10 studies from  the USA, Canada, France, Australia and New Zealand, 
Wong et al  highlighted the absence of evidence regarding the palliative care requirements of 
older patients particularly those presenting to emergency departments, with a  call for more 
research to help improve service provision [30].  Similarly Brewster et al [25] found  patients 
dying within 30 days of diagnosis  were more likely to be elderly and have  one or more 
emergency admission in the 30 days either before or after diagnosis. Our population based 
study supports the international evidence for high levels of emergency admissions and poorer 




Sixty percent of patients diagnosed with lung cancer in our study presented as an emergency 
admission. McPhail et al also found emergency presentation  remains predictive of short-term 
mortality in cancer patients  even when age, stage, and co-morbidity are accounted for [31].  A 
prospective mixed methods single centre study of lung cancer patients presenting as 
emergencies reported  palliative care needs were high  and  various information and support 
needs unmet [32]; the authors recommended a specialist palliative care assessment  be routinely 
offered. 
 
A  lack of  access to cancer diagnostics is a recognised short-coming in the Irish health system 
which has led to increased  referrals of patients  to emergency departments by general 
practitioners [33] and to initiatives to improve access to care. In 2012, the National Cancer 
Control Programme in Ireland initiated rapid access clinics providing direct access to 
consultant led assessment and diagnostic services for patients with suspected lung disease or 
cancer [34]. The clinics allow for suspect cases to be fast tracked and diagnosed on an urgent 
basis thereby facilitating earlier diagnosis and increased survival.  Our study results (on patients 
diagnosed from 2005 to 2012) provides baseline data on stage at diagnosis and survival for 
patients diagnosed before the introduction of these rapid access clinics.   
 
Comorbidity 
Comorbid  disease has been shown to delay diagnosis in colorectal cancer patients and 
particularly in older patients [35]; comorbid conditions were classified as ‘competing 
demands’ (unrelated to colorectal cancer) or ‘alternative explanations’ (sharing symptoms 
with colorectal cancer).  In a prospective study across five US hospitals, earlier consultation 
with specialist  palliative care teams  was associated with lower cost of hospital stay for patients 
admitted with an advanced cancer diagnosis [36]. A second related  study showed  the effect was 
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larger for patients with higher number of comorbidities [37]. Comorbidity was measured using 
the Elixhauser  comorbidity index [38] which counts  the presence of  thirty one serious 
conditions. We used the Charlson index [23] to derive a comorbidity score from the diagnosis 
episode as we did not have access to HIPE data before the cancer diagnosis. Furthermore under 
recording of comorbid disease in the HIPE data is a potential limitation and as other measures 
such as functional status were not available to us, it is probable we have under estimated the 
level of comorbid disease in our patient sample. Notwithstanding, we have shown short term 
survivors have more comorbid disease than longer term survivors and the odds of early 
mortality increases with increased comorbidity. Given this, earlier referral for palliative care 




Our study also reports short term survivors were more likely to have tumours which are less 
well characterised, (i.e. not staged and histologically unspecified), than patients who survive 
longer.  Current national  guidelines recommend patients with stage IV non-small-cell lung 
cancer should be offered concurrent specialist palliative care and standard oncological care at 
initial diagnosis [39] (see recommendation 2.8.1.1 page 109). It further recommends all patients 
with advanced stage lung cancer should have their palliative care needs assessed.  Using the 
stage IV criteria as an indicator for palliative care just over 50% of the short-term survivors 
from our study would be identified and this highlights the need for additional prognostic 






Place of death 
Our rate of  death in acute hospitals of 49% for lung cancer decedents is higher than that 
reported by Bekelman et al. for lung cancer decedents aged 65 years or older in  acute hospitals  
in   England (42.6%), Germany(45%), The Netherlands(29.5%), Norway (46.5%) and the 
United States (20.2)%  and lower than Canada (54.1%)[8].  The higher percentage of hospital 
deaths in our study is partially due to the high rates in the short term survivors, but also the 
Bekelman study was restricted to deaths for one year (2010) while our study had a broader time 
frame of eight years and included all lung cancer patients.  Moves to reduce deaths in acute 
hospitals adopted in the United States and the Netherlands (as described by Bekelman et al.) 
have been effective however without reporting place of death by survival time, it is unclear 
whether they benefit short term survivors.   
 
In an economic evaluation of specialist palliative care services in three parts of  Ireland which 
have heterogeneous structures and resources for these services,  Brick et al found that an area 
with well-developed specialist palliative care services and, where its role is understood, is 
likely  to have more referrals and that these will in general be earlier [40]. O’Leary et al, in a 
study of one specialist palliative care service in Ireland over a 6-month period found late 
referral to palliative care  was associated with receiving specialist palliative care in one care 
setting only but receiving care across multiple settings supported people to stay at home for 
longer [41].  
Death within 30 days of diagnosis means there is little time to determine and put appropriate 
care plans in place and death in hospital for these patients might be entirely appropriate.  In 
this context triggers for early assessment of palliative care for newly diagnosed lung cancer 
patients are very important so that the best care can be provided as soon as possible whether in 
hospital, in the community or at home.  
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 Strengths and Limitations 
A strength of our study is the use of high quality population based cancer registry data which 
has been verified and augmented by linkage to hospital episode data to death and certificate 
data.  Linked datasets provide novel opportunities for research at the population level, however 
there are limitations to their use.  For data confidentiality reasons, we cannot access hospital 
episode data for patients before a cancer diagnosis, so cannot examine health care utilisation 
leading to diagnosis. This information would facilitate a more accurate profile of the short term 
survivors in particular; multiple morbidities, especially in elderly patients, might explain short 
survival and/or post-mortem diagnoses of lung cancer.   In this study 10% of lung cancer cases 
recorded by NCRI had no corresponding HIPE record.  Failure to find a match can occur for 
several reasons including: typographical errors in fields used for matching, missing data on 
either system or no mention of cancer on the HIPE record, in which case the record would not 
be made available to NCRI. A cross reference of  HIPE data with death certificate data indicate 
5% of patients with place of death recorded as hospital  do not have a HIPE record and we 




A major focus of end-of-life care research has been to identify cohorts of patients who may be 
near end of life and would benefit from palliative care [42, 43].  
We have shown a high proportion of lung cancer patients who die within 30 days of diagnosis 
are older, have comorbid disease and are admitted through the emergency department. These 
characteristics, available at diagnosis, may be useful prognostic factors to guide decisions on 
early assessment for palliative care for lung cancer patients. Further research is needed on the 
palliative care needs of elderly patients admitted through the emergency department with 
suspected lung cancer.  
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Patients who die shortly after diagnosis are more likely to die in hospital so reporting place of 
death by survival time may be useful to evaluate interventions to reduce deaths in acute 
hospitals. It would also highlight sub groups of patients who might benefit from early 
assessment for and referral to palliative care. 
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Table 4.1.  Patient, tumour and admission characteristics at diagnosis, by survival category 
  
                                                 
a The diagnosis episode was the episode where the lung cancer diagnosis was made or the first episode occurring in the 
interval from 7 days before to 14 days after the lung cancer diagnosis. Episodes outside this interval were excluded from the 
analysis, n=1591. There was no matching HIPE data for n=1412 decedents. The denominator data is n= 2183 for short term 
survivors and n= 8659 for longer term survivors. 
 
 
b Due to small cell numbers (n=11), ‘Stage 0’ classification was merged with ‘Stage I/II’ classification 
 
c Due to small cell numbers (n=21), ‘Sarcoma’ classification was merged with ‘unspecified malignant’ classification. 
Morphologies based on International Agency for Research on Cancer classification [21] 
 
 Survival category  
   
Age (years) 0-30 days 
n=2595 




Tests  of association  
< 60 253  (10) 1990  (18) 2243 (16) χ2 =268.78, df(3), p<  0.001 
Somers' d =   0.082 60-69 569  (22) 3240  (29) 3809 (28) 
70-79 950  (37) 3835  (34) 4785 (35) 
80+ 823  (32) 2185  (19) 3008 (22) 
Gender     
Male 1606  (62) 6671  (59) 8277  (60) χ2 =5.88, df(1),  p=0.015  
Cramer's V =  0.021 Female 989  (38) 4579  (41) 5568  (40) 
Marital status     
Partner 1224  (47) 6193  (55) 7417 (54) χ2 =52.66, df(1),  p<  0.001 
Cramer's V =  0.062 Other 1371  (53) 5057  (45) 6428 (46) 
Smoker     
Ever 1803  (69) 8641  (77) 10444 (75) χ2 =78.77, df(3),  p<  0.001 
Cramer's V =  0.075 Never 219  (8) 915  (8) 1134 (8) 
Unknown 573  (22) 1694  (15) 2267 (16) 
Diagnosis episode admissiona     
Elective 360  (16) 3990  (46) 4350 (40) χ2 = 635.33, df(1),  p<  0.001 
Cramer's V =  0.242 Emergency 1823  (84) 4669  (54) 6492 (60) 
Diagnosis episode  Charlson 
score  
    
0 1362  (62) 6481  (75) 7843 (72) χ2 =134.08, df(2),  p<  0.001 
Cramer's V =  0.114 1 403 (18) 1166 (13) 1569 (15) 
>1     418 (19) 1012 (12) 1430 (13)  
Stageb     
Stage 0/I/II 183  (7) 2148  (19) 2331 (17) χ2 =365.11, df(3),  p<  0.001  
Somers' d =  0.098 Stage III 573  (22) 3246  (29) 3819 (28) 
Stage IV 1376  (53) 4606  (41) 5982 (43) 
Un-staged 463  (18) 1250  (11) 1713 (12) 
Histologyc     
Adenocarcinoma 447  (17) 3027  (27) 3474 (25) χ2 =735.46, df(5),  p<  0.001 
Cramer's V =  0.23 Carcinoma 254  (10) 1346  (12) 1600 (12) 
Large cell carcinoma 121  (5) 421  (4) 542 (4) 
Unspecified malignant 951  (37) 1715  (15) 2666 (19) 
Small cell  carcinoma 449  (17) 1708  (15) 2157 (16) 












                                                 
 
a The diagnosis episode was the episode where the lung cancer diagnosis was made or first episode 





95% confidence interval  p-value for Wald test 
Age group     
<60 years 1.00    
60-69 years 1.44 1.21 1.72 <0.001 
70-79 years 1.91 1.62 2.25 <0.001 
80+ years 2.70 2.27 3.22 <0.001 
Marital status     
Partnered  1.00    
Other 1.19 1.07 1.31 0.001 
Gender     
Male 1.00    
Female 0.81 0.73 0.90 <0.001 
Smoker     
Ever 1.00    
Never 0.98 0.82 1.17 0.906 
Unknown 1.48 1.29 1.68 <0.001 
Diagnosis  episode admissiona      
Elective 1.00    
Emergency 3.92 3.47 4.44 <0.001 
Diagnosis episode Charlson score      
0 1.00    
1 1.23 1.08 1.41 0.002 






Table 4.3. Characteristics and clinical data available at diagnosis associated with 
death within 30 days of diagnosis 
 
                                                 
 
a The diagnosis episode was the episode where the lung cancer diagnosis was made or first episode 




95% confidence interval  p-value for Wald test 
Age group     
<60 years 1.00    
60-69 years 1.45 1.22 1.74 <0.001 
70-79 years 1.99 1.68 2.36 <0.001 
80+ years 2.44 2.03 2.94 <0.001 
Marital status     
Partnered  1.00    
Other 1.15 1.04 1.28 0.007 
Gender     
Male 1.00    
Female 0.77 0.69 0.86 <0.001 
Smoker     
Ever 1.00    
Never 0.91 0.75 1.09 0.313 
Unknown 1.27 1.10 1.46 <0.001 
Diagnosis  episode admissiona     
Elective 1.00    
Emergency 2.96 2.61 3.37 <0.001 
Diagnosis episode Charlson score      
0 1.00    
1 1.32 1.15 1.52 <0.001 
>1 1.44 1.25 1.65 <0.001 
Stage     
Stage 0/I/II 1.00    
Stage III 2.12 1.73 2.62 <0.001 
Stage IV 3.37 2.77 4.11 <0.001 
Un-staged 3.47 2.76 4.37 <0.001 
Histology     
Adenocarcinoma 1.00    
Carcinoma 1.17 0.97 1.41 0.095 
Large cell  1.71 1.32 2.20 <0.001 
Unspecified malignant  2.91 2.49 3.41 <0.001 
Small cell  1.50 1.28 1.76 <0.001 






Table 4.4.  Post diagnosis characteristics; treatment, place of death and cause of death.  
 
                                                 




b The diagnosis episode was the episode where the lung cancer diagnosis was made or the first episode occurring in the interval from 
7 days before to 14 days after the lung cancer diagnosis. Episodes outside this interval were excluded from the analysis, n=1591. There 




 Survival category  







n= 13845 Tests  of association 
None 2169  (84) 3183  (28) 5352  (39) χ2 =2718.36, df(1), p< 
0.001,Cramer's V =  0.443 Any 426  (16) 8067  (72) 8493  (61) 
Diagnosis episode discharge codeb     
Death 1243  (57) 237  (3) 1480  (14) χ2 =4345.6 df(1), p<0.001,  
Cramer's V =  0.633 Other 940  (43) 8422  (97) 9362  (86) 
Place of death     
Hospital 1949  (75) 4850  (43) 6799  (49) 
χ2 =876.52, df(5),p<0.001, 
Cramer's V =  0.252 
Home 338  (13) 3200  (28) 3538  (26) 
Hospice 185  (7) 2084  (19) 2269  (16) 
Nursing Home 65  (3) 688  (6) 753  (5) 
Unknown 34  (1) 339  (3) 373  (3) 
No death certificate 24  (1) 89  (1) 113  (1) 
Cause of death     
Lung cancer 2320  (89) 10081  (90) 12401  (90) χ2 =0.096, df(1),  p=0.757, 





Figure 4.1; Percentage (a) receiving tumour–directed treatment and (b) place of death by 
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Chapter 5 is the Results chapter for the thesis from Study 2. It is presented as a published paper 
and addresses the broad PhD aims of   
 
• Identifying receipt of palliative care from administrative health data. 
• Comparing the characteristics of those who receive palliative care in acute public 
hospitals with those who do not. 








This study compares characteristics and place of death of cancer patients receiving specialist 
palliative care in acute hospitals with those who do not.  
 
Methods 
All patients with incident invasive cancer in Ireland (1994-2016 inclusive), excluding non-
melanoma skin cancer, who attended a cancer centre and died in 2016 were identified from 
cancer registry data. Patients were categorised based on a diagnosis code ‘Encounter for 
palliative care’ from linked hospital episode data.  Place of death was categorised from death 
certificate data.  Data were analysed using descriptive statistics, Chi squared tests and logistic 
regression. 
Results 
Of n=4103 decedents identified, 62% had a hospital based palliative care encounter in the year 
preceding death.  Age (p <0.001), marital status (p=0.017), deprivation index (p<0.001) and 
health board region (p=0.008) were independent predictors of having a palliative care 
encounter. Place of death  differed by palliative care  encounter group: 45% of those with an 
encounter died  in  hospital versus 50%  without an encounter, 33% versus 16% died in a 




Almost two thirds of cancer patients who attended a cancer centre and died in 2016 had a 
palliative care encounter. They were younger, less likely to be married, and more likely to be 
from deprived areas. Having accounted for sociodemographic factors, there was evidence of 
regional variation in receiving care. Demographic, clinical factors and the provision of health 
services in a region need to be considered together when assessing end of life care. 
Keywords:  







Place of death is an internationally recognised  measure to evaluate end of life care [1–4]. It is 
affected by patient sociodemographic and clinical factors and characteristics of the health 
service delivering care. An emerging body of evidence shows health service organisation must 
be considered when evaluating patient place of death [5–10]. 
A systematic review examining factors influencing death at home  in terminally ill cancer 
patients  found three groups of factors important:  those  related to the illness, the individual 
and the environment [9]. Environmental factors were considered the most important.  A study 
of  over  1.25 million  cancer  deaths in England in 2001-2010 by Gao et al [7]  found large 
variation in place of death by geographical area of which less than 25% could be explained by 
sociodemographic or clinical characteristics of the patient. A subsequent report proposed a 
population based framework to evaluate the role of different aspects of healthcare services in 
place of death. This  included  health service characteristics such as  service type e.g. adult 
inpatient hospice, hospitals, general practitioner and care homes, and capacity e.g. ratio of 
service facilities to user population, counts of services types within functional areas [8].  A 
study using the framework  for  all deaths in England in 2014 [6] found almost all health service 
characteristics studied were associated with some of the area-level variation in place of death 
with  service type and capacity were the strongest predictors.  
 
There is a lack of empirical studies examining the delivery of specialist palliative care to cancer 
patients in acute hospitals and whether this impacts place of death. The objectives of our study 
were to i) identify cancer patients who received specialist palliative care in acute hospitals in 
Ireland ii) to compare characteristics of patients receiving specialist palliative care with those 




 Setting   
Ireland has a mixed public private health care system where publically funded health care is 
managed by the Health Service Executive (HSE) and funded through the tax system. All 
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residents are entitled to use the public health system. There are eight designated cancer centres 
at publicly-funded hospitals where most cancer surgery takes place.  
 
 The National Clinical Programme for Palliative Care (NCPPC), formed in 2010,   recommends 
a ratio of 8 to 10 specialist palliative care beds per 100,000 population [11]. In  2015, no 
community health organisation (CHO) area had the recommended ratio [12] (table 5.1). The 
NCPPC defines specialist palliative care (level 3 care)  as care provided by health care 
professionals who work solely in palliative care and have extensive knowledge and skills in 
this specialty [13].  Each of the cancer centres have a specialist palliative care team. In 2020, 
there are 10 adult in-patient hospice units providing specialist palliative care in Ireland.  Neither 
the former Midlands nor South-Eastern health board region have an inpatient hospice (figure 
5.1). Access to hospice is by general practitioner or hospital consultant referral. 
 Data Sources 
The data sources for this study were the National Cancer Registry Ireland (NCRI), the Hospital 
Inpatient Enquiry (HIPE) database from the Health Pricing Office (HPO), and death certificate 
data from the Central Statistics Office (CSO), supplemented by data from the Death Events 
Publication Service (DEPS). We used a collated dataset from the Specialist Palliative 
Care Minimum Data Set (SPC-MDS) for the years 2015-2017 in a validation study of HIPE 
data. SPC-MDS provides data from each acute hospital showing the aggregate counts of in-
patient new referrals to the specialist palliative care team. Data collection from acute hospitals 
fully commenced in 2016 [12]. 
 
The NCRI records demographic, clinical and treatment information for all cancers diagnosed 
in Ireland, using internationally accepted conventions [14].  
HIPE is an electronic based information system that records demographic, clinical and 
administrative data on discharges from all acute public hospitals in Ireland.  Data are abstracted 
from medical records by trained clinical coders and entered into the HIPE system. Data quality 
is critical to the work of HIPE so that  coder training, data quality initiatives and the HPO 
software  ensure that data are being constantly reviewed [15]. HIPE data captures cases that 
have not had a histological verification of the diagnosis, or for which the registry failed to 
identify a pathology report. For confidentiality reasons, only HIPE episodes that mention a 




Every death in the Irish State must be recorded and registered within 3 months with the General 
Registers Office. Non-registration is rare because of the necessity of a death certificate for 
many legal purposes [16]. Cause of death is coded using ICD-10 codes and a software system 
used across Europe to improve international comparability. 
 
The NCRI routinely links HIPE data, DEPS data and death certificate data with registry data 
using probabilistic matching techniques, for case ascertainment and verification purposes. 
Completeness of case ascertainment is estimated to be 98.7% [17]. The NCRI has permission 
under the Health Act 1997 to collect and hold data on all persons diagnosed with cancer in 
Ireland without requiring individual consent. The use of that data for research is covered by the 
Statutory Instrument which established the Registry Board in 1991. All data were de-identified 
prior to analysis. 
  Data definitions 
Demographic information collected by the NCRI at cancer diagnosis include patient name, 
address, gender, date of birth, marital status and smoking status. Clinical information is coded 
using international guidelines including international classification of diseases (ICD) codes 
[14,18]. For comparison purposes, age categories and tumour grouping  were chosen to match 
those used in the  CSO Vital Statistics Annual Report 2016 [19]. 
Address  at diagnosis was used to assign a deprivation score using the Pobal HP deprivation 
index,[20]. The index measures the relative affluence or socio-economic disadvantage of a 
geographical area using information collected on education, unemployment and other 
socioeconomic factors from the 2016 Census of Population. Patients are assigned to a health 
board region based on their address at diagnosis. 
 Indicators for a palliative care encounter 
ICD-10-AM Diagnosis code Z51.5 - Encounter for palliative care 
Coding Standards for HIPE (page 36, [18])  state  “Palliative care should be assigned (as an 
additional diagnosis code) when the intent of care at admission is 'for palliation', or if at any 
time during the admission the intent of care becomes 'for palliation', and the care provided to 
the patient meets the definition above.” Palliative care is to be coded when there is 




Discharge Code - transfer to hospice 
The HIPE discharge code describes the patient destination on discharge. Categories include 
home, nursing home, transfer to another hospital, transfer to hospice and died.  
 
 Study participants 
The study population included patients with incident invasive cancer (ICD-O C00-C97) [21] 
excluding non-melanoma skin cancer, diagnosed from 1994-2016 inclusive, who attended one 
of  eight adult cancer centres in 2016 and died in 2016. The study population was restricted to 
patients who attended a designated cancer centre in 2016 because i) cancer centres meet 
required standards so that all the patients have had access to similar standards of care including 
specialist palliative care, ii) acute public hospitals began providing numbers of patients referred 
for specialist palliative care to the national SPC-MDS in 2016 and these numbers were used in 
a validation study and iii) specialist palliative care bed capacity is quantified by CHO regions 
which were established in 2015. 
Encounter for palliative care 
Patients were categorised to two groups: Encounter for palliative care (yes, no) based on having 
at least one indicator for palliative care   in their HIPE data for any acute public hospital in the 
year period preceding death (figure 5.2). 
 Main outcome measure 
Place of death was derived from DEPS data using place of death address. These were 
categorised to Home, Hospital, Hospice and Community care setting.  Community care 
included nursing homes and other long-term residential care settings.  
 Statistical Methods and Analysis 
Validation study for encounter for palliative care 
The number of cancer patients who had at least one indicator of palliative care recorded in their 
2016 HIPE hospital data was counted for each of the eight adult cancer centres. This was 
compared to an aggregate count of new specialist palliative care referrals for cancer patients in 
the SPC-MDS in 2016 by hospital.   
Comparison of study participants with all cancer deaths in 2016 
The demographic and clinical characteristics of the decedents in our study were compared to 
all  2016 cancer deaths  using data from the CSO  Vital Statistics Annual Report 2016 [19]. 
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Comparison of characteristics and place of death by encounter for palliative care  
Descriptive statistics are provided for categorical demographic and clinical variables for each 
group: encounter for palliative care (yes, no). Chi squared tests examined the association 
between categorical variables. Logistic regression analysis examined the association of 
sociodemographic factors and former health board region with palliative care encounter group. 
Age, gender, marital status, smoking status, deprivation index, former health board region, and 
age at death were included in the model. Odds ratios (OR) and 95% confidence intervals (95% 
CI) are reported. Tumour groups were excluded from the model because of specialisation at 
certain cancer centres, so that tumour group is related to geographic region. Model goodness-
of-fit was assessed using Hosmer and Lemeshow test [22]. Place of death was examined by 




  Identifying those with an encounter for specialist palliative care  
In a validation study, n=3455 patients were identified as having a palliative care encounter 
from HIPE data compared to n=3688 patients from the SPC minimum dataset. This represents 
a 6% difference. Four of the eight cancer centres closely matched the SPC-MDS aggregate 
counts with greater variation in the other four.   
For the main analysis, n=4126 decedents were identified (figure 5.2), representing 45% of all 
reported deaths in Ireland from malignant neoplasm  in 2016 (n=9171) [19]. They were younger 
and a higher proportion (39% versus 33%) were from the former Eastern health board region 
(table 5.2). Decedents were broadly similar in terms of cancer diagnosis apart from cancers of 
the digestive organs (C15-C18) and blood cancers (C81-C96); 26% of study decedents versus 
31% of all cancer decedents had cancer of the digestive organs while 11% of study decedents 
versus 8% of all cancer decedents had a blood cancer (table 5.2).  In total 85% of the decedents 
in our study were diagnosed in the five year period 2012-2016. 
 Comparison by palliative care encounter group 
Of the n=4126 decedents identified we excluded a further n=23 patients whose palliative care 
encounter occurred more than one year before death. Of the remaining n=4103 decedents, 62% 
had a palliative care encounter in the year preceding death and 38% did not, (table 5.3). 
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Age and deprivation showed the strongest association with a palliative care encounter (table 
5.3).  Overall median survival was 309 days (IQR 97-906 days). The palliative care encounter 
group had a shorter median survival of 296 days (IQR 93-850 days) versus 323 days (IQR 108-
1012 days) in the no encounter group.  Median time from the admission date of the last 
‘encounter for palliative care’ episode to death was 28 days (IQR 13-53 days).  
Of those with a Z51.5 code, 82% occurred at a cancer centre and 18% occurred in other acute 
hospitals. 
The North Western region had the highest proportion (73%) of decedents in receipt of a 
palliative care encounter while the Midlands region had the lowest (57%), (table 5.4). 
 Logistic regression analysis 
Decedents who were not married had increased odds of having a palliative care encounter (OR 
1.22, 95% CI 1.07-1.39). Using the least deprived quintile as a reference, those in the most 
deprived quintile had increased odds of an encounter (OR 1.59, 95% CI 1.25-2.03), (table 5.5). 
Relative to those under 65 years of age  odds of a palliative care encounter decreased as age 
increased from  0.78 (95% CI 0.66-0.92) in  the  65-74 year  age-group to  0.59 (95% CI 0.47-
0.74) in  the 85 years and over age-group. Accounting for sociodemographic factors, decedents 
in the Midlands and South East were significantly less likely to have a palliative care encounter 
relative to those in the Eastern health board region. 
  Place of death 
Hospital was the most common place of death (47%) followed by hospice (27%) and home 
(22%), (table 5.6). Place of death  differed between the palliative care  encounter groups, 45% 
versus 50%  died  in  hospital, 33% versus 16% died in a hospice and  18% versus 28%  died 
at home in the encounter versus the no encounter  group. 
 
  Discussion 
 
Almost two thirds of cancer patients who attended an adult cancer centre in 2016 and died in 
2016 had a palliative care encounter. They were younger, less likely to be married, and more 
likely to be from deprived areas than those who didn’t. Proportions having palliative care varied 
by health board region. Hospital was the most common place of death across the groups, but 
those having a palliative care encounter were proportionately twice as likely to die in hospice. 
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 Strengths and weaknesses 
This study uses high quality population based cancer registry data, linked to hospital episode 
data and death certificate data and is population based, however there are some limitations. 
Variables from the cancer registry dataset including marital status and smoking status are 
collected once at diagnosis. The majority (85%) of our study participants were diagnosed 
within the previous five years but these variables may have changed over that time.  
 
Address  at diagnosis was used to assign a deprivation score using the Pobal HP deprivation 
index [20], however  23% of 2016 decedents  are classified as having an unknown deprivation 
score. This usually arises because the patient address cannot be resolved to a single geographic 
area.  
 
Our study dataset represents 45% of all malignant cancer deaths reported in Ireland in 2016. 
Although broadly similar in characteristics, the decedents in our study were younger relative 
to the total population of 2016 cancer decedents. A smaller proportion (5%) had a cancer of 
the digestive organs and a higher proportion (3%) had a blood cancer diagnosis.  It has been 
reported that patients treated at cancer centres are younger than those treated in other public 
hospitals. Differences in referral patterns has been cited as one explanation for this, for example 
patients considered better candidates for treatment [24]. The majority of decedents in our study 
were diagnosed in the 5 year period 2012-2016, 50% died within one year and 75% within 
three years of diagnosis which indicates our study population are representative of recently 
diagnosed cancer patients in the active phase of treatment.  
 
Using HIPE to identify those having a palliative care encounter may underestimate the actual 
numbers seen.  A single centre study in New York examined the validity of the ICD-9 code 
V66.7 (Encounter for palliative care) from hospital episode data [25]. The code had high 
specificity (99.1%) and low sensitivity (49.9%); sensitivity was higher in patients with non-
metastatic cancer (61.9%), and metastatic cancer (66.3%). The authors concluded studies using 
this code would identify patients who have a high likelihood of having received care, but will 
not capture all patients who receive palliative care. We also cannot be certain a Z51.5 
diagnostic code guarantees a patient received specialist palliative care i.e. care provided by 
health care professionals who work solely in palliative care. To mitigate this, we restricted our 
study population to decedents who attended one of eight cancer centres in 2016, each of which 
have specialised cancer services and specialist palliative care teams. We included discharge to 
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a hospice as an indicator for palliative care given the likely need for a consultation with the 
palliative care team before discharging to this setting. Lastly we undertook a validation study 
where HIPE patient-level counts at four of eight cancer centres closely matched the SPC-MDS 
aggregate counts with greater variation in the other four. For the SPC-MDS, the treating 
clinician decides which disease is prompting the referral to end of life care whereas the NCRI 
uses international guidelines to determine cancer [14]. The SPC-MDS counts are new referrals 
only while this distinction is not available from HIPE.  
  Comparison with other studies 
Palliative care encounter and age 
There was a trend of decreasing odds for a palliative care encounter with increasing age. This 
is consistent with results from a previous retrospective  study of  patients with advanced cancer 
at a single medical centre in Houston, Texas [26]. Access to palliative care for older adults is a 
recognised problem [27,28]. Reasons cited include  attitudinal differences to the care of older 
people, a focus on curative treatments within hospitals and a lack of resources [27]. A 
qualitative study of older patients (aged 70 or older) reported that older patients may have  less 
clear early signs indicating that they need palliative care and are  not referred [28].  The authors 
noted the lack of a clear diagnosis of dying may explain why the palliative care needs of older 
patients in particular are not recognised. The patients in our study represent cancer patients in 
the active phase of treatment so further investigation of why the older decedents within this 
population were less like to receive a palliative care encounter is warranted.  Calls to more  
fully characterise cancer patients treated outside these centres have also been made [24]. Our 
study can provide a baseline for comparisons, particularly for palliative care. 
 
 Palliative care encounter and marital status  
We found patients who were not married were more likely to have a palliative care encounter. 
This  differs from the results of a 2012 study that found married patients were more likely to 
have a palliative care consultation [26].  Demographic information including marital status was 
retrieved was from the medical charts for these patients. It is not clear if this happened at the 
date of diagnosis of cancer or advanced cancer for the n=816 patients in the study. That study 




Palliative care and smoking status 
A perceived and implicit bias against patients with smoking-related lung disease has been 
reported as a potential barrier to palliative care [29]. Smoking status was unknown for 38% of 
our study population so we could not reliably examine the association between smoking status 
and receipt of palliative care in cancer patients, 22% of whom had cancer of the respiratory and 
intrathoracic organs. Removing smoking status from the logistic regression model did not 
change the results. 
 
 Palliative care encounter and deprivation 
Although more than a quarter of the decedents in our study have unknown deprivation category, 
there is a clear positive association of a palliative care encounter with increasing deprivation.  
In England inpatient hospice death is more likely among decedents living in less deprived areas 
than among those living in more deprived areas [30]. A broader review  suggested use of 
specialist palliative care in cancer patients may modify the effect of socioeconomic status on 
place of death [31]. Our study supports this, however access to specialist palliative care itself 
may be driven by socioeconomic factors. 
 
Palliative care encounter and regional variation 
Having accounted for sociodemographic factors, decedents in the South Eastern and Midlands 
regions had a statistically significant decreased odds of a palliative care encounter relative to 
the Eastern region. Regional-level variation in specialist palliative care services in Ireland is  
well documented [32,33]. Neither the South Eastern nor Midlands regions have an inpatient 
hospice and limited inpatient specialist palliative care beds which may explain why decedents 
from these regions have reduced access to specialist palliative care.  
 
Palliative care encounter and place of death  
Hospital was the most common place of death for all the decedents in our study which  is 
broadly consistent with previous studies [6,7,34,35]. Interestingly, this was true for the group 
who had a palliative care encounter, although the proportions dying in hospital (45% versus 
50%) and at home (18% versus 28%) were lower.  This may be due to limited inpatient hospice 
care facilities and specialist palliative care beds which is a known problem in Ireland [11]. 
Studies to investigate differences in end of life care between the two groups particularly for 





Access to specialist palliative care affects subsequent place of death. Demographic, clinical 
factors and the provision of health services in a region affect access to specialist palliative care 
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Table 5.1. Estimation of Specialist palliative care bed (SPC) capacity by health board region 




* Source:  http://hospicefoundation.ie/wp-content/uploads/2018/01/National-Survey-of-Patient-Activity.pdf. 
Table 3, page 12. (Weafer JA, Toft S. National summary of patient activity data for adult specialist palliative 
care services in the Republic of Ireland, 2012-2015) 
† See supplementary data file, figures 1 and 2 for additional information. 
‡All the specialist palliative care beds are in the two hospices located in the former North Western health board 
region. 
Former health 
board region  
CHO 
area 
CHO   




Former health board region geographical 
overlap with CHO† 
Estimated  
health board  
SPC 
capacity  
North Western 1 4.1 Contained completely within CHO 1 High‡ 
 
North Eastern 1 4.1 Split between CHO 1 and CHO 8 - 
North Eastern 8 0.0 Split between  CHO 1 and CHO 8 - 
Midlands  8 0.0 Contained completely within CHO 8 Low 
Western 2 4.0 Same region - 
Mid-Western 3 7.9 Same region High 
Southern 4 6.6 Same region  
South Eastern 5 0.4 Same region Low 
Eastern 6 3.3 Split  between  CHO 6, CH0 7 and CHO 9  - 
Eastern 7 6.5 Split  between  CHO 6, CH0 7 and CHO 9 - 
Eastern 9 7.4 Split  between  CHO 6, CH0 7 and CHO 9 - 
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Table 5.2. Comparison of clinical and demographic characteristics of all deaths from 
malignant neoplasm in 2016 with the study dataset.  
*Source: https://www.cso.ie/en/releasesandpublications/ep/pvsar/vitalstatisticsannualreport2016/deaths2016/  
[19]  









Attended a cancer 
centre in  2016 and 




Gender   
Female 4370 (48 ) 1867 (45 ) 
Male 4801 (52 ) 2259 (55 ) 
Age at death   
0–14 18 (0 ) <10 (0 ) 
15–24 15 (0 ) <10 (0 ) 
25–34 68 (1 ) 42 (1 ) 
35–44 169 (2 ) 111 (3 ) 
45–54 566 (6 ) 323 (8 ) 
55–64 1369 (15 ) 747 (18 ) 
65–74 2512 (27 ) 1255 (30 ) 
75–84 2839 (31 ) 1195 (29 ) 
85 & over 1615 (18 ) 442 (11 ) 
   
Cancer type†    
C00–C14  (Lip, oral cavity and pharynx) 188 (2 ) 146 (3 ) 
C15–C26  (Digestive organs) 2856 (31 ) 1221 (26 ) 
C30–C39  (Respiratory and intrathoracic organs) 1985 (22 ) 1033 (22 ) 
C40–C41  (Bone and articular cartilage) 31 (0 ) 11 (0 ) 
C43–C44  (Skin) 263 (3 ) 117 (2 ) 
C45–C49 (Mesothelial and soft tissue) 122 (1 ) 58 (1 ) 
C50  (Breast) 763 (8 ) 405 (9 ) 
C51–C58  (Female genital organs) 537 (6 ) 267 (6 ) 
C60–C63  (Male genital organs) 531 (6 ) 341 (7 ) 
C64–C68  (Urinary tract) 458 (5 ) 269 (6 ) 
C69–C72  (Eye, brain and other parts of central nervous system) 344 (4 ) 178 (4 ) 
C73–C75  (Thyroid and other endocrine glands) 46 (1 ) 26 (1 ) 
C76–C80  (Ill–defined ( secondary and unspecified sites) 316 (3 ) 136 (3 ) 
C81–C96 (Lymphoid, haematopoietic and related tissue) 731 (8 ) 545 (11 ) 
Former health board region   
Eastern  3038 (33 ) 1620 (39 ) 
North East 819 (9 ) 265 (6 ) 
South East 1060 (12 ) 471 (11 ) 
West 892 (10 ) 509 (12 ) 
Midlands 522 (6 ) 123 (3 ) 
North West 586 (6 ) 148 (4 ) 
South 1419 (15 ) 608 (15 ) 
Mid West 835 (9 ) 382 (9 ) 
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Table 5.3. Patient demographic and clinical variables by palliative care group. 
 






















Smoker Status      
Ever 587 (38) 1100 (43) 1687 (41) 
p <0.001 
 
Never 319 (21) 548 (21) 867 (21) 
Unknown 639 (41) 910 (36) 1549 (38) 
Marital Status      
Married 876 (57) 1354 (53) 2230 (54) 
p =0.017 Other 669 (43) 1204 (47) 1873 (46) 
Gender      
Female 667 (43) 1186 (46) 1853 (45) 
p =0.046 Male 878 (57) 1372 (54) 2250 (55) 
Deprivation      
1 Least 234 (15) 306 (12) 540 (13) 
p <0.001 
 
2 208 (13) 302 (12) 510 (12) 
3 221 (14) 370 (14) 591 (14) 
4 195 (13) 373 (15) 568 (14) 
5 Most 242 (16) 513 (20) 755 (18) 
Unknown 445 (29) 694 (27) 1139 (28) 
Age at death      
<65 years 382 (25) 843 (33) 1225 (30) 
p <0.001 
 
65–74 465 (30) 783 (31) 1248 (30) 
75–84 502 (32) 688 (27) 1190 (29) 
85 & over 196 (13) 244 (10) 440 (11) 
Tumour count per patient     
1  tumour 1306 (85) 2223 (87) 3529 (86) 
p =0.034 
 
>  1  tumour 239 (15) 335 (13) 574 (14) 
Tumour group*    
C00–C14  (Lip, oral cavity and pharynx) 46 (3) 100 (3) 146 (3) 
p <0.001 
 
C15–C26  (Digestive organs) 458 (25) 759 (26) 1217 (26) 
C30–C39  (Respiratory and intrathoracic organs) 357 (20) 668 (23) 1025 (22) 
C40–C41  (Bone and articular cartilage) <10 (0) <10 (0) 11 (0) 
C43–C44  (Skin) 47 (3) 70 (2) 117 (2) 
C45–C49 (Mesothelial and soft tissue) 17 (1) 41 (1) 58 (1) 
C50  (Breast) 157 (9) 241 (8) 398 (8) 
C51–C58  (Female genital organs) 74 (4) 192 (7) 266 (6) 
C60–C63  (Male genital organs) 157 (9) 183 (6) 340 (7) 
C64–C68  (Urinary tract) 100 (6) 168 (6) 268 (6) 
C69–C72  (Eye, brain and other parts of central nervous 
system) 63 (3) 114 (4) 177 (4) 
C73–C75  (Thyroid and other endocrine glands) 10 (1) 16 (1) 26 (1) 
C76–C80  (Ill–defined ( secondary and unspecified sites) 64 (4) 72 (2) 136 (3) 
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Total 1616 265 470 506 122 148 597 379  
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Table 5.5. Odds ratios and 95% confidence intervals for a palliative care encounter by 







Variable  Odds ratio(95% CI) 
Smoker status  
Ever 1.0 
Never 0.97 (0.81, 1.15) 
Unknown 0.77 (0.66, 0.89) 
Marital status  
Married 1.0 
Other 1.22 (1.07, 1.39) 
Gender  
Female   1.0 
Male 0.9 (0.79, 1.02) 
Deprivation  
1 Least   1.0 
2 1.1 (0.85, 1.41) 
3 1.3 (1.01, 1.66) 
4 1.46 (1.13, 1.89) 
5 Most  1.59 (1.25, 2.03) 
Unknown 1.26 (1.01, 1.56) 
Age category  
< 65 years 1.0 
65-74 years 0.78 (0.66 , 0.92) 
75-84 years 0.63 (0.53, 0.75) 
85 years and over 0.59 (0.47, 0.74) 
Former health board region  
Eastern  1.0 
North East 1.15 (0.87, 1.54) 
South East 0.77 (0.62, 0.97) 
West 1.12 (0.90, 1.39) 
Midlands 0.66 (0.4 , 0.97) 
North West 1.38 (0.94 , 2.05) 
South 0.82 (0.67, 1.0) 











Place of death 
No 
encounter 














Chi squared test 
of association 
Hospital 768  (50 ) 1159  (45 ) 1927  (47 ) 
p < 0.001 
 
Hospice 253  (16 ) 839  (33 ) 1092  (27 ) 
Home 434  (28 ) 472  (18 ) 906  (22 ) 
Community care 
setting 90  (6 ) 88  (3 ) 178  (4 ) 
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 * A further n= 23 cases were excluded where look back period from the date of death to the admission date of last 
palliative care episode was greater than one year. HIPE, Hospital Inpatient Enquiry. 
All incident invasive cancers (ICD-O3, C00-C97), 
excluding non-melanoma skin cancers, diagnosed from 
1994-2016 inclusive.  
Patients with at least one episode in one of the 8 cancer 
centres in 2016.  
n=24909 
Died in 2016 
n= 4137 
Alive at 31/12/2016 
n= 20772 
Excluded n= 11 records 
due to date 
discrepancies 
 
Encounter for palliative care 
*n=2558 
Patients with at least one diagnostic code of 
‘Z51.5 - encounter for palliative care’ or a 
‘discharge to hospice’ recorded in their 
episode data for any HIPE hospital in 2015-
2016, inclusive  
(2084 decedents were ‘Z51.5’ only, 70 hospice only and 404 
both) 
 
No encounter for palliative care 
n=1545 
Patients with no record of a ‘Z51.5 - 
encounter for palliative care’ diagnostic 
code or ‘discharge to hospice’ recorded in 
their episode data for any HIPE hospital in 
2015-2016, inclusive  
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Figure 5.3 Former health board regions in Ireland with inpatient  
hospice location indicated by black dots. 
 
 
















Figure 5.5 Odds ratios† and 95% confidence intervals for a palliative care encounter by 
sociodemographic factors and former health board region 
 
 
†Reference: smoker-‘ever smoker’, marital status-‘Married’, gender ‘Female’, deprivation- 






Figure 5.6 Place of death by former health board region for decedents who had an encounter 
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Chapter 6 is the final Results chapter from the thesis.  It draws together the experience of using 
administrative health data for PEoLC research in cancer patients and extrapolates the 
knowledge gained to evaluate the potential and challenges of other national non-cancer health 




Background: This study aims to examine the potential of currently available administrative 
health and social care data for palliative and end-of-life care (PEoLC) research in Ireland. 
Objectives include to i) identify data sources for PEoLC research ii) describe the challenges 
and opportunities of using these and iii) estimate  the impact of recent health system reforms 
and changes to data protection laws. 
 Methods: The 2017 Health Information and Quality Authority catalogue of health and social 
care datasets was cross-referenced with a recognised list of diseases with associated palliative 
care needs. Criteria to assess the datasets included population coverage, data collected, data 
dictionary and data model availability and mechanisms for data access. 
Results: Nine datasets with potential for PEoLC research were identified, including death 
certificate data, hospital episode data, pharmacy claims data, one national survey, four disease 
registries, (cancer, cystic fibrosis, motor neurone and interstitial lung disease) and a national 
renal transplant registry.  The ad hoc development of the health system in Ireland has resulted 
in i) a fragmented information infrastructure resulting in gaps in data collections particularly 
in the primary and community care sector where much palliative care is delivered, ii) ill-defined 
data governance arrangements across service providers, many of whom are not part of the 
publically funded health service and iii) systemic and temporal issues that affect data quality. 
Initiatives to improve data collections include introduction of i) patient unique identifiers, ii) 
health entity identifiers and iii) integration of the eircode postcodes. Recently enacted general 




Conclusions: Ongoing reform initiatives and recent changes to data privacy laws combined 
with detailed knowledge of the datasets, appropriate permissions, and good study design will 
facilitate future use of administrative health and social care data for PEoLC research in Ireland. 
 





Administrative health data is generated through the provision and administration of health and 
social care by health care service providers and other institutions.  
Its use for research purposes is an area of growing interest 1– 5 . Internationally initiatives to 
harness the potential of linked administrative health data for research purposes are well 
developed in Australia 6– 8 , the UK 9– 11 the Nordic countries (Norway, Sweden, Finland, 
Denmark, Greenland and Iceland) 12 and Canada 13 . However data linkage is a complex process 
and methodologies vary 14, 15 . In Ireland the need to develop a coherent and integrated approach 
to health information 16 and the potential of routine data for health research 17 is recognised. 
Initiatives to harness that data for research purposes have started but these are at an early stage 
18. The Health Service Executive (HSE), Ireland’s public health and social care service 
provider, is developing an open data strategy in recognition of the fact that the data it holds are 
a valuable asset that can improve healthcare delivery and planning 19 . 
Kane et al. reported that 80% of deaths in Ireland between 2007–2011 were from conditions 
recognized as having associated palliative care needs, with 30% of deaths from cancer and 50% 
from non-cancer conditions including neurodegenerative disease and dementia 20 . Significant 
barriers to high quality palliative care research exist 21– 23 . These include identifying and 
recruiting subjects, increased ethical concerns for vulnerable patients who are often seriously 
ill and methodological concerns including loss to follow up, recall bias or difficulties 
measuring endpoints such as pain or symptom burden 22 . Some of these issues can be addressed 
using routine data. Davies et al. described a number of initiatives that use routine data for 
palliative and end of life care (PEoLC) research in England and elsewhere 2 . The study 
identified three priorities for the future use of routine data; these were i) safe and ethical access 
to data, ii) improved data linkage and iii) improved PEoLC data collections. In Belgium, 
Maetens et al. identified and described the steps to access, interrogate and link seven population 
level databases for end-of-life research 24 . In Ontario, Tanuseputro et al. used a range of routine 
data sources to examine the delivery of palliative care across acute care, outpatient clinics, and 
home care health sectors at the population level 25 . 
In Belgium, health insurance is legally mandatory so that data discovery relied mostly on access 
to claims databases which are managed by a single agency. In Ontario, claims data from 
Ontario Health Insurance Plan database augmented by linkage to a number of other 
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administrative databases held at a single institute, formed the basis of data capture. These 
studies demonstrate that while there are universal challenges to using administrative health data 
for research, the context is local and requires examination at the local level. Initiatives to use 
administrative health and social care data in Ireland are beginning but to-date its use for 
quantitative PEoLC research 26, 27 has been limited. 
Our aim is to identify the challenges and opportunities of administrative health and social care 
data for PEoLC research in Ireland. The study is timely given the recent initiatives to realise 
the potential of Irish health data 18, 19 and the emerging body of international studies using 
administrative health data 2, 24, 25 . Our objectives are i) to identify administrative health and 
social care data available that may be useful for PEoLC research ii) to describe both the 
challenges and opportunities using these data for PEoLC based on our experiences to-date 
using linked cancer registry data, hospital episode data and death certificate data and iii) to 
describe how recent initiatives to improve the health information environment and changes to 





Ireland has a mixed public private health care system where publically funded health care is 
managed by the HSE and funded through the tax system. All residents are entitled to use the 
public health system. There are three private health insurance providers in Ireland and in 2018, 
45% of the population had private health insurance 28 . Privately insured patients in Ireland may 
be treated in public or private hospitals. The HSE National Clinical Programme for Palliative 
Care oversees the management and organisation of palliative care services in Ireland 29. 
Specialist palliative care is delivered by the HSE along with a number of voluntary service 
providers. Specialist palliative care teams provide care in acute hospitals, community settings 




 Identifying potential datasets for PEoLC research 
The Health Information and Quality Authority (HIQA) is an independent body that evaluates 
the quality of the information available on health and social care and makes recommendations 
to improve quality, minimise inconsistencies and fill gaps where data are not available 30, 31 . 
Quality is defined as data that are complete, valid, accurate, reliable, relevant, legible and 
available in a timely manner 32 . HIQA advocates eight guiding principles for organisations 
collecting data that include formalised governance arrangements, facilitating appropriate 
access to the data to optimise its benefits, continuous monitoring/improvements of data quality 
and effective information governance procedures. Standards for data quality include the use of 
data dictionaries, classification systems and clinical terminologies 30 . A data dictionary is a 
descriptive list of names, definitions and attributes of data elements to be collected in an 
information system or database and aids in the standardisation of data definitions 33 . Related 
to the concept of data dictionaries, data models describe how the data are organised and stored 
within an information system or database. This affects how relevant data from different systems 
data can be identified, extracted and compared. Data dictionaries and data models hold data 
about the data, also called metadata. 
HIQA produces a catalogue of national health and social care data collections using a 
standardised template to describe existing data collections 16 . The 2017 catalogue was cross-
referenced with a recognised list of diseases with associated palliative care needs (Table 1), 
based on a methodology by Murtagh et al. 34 . Given Ireland’s aging population and identified 
future palliative care needs for cancer, neurodegenerative disease and dementia 20 particular 
focus was given to disease registry collections. Criteria used to assess the datasets included an 
examination of population coverage, the data collected, the availability of data dictionaries and 





In total, nine  datasets were identified from the HIQA catalogue with potential for PEoLC. 
These include population based death certificate data, hospital based episode data for all 
patients treated in public acute hospitals in Ireland, pharmacy claims data for all people eligible 
for medical cards, one nationally representative cohort study of people aged 50 and over,  four 
disease registry collections and a national renal transplant registry. Four have data dictionaries 
and six have a process to request access to the data. To our knowledge there is no record of a 
requirement for payment (for non-commercial organisations) to access any of the data sources 
mentioned here 36 . Key characteristics of the datasets are described in Table 2. Based on our 
previous experience using cancer registry data linked to death certificate data and hospital 
episode data 37, 38 we describe the strengths and weaknesses of these datasets for PEoLC 
research.  
 Death certificate data 
Every death in Ireland is legally required to be notified to the state within three months of 
death, so death certificate data is population based at the national level. Death is a unique event 
so a person should only have one death certificate record. The Department of Social Protection, 
Central Statistics Office (CSO) and General Register Office collect and record date of death, 
address of residence of deceased, place of death, cause of death, occupation of deceased, age 
of deceased, sex of deceased, and marital status of deceased. Cause of death for all deaths 
registered from 2007 onwards are coded using ICD10 codes 39. Place of death is recorded as an 
address and is not classified e.g. into home, hospital, hospice, or long-term care facility 40 . 
Information on how to access the data are available here. 
123 
 
 Hospital Episode data 
The Hospital In-Patient Enquiry system (HIPE) collects demographic, clinical and 
administrative data on discharges from, and deaths in, all acute public hospitals nationally. 
Details of each episode of care is recorded as a single record so that over time an individual 
can have multiple records within and across HIPE hospitals. HIPE is the only source of 
morbidity data available nationally for acute hospital services 41 . In 2016, 53 hospitals were 
contributing to HIPE. Data are not available in HIPE for emergency department attendances 
unless the patient is admitted to hospital. Data are also not available for 22 private hospitals. 
Clinical coders review the records of each patient and extract the relevant clinical data, and 
translate it into codes using the ICD-10-AM/ACHI/ACS 8th edition 42 . As well as a source of 
clinical information for many chronic diseases with associated palliative care needs (e.g. 
dementia, neurodegenerative diseases and cancer), diagnostic codes include ‘Z51.5 - Palliative 
care’ recorded when a patient has been seen by the palliative care team 42 . The guidance for 
recording palliative care in HIPE changed with the introduction of the 10th edition ICD-10-
AM/ACHI/ACS from January 2020. Palliative care should be recorded only where there is 
documented evidence that the patient has been provided with palliative care 43. 
Notwithstanding evidence of variation in how the code is used across hospitals, currently HIPE 
is the only available population level administrative dataset where a record of a patient being 
seen by a palliative care specialist can be identified 44. Additional relevant information for 
PEoLC research include admission type (elective/emergency) and patient destination on 
discharge with categories that include home, nursing home, transfer to another hospital, transfer 
to hospice and/or died. Information on accessing data and a data dictionary for HIPE data are 
available from http://www.hpo.ie/  
 
Opportunities for data validation 
The Minimum Data Set (MDS) is a national survey of demographic and patient activity data 
for specialist palliative care services in Ireland 45 Monthly aggregate data from specialist 
palliative care inpatient units, community (homecare) services, day care services and acute 
hospitals are returned to a national office. The Specialist Palliative Care MDS does not contain 
patient level data and is not listed in the HIQA catalogue. A summary analysis of MDS 45   for 
the period 2012 to June 2016 reported several metrics including 
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• The number of new patients in receipt of inpatient specialist palliative care, community 
care, and day care. 
• Place of care prior to admission to inpatient units. 
• The number of admissions and discharges from inpatient units. 
• Inpatient bed availability and occupancy. 
• The provision of care to non-cancer patients. 
• Wait times for inpatient care and community care. 
• Specialist palliative care in the community and place of death. 
Data from all acute hospitals was incomplete at the time of analysis and excluded from the 
report, however MDS aggregated data of specialist palliative care activity in acute hospitals in 
2016 has been used to validate HIPE coding of palliative care 38 . 
 
 Primary Care Reimbursement Service data  
The HSE Primary Care Reimbursement Service (PCRS) is responsible for making payments 
to healthcare professionals including general practitioners (GPs), dentists and pharmacists, for 
the free or reduced costs services provided to the public under the General Medical Scheme 
and/or other schemes 46 . Access to the schemes is means-tested on a rolling basis and/or 
determined by specified long-term disease. Qualifying individuals are given a medical card 
with a unique medical card number (MCN). Eligibility for a medical card can change with 
changing circumstances so that over time, one person can have had a number of medical cards. 
In 2018, 43.4% of the population (over 2 million people) were eligible for a medical or GP 
visit card 47. The PCRS dataset is one of the few national datasets that collects data in primary 
and community care settings. All expenditures around pharmaceuticals (drugs/medicine costs) 
are recorded against an MCN so that the data are transaction based. A data model is not 
currently available for PCRS so it is not clear how an individual is linked with medical card(s) 
within the PCRS database or whether an individual or a medical card is recorded more than 





 The Irish Longitudinal Study on Ageing 
The first wave of data collection for the Irish Longitudinal Study on Ageing (TILDA) surveyed 
a nationally representative sample of over 8500 people, aged 50 years and over, beginning in 
October 2009 with a further four waves of data collection in 2012, 2014, 2016 and 2018 48 . 
Each individual within the TILDA dataset has a unique identifier and a wide range of data on 
the health, economic and social aspects of participants' lives are collected through personal 
interviews, self-completion questionnaires and health assessment measures 49 .TILDA is 
unique in Ireland in that it contains detailed longitudinal data on education, income and 
occupation in this age group which is not readily available elsewhere. 
TILDA data has been linked at the person level with death certificate data, matching on the 
basis of name, address and month and year of birth. Matching was performed for all individuals 
who died between Wave 1 (2009/2011) and March 2018, and of a total of 863 confirmed deaths 
among the TILDA sample, matching death records were obtained for 779 decedents (90.3%) 
50 .  By law every death is registered and this is reflected in the high match rate achieved.  
Matching allows for detailed research around end of life care given the depth and breadth of 
information collected prospectively before death by TILDA. This work demonstrates person 
level data linkage with the other datasets described here is feasible. Anonymised data and 
documentation on TILDA are available for download from the Irish Social Science Data 
Archive 51 . 
 Cancer registry data 
The NCRI collects data nationally for incident tumours recorded at the level of the patient, that 
is each patient should be recorded once only in the registry database. This relational data model 
simplifies data linkage where data are matched at the person level using demographic details. 
Over time a patient may have additional tumour and management data attached to their patient 
record. Information collected includes patient demographics (age and sex), type of cancer (site 
and staging), treatments and selected procedures, date and cause of death (from linked death 
certificate data). Clinical information is coded using international guidelines including 
international classification of diseases (ICD) codes 35, 52 . The focus of data collection is on the 
first year post-diagnosis with limited data collection thereafter. Completeness of case 
ascertainment is estimated to be 98.7% 53 . Information on accessing data from the NCRI is 




 Other disease registries 
Population based disease registries are a good starting point for PEoLC research because 
selection bias is reduced since the whole population with the disease are identified. The Irish 
Motor Neurone Disease (MND) register was established in 1995 and collects data on all known 
patients diagnosed with MND each year and currently it holds information on over 2,200 
patients 54 . Individual level demographic data are recorded so that linkage to HIPE, death 
certificate data and PCRS data should be feasible. Date of disease onset is also captured so that 
studies on the patient’s PEoLC needs throughout the disease trajectory are possible. 
The Cystic Fibrosis registry requires patient consent for data collection. In 2017 it was 
estimated the registry coverage of the cystic fibrosis population was just over 90% 55 . The 
characteristics of those patients not captured are unknown, so studies using the cystic fibrosis 
registry may be subject to selection bias. Detailed demographic information that includes name 
and address, date of birth and ethnicity are recorded. Additional information includes 
information on diagnostic tests, genotype, symptoms and method of diagnosis, age at diagnosis, 
number of hospitalisations between annual assessments, complications and other clinical data 
and social data. Data linkage to death certificate data, HIPE data and PCRS data should be 
feasible. The cystic fibrosis registry is unique among the datasets described here in that it 
collects ethnicity data 56 . 
The Irish Thoracic Society Interstitial Lung Disease (ITS-ILD) Registry began collecting data 
in 2016. Patient written consent is required for data collection. The first annual report (2018) 
on 154 patients found 46% of patients with idiopathic pulmonary fibrosis were referred through 
primary care, 12% of patients were referred for lung transplant assessment and 13% were 
referred to palliative care 57 . A key finding is that most patients with idiopathic pulmonary 
fibrosis will need a lung transplant or palliative care. While only preliminary information on 
disease stage and no information on survival times were provided, the report demonstrates the 
value of disease registries in providing detailed information necessary to assess the need for 
palliative care services. 
 National Renal Transplant Registry 
The National Kidney Transplant Service for the Republic of Ireland was established in 1986 
and is coordinated through Beaumont Hospital 58 . The National Renal Transplant Registry 
collects data on parameters at time of transplant, renal disease and source of transplant. Patient 
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data collected includes gender, area of residence and date of birth. The information is used to 
assess graft survival and patient survival, monitor factors affecting outcome and monitor 
performance 16 .  Three further national transplant services exist in Ireland:  the National Heart 
and Lung Transplant Service, the National Liver Transplant Service transplant and the National 
Pancreas Transplant Centre 59 . Person level data from the transplant databases has been linked 
to cancer registry data to examine cancer incidence after organ transplantation 60 . 
 
 Considerations for PEoLC research 
 
 Structural issues in healthcare organisation and delivery 
The ad hoc development of the Irish health system has contributed to an information 
infrastructure that often does not link across service providers thus leading to duplication, 
fragmentation and increased costs. Patients cannot be easily tracked from hospital to 
community based care leading to large gaps and silos of under used data 30 . Gaps exist 
particularly from the primary and community care sector as well as from outpatient clinics and 
emergency department attendances that don’t result in hospital admission. The lack of 
community and social care data is particularly relevant for PEoLC as a considerable amount of 
palliative care is delivered in the community. 
 
 Data governance 
A second consequence of the ad hoc development of services means how data is managed and 
accessed across providers, many of whom are not part of the HSE, is not well defined. Private 
hospitals do not contribute to the HIPE national data collection so that studies based on HIPE 
data cannot be generalised to the whole population. Biases and omissions in the available data 
cannot be adequately assessed. Similarly inpatient hospice services in Ireland are mostly 
provided by charities, partially funded by the HSE but with separate and distinct governance 
structures 61 . Data models describing how the data are stored and organised are generally not 
available so that gauging the workload to manage and link data can be complex. Data 
dictionaries are generally not available so the datasets usefulness for PEoLC research cannot 




 Individual health identifiers 
The 2014 Health Identifiers Act 62  mandated the creation of an individual health identifier (IHI) 
register so that all health service users can be uniquely identified. While work is ongoing to 
introduce IHIs across the Irish health system, they have not yet been widely incorporated into 
the national data collections described above. In the absence of unique identifiers, linking 
patient records across datasets requires probabilistic matching techniques 63, comprehensive 
strategies to guide the process including data cleaning and standardisation techniques 64  and 
detailed knowledge of the datasets to be linked. Address can be used in matching but over 35% 
of addresses in Ireland share their address with at least one other property. Eircode, Ireland’s 
postcode system, was launched in July 2015 where a unique postcode is assigned to each 
residential and business address. The integration of eircodes will facilitate probabilistic data 
matching of administrative datasets and allow geospatial analysis of the data. 
Issues affecting quality or completeness of data within each dataset can affect the efficacy and 
accuracy of probabilistic matching. Issues can be systemic e.g. how the data are organised and 
stored. Temporal issues can include health service reconfigurations, changes to eligibility 
criteria (e.g. eligibility for medical cards) and/or changes in classifications systems over time. 
 Health Service Providers Identifiers 
The 2014 Health Identifiers Act 62  also legislated for the development of a national database 
to capture, maintain and publish quality assured and verified standard codes and identifiers for 
health related entities i.e. practitioners, organisations, services, locations, and information on 
the relationships between them 65  . The repository will hold up-to-date information on health 
sites/locations, health care providers and services provided by the HSE and Private/Voluntary 
Organisations in Ireland. The introduction of health service provider identifiers will facilitate 
classification and enumeration of services that will benefit PEoLC research. 
Place of death is an important outcome measure at a population level. In PEoLC research, place 
of death is commonly standardised to Own Residence, Hospital, Care Home and Hospice based 
on the place of death address 66. There are no standards in use for Irish mortality data 40 so that 
categorising place of death based on the address of a healthcare facility can be difficult without 
local knowledge. Facilities range from specialised centres to large regional hospitals, general 
hospitals, community and district hospitals, public and private nursing homes. Some facilities 
provide different services on the same site e.g. nursing home and hospice services. Ambiguity 
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around place of death could be reduced by requiring institutions to self-categorise the main 
services they provide from a standardised list. 
 Electronic Health records 
The introduction of a national Electronic Health Record (EHR) in conjunction with IHI’s are a 
key part of the HSE’s strategic e-Health Programme 67.  EHRs are the means by which data 
can be recorded and shared across organisations and care settings 68.  Core functions will allow 
electronic prescribing and case management as well as the ability to aggregate data from these 
systems into a comprehensive national record, accessible to health and social care 
professionals, patients, service users and carers. 
 
The 2020 HSE National Service Plan commits to progressing procurement of an electronic 
health record (EHR) solution in the National Children’s Hospital which will inform the 
procurement of an EHR solution for all health and social care services 69, p. 20. To-date an 
electronic health record had been introduced at several maternity hospitals in Ireland 70. Several 
projects benefitting from the improving electronic health infrastructure have already been 
realised 71. 
 
 In Scotland the availability of electronic medical records have been used to develop electronic 
palliative care summaries to improve  patient care for those  accessing out–of-hours services 
72. In England the impact of advance care planning (ACP) discussions have been evaluated in 
a hospice setting where that information has been  recorded in the electronic patient record 73. 
A wider initiative that relies on the existence of electronic medical record has been in 
development for some time in England. The Electronic Palliative Care Coordination Systems 
aims to enable advance care planning, improve communication  and coordination at end of life  
by providing up-to-date key information on patients believed to be in their last year of life 74. 
These studies from other countries demonstrate the opportunities for PEoLC research in Ireland 





 Health region 
Several reconfigurations of the Irish health service have occurred since 2005, each of which 
can impact the continuity and quality of data collected. For example health boards have been 
replaced by HSE administrative areas and more recently by Community Health Organisation 
areas (CHO). In 2019, the Sláintecare report recommendation for a ‘common unit of 
geography’ for data collection and integration to increase capacity for cross-organisational 
research (Information and Research, page 24) has been initiated with the announcement of six 
integrated health regions to replace the CHOs 75  . The data collection systems have not kept 
pace with these changes so that a patient cannot be accurately assigned to a CHO area using 
address data alone. Eircode postcodes could be used to assign every household to a distinct 
CHO and/or other geographical units. This would eliminate any ambiguity for both service 
providers and service users on where to seek health care in the first instance, help establish 
criteria for access to services and facilitate meaningful research around service provision by 
health region.  
 
 General Data Protection Regulations 
In May 2018 the General Data Protection Regulation (GDPR) became law in the European 
Union76, 77. It regulates the processing of personal data relating to individuals in the EU so that 
personal data are 
• 1. Processed lawfully, fairly and transparently. 
• 2. Collected for specific legitimate purposes only. 
• 3. Adequate, relevant and limited to what is necessary. 
• 4. Accurate and kept up to date. 
• 5. Stored only as long as is necessary. 
• 6. Protected with appropriate security measures, ensuring its integrity and 
confidentiality. 
Included in GDPR is the principle of patient consent where by valid consent from individuals 
is required for the processing of their personal data. Consent must be a “freely given, specific, 
informed and unambiguous indication of the individual’s wishes”. GDPR force a stricter data 
governance regime on organisations so that data controllers i.e. the organisations collecting 
data, can be required to prove compliance with GDPR requirements. 
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The measures for data processing for health research are given more specific effect through 
Ireland’s Health Research Regulations Act (HRR)78. Some of the specific measures enshrined 
by HRR Act were considered restrictive 79 . Of particular concern were the requirements for 
explicit consent or approval from the Health Research Consent Declaration Committee 
(HRCDC) 80 for ongoing research involving retrospective chart reviews, use of biobank 
materials and research with individuals who lack capacity to consent. In 2021 the Department 
of Health amended the HRR  to  address these issues and clarify situations where  a health 
research declaration consent application is required 81.Under the new amendments,  low risk 
retrospective chart reviews  that have been approved by a research ethics committee and meet 
specified transparency requirements,  no longer require a health research consent declaration 
82.  
The requirements for compliance with GDPR and in particular the HRR are complicated by 
the fragmented health data infrastructure. Guidance notes are available to assist data controller 
organisations when making an application to the HRCDC for a consent declaration. In addition 
a public log of HRCDC applications provide an insight to the working of the committee. 
Information on the decision process for existing applications that include the decision outcome, 
any specific conditions attached and/or additional recommendations can alert researchers to 




Ireland does not have a universal healthcare system so there are no population-level insurance 
claims databases with national coverage unlike those used extensively in Belgium 24 and 
Ontario Canada 25 for PEoLC research. The Irish health system is characterised by a fragmented 
information infrastructure so that only death certificate data and a small number of the disease 
registry data collections are fully population based with national coverage. In this context, the 
use of cancer registry data complete with information on date, cause and place of death from 
linked death certificate data is a valuable tool for cancer PEoLC research. Because there is full 
coverage, biases due to missing data in the linked datasets can be better assessed and evaluated. 
Studies using cancer registry data linked to hospital episode data for PEoLC research have been 
published in Ireland. One study examined the palliative care needs of lung cancer patients 37 
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and a second evaluated the receipt of specialist palliative cancer care in acute hospitals 38 . A 
feature of these studies is careful study design driven by background knowledge of the data 
available. Cancer registry data allow cancer subtypes to be examined individually taking 
account of differences in survival, for example lung cancer is characterised by short survival 
times. For data protection reasons, only hospital episode data that mention a cancer diagnosis 
are made available to the cancer registry for linkage. Hospital episodes at or following cancer 
diagnosis and shortly before death, (particularly where cancer is a cause), are most likely to 
mention a cancer diagnosis and be provided to the cancer registry. In this context hospital 
episode data is more likely to be complete for cancers with short survival times, such as lung 
cancer. 
Cancer registry data has also been linked to PCRS pharmacy claims data to examine the effects 
of drugs on cancer progression and survival 83- 85 .  In PEoLC, a goal of anticipatory prescribing 
is to allow patients have their symptoms managed at home at end of life 86 . Anticipatory 
prescribing includes opioid for pain, sedatives for anxiety and agitation as well as anti-emetics 
for nausea and vomiting 87. In this respect the PCRS database could be a valuable resource for 
PEoLC research in the community where there is a recognised lack of data. Although not fully 
population based, a number of studies have described how PCRS can be used to study specific 
populations 88  and particularly those aged 70 years and over 89. 
The Irish MND registry has been used extensively for research 90- 92, including an examination 
of the role of palliative care within a broader multidisciplinary approach to care 93. The evidence 
base for palliative care for neurodegenerative diseases in general is lacking for MND patients 
94. A recent study has suggested certain triggers may be used to recognize the end-of-life phase 
in neurological patients. These include recurring infection, weight loss, dysphagia and 
aspiration pneumonia 95. Linkage to HIPE data to explore these triggers in MND patients may 
be one avenue for future research.  
In recent years lung transplantation for cystic fibrosis patients has become more common as 
patients survive longer with advances in care and treatment 96. The changing practices impact 
the location and intensity of end-of-life care of people with cystic fibrosis and warrants further 
examination 97, 98. The first report from the ITS-ILD Registry indicates most patients with IPF 
will ultimately need lung transplant or palliative care 57. For both the cystic fibrosis and the 
ITS-ILD registries, data linkage to administrative health data including HIPE data and death 
certificate data could be used to examine changing patterns in treatment and/or place of death. 
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Patients requiring transplant have advanced illness and may have unmet palliative care needs 
99- 101. While specific data sources for many of the diseases listed in Table 1 are not available 
in Ireland, data from the national transplant services (cardiopulmonary, liver and renal 
diseases) has been linked to cancer registry data 60 and could  be used  to  identify cohorts of 
patients with palliative care needs. 
 Conclusions 
 
Health and social care  data collections are a powerful tool for PEoLC research 1, 2, 24 and these 
are available in  Ireland 16– 18 . Previous studies have shown that, with the appropriate 
permissions, detailed knowledge of the datasets and good study design, these data can be used 
for PEoLC research in Ireland 37, 38 . Since 2018, more stringent requirements around data 
governance, data sharing and the requirement for informed consent arising from legislative 
changes to GDPR and Irish Health Research Regulations have impacted on the use of 
administrative health and social care data for research. The planned reforms of the Irish health 
services 17, 67   together with the HIQA recommendations for standards for data quality 30 should 
improve the Irish health information infrastructure and research potential of administrative 
health and social care data. Streamlining the existing fragmented health service should clarify 
data governance and ownership issues. Improved data standards requiring data models, data 
dictionaries and the development of minimum datasets will allow researchers to evaluate the 
research potential of a dataset in advance and gauge the level of effort required to access and 
use the data. The introduction of IHI’s for both service users and providers will improve data 
privacy by negating the need to store identifiable data name and/or date of birth etc. more than 
once. The increased security provided by IHI’s will facilitate data pseudonymisation while data 
linkage and data sharing based on a common IHI between datasets, i.e. deterministic linkage 
rather than probabilistic matching should be possible. The introduction of EHRs will transform 
data sharing across health care settings and IHIs are a key enabler of this.  These changes will 
take time to fully implement but should allow the full power of administrative health and social 
care data for PEoLC research to be realised in due course. 
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Table 6.1 Conditions associated with palliative care needs and their International 
Classification of Disease codes. 
Condition ICD-10 codes *  
Malignant neoplasm  C00-C97 
Heart disease, including cerebrovascular disease I00-I52, I60-I69 
Renal disease N17, N18, N28, I12, I13 
Liver disease K70-K77 
Respiratory disease, J06-J18, J20-J22, J40-J47 & J96 
Neurodegenerative disease G10, G20, G35, G122, G903, G231 
Alzheimer’s, dementia and senility F01, F03, G30, R54 
HIV/AIDS B20-B24 
Source: 34, * 35 
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Table 6.2. Health and social care datasets with national coverage potentially relevant for palliative and end-of-life care (PEoLC) research. 
 





Vital Statistics  
- Death  
Registration  
All National  
population  
based 
Death certificates Individual No No Further information on data for research can 
be  







All National for all  
acute public  
hospitals  
A HIPE discharge record is 
created when a patient is  
discharged from (or dies in) 
hospital. Administrative,  
demographic and clinical 
information are collected for  
a discrete episode of care in 
53 hospitals  
Episode of  
care  
Yes Same  
as data  
dictionary 
Datasets for HIPE discharges are provided to a  
number of State agencies in order to address 
specific  
data requirements.  
 
Data requests can be submitted by email to  
HIPEData.Requests@hpo.ie  
 
Further information on HIPE can be found at 
http://www.hpo.ie/  
Primary Care  
Reimbursement  
Service (PCRS). 
All Nationally to  
all population  
entitled to a  
medical card  
The data  
covers the  
main national  
health schemes  
throughout the  
country.  
The PCRS is responsible  
for making payments to 
Healthcare Professionals, e.g.  
GPs, dentists, pharmacists  
and optometrists/  
ophthalmologists, who 
provide free or reduced cost  
services to members of the 
public across a range of 
community health schemes. 
Script based  
transactions  
No No Reports based on PCRS data are available from 
the  









The Irish  
Longitudinal  




A nationally  
representative  
sample of  
adults aged  
50 and over,  
resident in  
Ireland  
n=8,504 
TILDA collects information on 
all aspects of health,  
economic and social  
circumstances from people 
aged 50 and over in a series of 
data collection waves once 
every two years beginning in  
October 2009.  





Further documentation is available at  
https://tilda.tcd.ie/data/documentation/  
National Cancer  








All incident tumours  
recorded  
Individual Yes Yes Anonymised aggregated data are available for  
download from the NCRI website. Requests for  
individual level data are examined on a case by 
case  
basis. See website for details  
https://www.ncri.ie/  







All known  
patients  
diagnosed  
with MND in  
the Republic of  
Ireland. 
Hospital In-Patient Enquiry 
(HIPE) discharge data in all  
major hospitals are searched 
to ascertain and confirm all 
MND diagnosis. The Central  
Statistics Office (CSO) Deaths 
Register is searched to capture 
MND cases where  
the subject passed away 
shortly after diagnosis. The 
register is based on direct 
nationwide chart  
review/confirmation by the 
diagnosing physician. 




Email: ResearchMND@tcd.ie  
 
Further information can be found at 
http://mnd.ie  
Cystic Fibrosis  




All consenting  
persons with  
CF in the  
Republic of  
Ireland. 
Participation is voluntary,  
enrolment is based on  
patient consent to have their  
medical record details added  
to the registry. Data is taken  
Individual On 
request 
No Further information and requests for registry 
data  
can be made by downloading and completing 
the  
CFRI Data Application Form  
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from patient medical charts  
by registry staff  
Irish Thoracic  
Society  









All consenting  
persons with  
ILD in the  
Republic of  
Ireland 
Participation is by consent.  
The registry aims to identify,  
record, analyse, and store  
information relating to the  
prevalence, incidence, and  
treatment of ILD in the  
Republic of Ireland. 
Individual No No Further information available by contacting 
the Irish  
Thoracic Society at  
https://irishthoracicsociety.com/contact-us/  















from 1964 to 
date  
 
The registry is maintained for 
the recipients of renal and 




No  No For further information contact 









Chapter 7:   Discussion  
 
The overarching objective of this thesis is to explore the potential of administrative health data 
for PEoLC research in Ireland. Research objectives included using the available linked data to 
identify vulnerable subgroups in need of palliative care, to identify and compare characteristics 
of those who receive palliative with those who do not and to explore the impact of receipt of 
palliative care on place of death. By drawing together the experience of using administrative 
health data for PEoLC research in cancer patients the knowledge gained was extrapolated to 
other national non-cancer health and social care data collections.  In this way several guiding 
principles for using Irish administrative health and social care data for PEoLC research have 




Internationally over the last decade linked administrative health data has been used to examine 
three broad strands of palliative care research (1) identification of those in need of palliative 
care, particularly subgroups e.g. the elderly, the frail or the very young, (2) investigation of the 
delivery and effectiveness of palliative care - usually using large administrative claims 
databases, disease registers and/or hospital episode data and (3) prognostication of patient 
outcomes.  In general these studies originate from countries with well-developed health 
systems, mature data collection infrastructures and where universal health coverage is 
available. Three studies examined the potential of administrative health data for PEoLC 
research at a country level (Davies et al., 2016; Maetens et al., 2016; Tanuseputro et al., 2017). 
Themes common to the studies include identifying the available data, determining how that 
data can be safely and ethically accessed and then using the data to examine the delivery and 
effectiveness of palliative care.  Country specific studies are important because the organisation 
of a health system impacts how palliative care is organised and delivered. This in turn 
determines what administrative health data are available for PEoLC research and whether it 
has potential to drive evidence-based palliative care practice and policy at the national level.  




Informed by the international experience of using administrative health data for PEoLC 
research and with detailed knowledge of available datasets, population based cancer registry 
data linked to hospital episode data and death certificate data two studies were undertaken. The 
first examined whether cancer subgroups in need of palliative care can be identified from 
administrative health data and is broadly aligned with the international research agenda of 
identifying palliative care need in vulnerable subgroups. The second study examined whether 
receipt of palliative care can be identified from hospital episode data and so allowing a 
comparison of those who receive palliative care in acute public hospitals with those who do 
not. This study fits with the second strand of international research i.e. identifying receipt of 
palliative care from administrative health data. 
 
These studies demonstrated the practical challenges of using linked administrative health data 
and their potential for PEoLC research.  Based on the experiential knowledge  from these, a 
broader examination of the potential of Irish health and social care datasets for PEoLC research 
and the likely impact of ongoing initiatives to reform the Irish health service formed the basis 
of a third study.  
 
 Palliative care in cancer subgroups 
 
In Ireland lung cancer remains the leading cause of death in both sexes with a 5-year survival 
rate of 20%, also 70% of  lung cancer patients are diagnosed  at a late stage  i.e. stage III or IV, 
(National Cancer Registry Ireland, 2019c).  Our first study compared the characteristics of 
short-term lung cancer survivors i.e. those that died within 30 days of diagnosis with those who 
survived longer, for patients diagnosed between 2005 and 2012 and who died before 01-01-
2014. Having adjusted for stage and histologic type at diagnosis, we showed short-term 
survivors were older (aged 80 years and over), had comorbid disease, presented through the 
emergency department and did not have a partner (Kelly et al., 2018). These results are 
consistent with  evidence for  high levels of emergency admissions in  older (65 years and 
older)  breast and colorectal cancer patients in Scotland diagnosed between  2003–2007 
(Brewster et al., 2011) and contributes to the  evidence base of the need for palliative care in 




In Ireland current national guidelines recommend patients with stage IV non-small-cell lung 
cancer should be offered concurrent specialist palliative care and standard oncological care at 
initial diagnosis (National Cancer Control Programme, 2017, p. 109). Using this criteria alone 
as an indicator for palliative care, just over 50% of the short-term survivors from our study 
would be identified. This highlights the need for additional prognostic indicators for early 
assessment for palliative care for lung cancer patients in Ireland.  We have shown older age 
(aged 80 years and over) combined with comorbid disease and presentation through the 
emergency department may be useful prognostic factors for early assessment for palliative care. 
Further characterisation of emergency admissions that result in a cancer diagnosis, in terms of 
the reason for admission, the time (e.g. out of hours) and day of admission would indicate the 
urgency of the admission. Information on hospital presentations before a cancer diagnosis 
would allow an assessment of the impact of comorbid disease on delayed diagnosis and/or late 
presentation.  
 
Bekelman et al reported death rates in acute hospitals ranging from 54% in Canada to just over 
20% in the United Sates for lung cancer decedents over 65 years of age in 2010 across 6 
developed countries (Bekelman et al., 2016). In our study 75% of the short-term survivors died 
in hospital compared to 43% of longer term survivors.  Patients who die shortly after diagnosis 
may have had too little time for adequate assessment and appropriate care plans (curative or 
palliative) to be put in place. In this context, reporting by survival time provides an added 
context to evaluate care received at end of life and may help explain differences in the rate of 
death in acute hospitals across different health care settings. The interplay between survival 
time, treatment and place of death is another area for future research. Techniques such as 
quantile regression analysis that assess differences in characteristics of the patient cohort over 
specific percentiles (or quantiles) of survival time may be informative.  
 
A major limitation of studies that use administrative health data is the lack of consensus on the 
end-of-life time frame (Luta et al., 2015). Few account for differences in survival times by 
disease type and/or disease subgroups.  Retrospective studies of cancer have used look-back 
periods from death of six or twelve months and many do not distinguish differences in survival 
by cancer type (Langton J.M. et al., 2014). In Ireland, the NCPPC does not use end-of-life to 
refer to a defined timeframe before death (The National Clinical Programme for Palliative Care, 
& HSE Clinical Strategy and Programmes Division., 2014).  Cancer registry data provides 
detailed information on cancer type, date of incidence and date of death so that survival time 
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by cancer type may be determined.   A study that looks forward from an event such as a cancer 
diagnosis is more robust than looking back from death, particularly for cancers with poor 
survival such as lung cancer.  The approach also mitigates potential biases in subject selection 
(Bach et al., 2004).  
 
 
Our study for lung cancer patients could be replicated for other cancer types particularly those 
with short survival times including liver, ovarian and pancreatic cancer. Other areas for 
research include an evaluation of the impact of the rapid access lung clinics for suspected lung 
cases established in 2012 (Health Service Executive, 2020), using our study results (on patients 
diagnosed from 2005 to 2012) as baseline data. Outcomes could include (1) cancer stage at 
diagnosis for non-small cell lung cancers to determine whether patients are diagnosed earlier, 
and (2) the numbers of admission to the emergency departments to check for a reduction in 
patients diagnosed from admissions to the emergency departments. Further studies that 
examine the extent to which inadequate screening, late diagnosis and/or rapid decline from 
diagnosis contribute to poor prognosis are required. Patients who die shortly after diagnosis 
may have had too little time for adequate assessment and appropriate care plans (curative or 
palliative) to be put in place.  
 
 Identifying receipt of palliative care 
 
A broad body of literature exploring biases in terms of who receives palliative care has emerged 
over the last decade. This includes barriers to receipt of palliative care based on age (Gardiner 
et al., 2011; Parajuli et al., 2020), race (Coupland et al., 2011; Gardner et al., 2018) and gender 
(Haviland et al., 2020). Other cited barriers are a reluctance by the healthcare provider to refer 
patients for palliative care, reluctance of the patient and/or family to be referred, as well as 
restrictive specialist palliative care service program eligibility criteria (Hawley, 2017). In order 
to explore these issues, the ability to identify and characterise who receives palliative care and 
who does not is increasingly important.   
 
A strength of administrative health data for PEoLC research lies in the ability to determine that 
palliative care has been received.  Internationally studies that used administrative health data 
to identify receipt of palliative care are predominantly from regions that provide universal 
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health care e.g. Belgium (Maetens et al., 2016), Ontario (Jang et al., 2015; Tanuseputro et al., 
2017) and Taiwan (Chang et al., 2016; Wang et al., 2016). Ireland does not have universal 
health care insurance and while in 2017 approximately 43% of the population have private 
health insurance across three providers (Department of Health, 2018) health claims data were 
not available. Relative to other countries, this is a gap in Irish administrative health data. 
 
Several studies from Australia used a consultation or care with the hospital based palliative 
care services from hospital episode data to identify receipt of specialist palliative care (Philip 
et al., 2015; Rosenwax et al., 2016; Sundararajan et al., 2014). Coupland et al used death in a 
hospice to identify patients in receipt of palliative care (Coupland et al., 2011).  In our second 
study we used HIPE hospital episode data to derive two indicators for receipt of palliative care 
(Kelly et al., 2020). These were (1) HIPE ICD-10-Australian Modification diagnosis code 
Z51.5: encounter for palliative care and (2) HIPE discharge code: transfer to hospice.   
 
Using HIPE to identify those having a palliative care encounter may underestimate the actual 
number of encounters. The annual National Audit of Hospital Mortality (NAHM) report 
produced by the National Office of Clinical Audit (NOCA) uses HIPE data to report hospital-
based mortality data. The 2018 NAHM report describes variation in the application of the 
palliative care code between hospitals (National Office of Clinical Audit, 2019). This is partly 
because the Z51.5 code does not differentiate between treatment being provided by a palliative 
care specialist/team and an assessment being provided by the specialist/team where no further 
treatment is required. This ambiguity may result in under recording of Z51.5 as the 2018 
NAHM report notes that accurate recording of the activity by the clinicians is necessary. 
Guidance to clinical coders states that the Z51.5 palliative care code should be assigned when 
there is documentation that the patient has been seen by or attended to by a palliative care 
specialist or palliative care team (Healthcare Pricing Office (HPO), 2016).   
 
To mitigate these risks, our study population was restricted to decedents who attended one of 
eight cancer centres in 2016, each of which has specialised cancer services and specialist 
palliative care teams. We included the  discharge to a hospice as an indicator for palliative care 
given the likely need for a consultation with the palliative care team before discharging to this 
setting and  we undertook a validation study which compared HIPE patient-level counts at the 
eight cancer centres to SPC minimum data sets aggregate counts. The counts closely matched 
in four of the cancer centres with greater variation in the other four (Appendix G). Our 
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validation study cannot identify a situation  within a hospital where there are roughly equal 
number of patients who have the ICD code but didn’t get SPC (false positives) and patients 
who don’t have the ICD code but did get SPC (false negatives) and therefore that aggregate 
counts would still match despite misclassification.  In this context more robust validation of 
palliative care coding is required. Stubbs et al describe a single centre validation exercise of 
the Z51.5 code against health records which could be adapted for the eight adult cancer centres 
in the first instance (Stubbs et al., 2020).   
 
 
 In a further validation exercise we compared the demographic and clinical characteristics of 
the decedents in our study to all 2016 cancer deaths using data from the CSO Vital Statistics 
Annual Report 2016, (Central Statistics Office, 2019c).This showed that decedents in our study 
population were younger relative to the total population of 2016 cancer decedents. It has been 
reported previously that patients treated at cancer centres are younger than those treated in 
other public hospitals; this may be due to preferential referral of younger patients to the cancer 
centres as better candidates for treatment, (National Cancer Registry Ireland, 2019b). In our 
study mitigating against the risk of under estimation of palliative care encounters by focussing 
on cancer centres, introduced a population level selection bias against older cancer patients 
who are less likely than younger patients to be referred to these cancer centres. Furthermore it 
should be acknowledged that patients who receive palliative care were prospectively more 
likely to die so their death was more foreseeable, perhaps more planned and thus likely to occur 
outside hospital settings.  
 
 
This cohort study is by definition non-randomised so the potential for further unobserved 
confounding must be considered. A myriad of complex factors determines who receives 
palliative care and who does not so that there may be systematic differences in the 
characteristics of these patient groups that are unobserved and not available from 
administrative health data (Kaufman et al., 2021). For example our study did not account for 
patient and family preference for palliative and/or curative care and where that care is given.  
 
These considerations demonstrate the limitations of administrative health data for PEoLC 
research, particularly with respect to unobserved confounding and bias.  To minimise the risks 
as far as possible it is important to have a detailed background knowledge of the health 
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administrative datasets to be used and a robust study design with external validation where 
possible. Data quality is particularly important and challenges remain when using HIPE data 
alone to identify palliative care receipt. The 10th Edition of the classifications used in HIPE, 
the International Statistical Classification of Diseases and Related Health Problems, Tenth 
Revision, Australian Modification/ Australian Classification of Health 
Interventions/Australian Coding Standards (ICD-10- AM/ACHI/ACS), introduced for all 
patients discharged from January 1st 2020 changes how the palliative care code is applied. The 
10th edition states that the palliative care code will only be coded as an additional diagnosis 
when there is documented evidence that the patient has been provided with palliative care. To 
improve the quality of palliative care coding, the NCCP and HPO will develop guidance on the 
accepted documented wording to provide evidence of palliative care treatment for patients.  A 
key recommendation of the 2018 NAHM report is that the guidance will be shared with all 
clinicians to ensure consistency in documenting palliative care treatment, (National Office of 
Clinical Audit, 2019, p. 47) 
 
 
 Specialist palliative care in acute hospitals  
Almost two thirds of cancer patients in our study who attended a cancer centre and died in 2016 
had a palliative care encounter. They were younger, less likely to be married, and more likely 
to be from deprived areas. This is the first time this information has been reported in an Irish 
context and we are aware of only one other study examining receipt of palliative care among 
cancer patients in an acute hospital setting.  Hui et al report reported that 45% (n= 366 of 816) 
of advanced cancer patients at a single comprehensive cancer centre in Houston Texas had a 
palliative care referral before they died (Hui et al., 2012). The diagnosis date of advanced 
cancer and the first date of receipt of palliative care services was determined by expert review 
of patient medical records in the Hui study. Multivariable analysis showed that younger 
patients and married people were more likely to have access to palliative care.  
Access to palliative care for older adults is a recognised problem (Gardiner et al., 2011; Lloyd 
et al., 2016). Reasons cited include attitudinal differences to the care of older people, a focus 
on curative treatments within hospitals and a lack of resources (Gardiner et al., 2011). In 
addition older patients may have less clear early signs indicating that they need palliative care 
and are not referred (Lloyd et al., 2016).  Hui et al found no differences in referral to palliative 
care by ethnicity, education, and religion. These variables were not collected in the datasets 
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available to us and were not examined in our study.  The lack of ethnicity data in many Irish 
health and social care data collections is a recognised limitation for equality monitoring 
(Hannigan et al., 2019). Also some variables, for example, marital status can change over time. 
In the NCRI dataset, information on variables such as marital status are collected only once at 
diagnosis so that changes over time are not captured. 
 Impact of health care organisation on palliative care receipt 
Having accounted for available sociodemographic factors (age, gender, marital status and 
deprivation), there was evidence of regional variation in receiving palliative care.  Decedents 
in the South Eastern and Midlands regions of Ireland had a statistically significant decreased 
odds of a palliative care encounter relative to the Eastern region. Regional-level variation in 
specialist palliative care services in Ireland is well documented (Department of Health and 
Children, 2001; Irish hospice Foundation, 2006; Brick et al., 2015; Irish Hospice Foundation, 
2018).  Neither the South Eastern nor Midlands regions have an inpatient hospice and limited 
inpatient specialist palliative care beds which may explain why decedents from these regions 
have reduced access to specialist palliative care.  
 
In this study the level of palliative care services were categorised by CHO region, which 
replaced the former health board regions in 2015.   The health administrative data collection 
systems have not kept pace with these changes so that for our study a patient could not be 
accurately assigned to a CHO using address data alone. Our study relied on the geographic 
overlap between the former health board region and the current CHO area to assess the 
relationship between service provision and access to specialist palliative care. Further 
reorganisation of the Irish health system is planned. The 2017 Sláintecare report on  health 
service reform  identified a lack of coordination between hospital groups and CHOs and  
proposed the establishment of Integrated Care Regional Organisations  to coordinate  acute, 
primary and social care (Healthcare, 2017), Section 3.8). In 2019 six new health regions were 
announced, two of these map directly to the existing CHO areas 3 and 4 which themselves map 
directly to the former Mid-Western and Southern health boards respectively (Health Regions, 
2020). Maintaining data collection systems to keep abreast of service reconfigurations is 
challenging and some time lag is to be expected. As we have found, assigning patients to the 
appropriate health region or unit is problematic. The Eircode postcode system could be used to 
assign every household to a distinct CHO and/or other health unit. This would eliminate any 
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ambiguity for both service providers’ and service users on where to seek health care in the first 
instance, and help establish criteria for access to services.  
Health service providers identifiers (Health Identifiers Act 2014, 2014), will allow 
classification and enumeration of services in terms of service type, capacity and location. This 
combined with postcode data will allow a more in depth analysis of the role of health care 
service factors in access to PEoLC. The conceptual framework proposed by Gao et al 
evaluating the role of health service characteristics in place of death could inform the work 
(Gao et al., 2018).  At the simplest level geographical distances to services such as inpatient 
hospice can be measured. 
 
 Palliative care and place of death 
Hospital was the most common place of death for all the decedents in our study which is 
broadly consistent with previous studies (Gao et al., 2014, 2019; Ó Céilleachair et al., 2011; 
Sharp et al., 2010). Patients from more deprived areas were more likely to have a palliative 
care encounter in acute hospitals, and while a significant proportion (45%) died in hospital they 
were still less likely to die in hospital than the patients who didn’t have a palliative care 
encounter in hospital.  A systematic review   of nine studies (Spain (1), United States (2), Japan 
(3), Canada (2) and New Zealand (1)) reported that the use of specialist palliative in any setting 
including hospice care, home care, inpatient or outpatient care in cancer patients may modify 
the effect of socioeconomic status on place of death (Chen H., et al., 2016) which is consistent 
with our study results. 
The interrelationship between deprivation, receipt of palliative care, health service organisation 
and place of death is complex. A study of all deaths in England in 2014 (Gao et al., 2019) found  
health service type (adult inpatient hospice, hospitals, general practitioner and care homes)  and 
capacity (ratio of service facilities to user population, counts of services types within functional 
areas) were the strongest predictors of the area-level variation in place of death.  In our study, 
death in hospital, even for those who received palliative care, may be due to limited inpatient 
hospice care facilities which is a known problem in Ireland (Department of Health and 
Children, 2001; Irish hospice Foundation, 2006; National Clinical Programme for Palliative 
Care, 2019).  
Eighteen percent of patients who received palliative care in acute hospitals died at home 
compared to 28% in the non-encounter group. Further investigation of the experiences of 
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patients who die at home and their families is warranted, in particular with regard to receipt of 
palliative care in the community where there are recognised large gaps in the availability of 
data (Health Information and Quality Authority, 2013) 
 In an economic evaluation of palliative care in Ireland, Brick et al present a detailed 
methodology to derive formal and informal costs per patient in receipt of specialist palliative 
care over the last year of life across three comparator health areas in Ireland (Brick et al., 2015).  
Local palliative care teams identified eligible study participants (decedent and key informants) 
and the study population comprised 215 participants who received SPC during the last year of 
life (2011), including 80 in the HSE Midlands, 75 in the HSE Mid-West and 60 in the HSE 
South East.   Broadly the study reported the most costly component of care in the Midlands 
and South East health areas in the 12 months (first 9 month and last 3 months) before death 
was hospital care followed by informal care. In contrast in the Mid-West the most costly 
component of care in the three-month period before death was specialist palliative care, 
followed by hospital care and informal care.  Variation in mean hospital costs in the three 
month periods before death suggested the ability to access in-patient hospice beds leads to 
savings within hospitals in the last three months of life and reduced inappropriate hospital 
admissions. Although total cost per patient were higher in the Mid-West compared to the other 
two areas, the number of decedents in the Mid-West sample who died in hospital was much 
lower. The authors concluded that given a clearly stated preference in most cases for a death 
outside of hospital it is likely that this higher cost is generally associated with a better 
experience for patients and families. Using HIPE data to identify patients in receipt of palliative 
care in acute public hospitals and the costing methods already described, a wider economic 
evaluation of palliative care services in Ireland should be possible.  
 
 The potential of Irish health and social care datasets for PEoLC research 
 
Most  authors who have used  administrative  health data for PEoLC research have  cited the 
importance of knowing the data and the health service environment from which it derives 
(Langton et al., 2014; Luta et al., 2015; Davies et al., 2016; Maetens et al., 2016; Tanuseputro, 
2017). Our experience using linked administrative health data in the first two studies   





The health information infrastructure is a product of the health system from which it derives. 
Starting in 2005 the Irish health system has undergone several reconfigurations and currently 
the Sláintecare health service reform plan is three years into a ten year strategy (Burke et al., 
2018).  Each configuration affects the data infrastructure and has implications for data 
collection and the health information infrastructure. Our third study sought (1) to identify 
available administrative health data that may be useful for PEoLC research, (2) to describe both 
the challenges and opportunities using these data for PEoLC based on our experiences to-date 
using linked cancer registry data, hospital episode data and death certificate data and (3) to 
describe how recent initiatives to improve the health information environment and changes to 
data protection laws will impact future use of administrative health data in Ireland.  
 
The HIQA catalogue of national health and social care data collections (Health Information 
and Quality Authority, 2017)  cross referenced with a recognised list of diseases with associated  
palliative care needs  (Murtagh et al., 2014) was used to identify datasets that may have 
potential for PEoLC research in Ireland. Including the datasets available for this thesis, (cancer 
registry data, hospital episode data and death certificate data) we identified and described in 
detail a further four data collections with potential for PEoLC research namely PCRS, Irish 
Motor Neurone Disease Register, National Hepatitis C database and TILDA. Of these TILDA 
has been used for PEoLC research (May et al., 2017). 
 
The challenges of using linked administrative health data for PEoLC research arise from the 
social and political context in which the data are generated and used. In Ireland the challenges 
arise primarily due to structural issues with health care delivery and organisation against a 
background of recently strengthened data protection regulations. In Ireland’s mixed public 
private health system, data outside the public system are often governed by individual 
institutions so identifying who owns the data and the mechanism for accessing it can require 
an individual approach to each institution.   This is further complicated where an institution is 
financed from multiple sources including the HSE, privately and through fundraising.  Often, 
there is little standardisation across institutions collecting data, so that even if the data were 
available for sharing, linking data from different sources would require considerable expert 
knowledge and oversight.   
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 Recent developments 
The need to improve Ireland’s health information infrastructure is recognised and a coordinated 
health information strategy was instigated, in tandem with the health service reconfigurations 
that began in 2005. The 2004 National Health Information Strategy (Department of Health and 
Children (DOHC), 2004) included the establishment of HIQA (Home | HIQA, 2020) who have 
produced several reports with recommendations to improve Ireland’s National Health and 
Social Care Data Collections (Health Information and Quality Authority, 2013, 2017a). 
Building on this, several developments to improve the Irish health information infrastructure 
have emerged in recent years. These include the HSE and Department of Health’s eHealth 
strategy (eHealth Ireland, 2018) whose aim is develop safer, more efficient, high quality 
integrated healthcare systems. The eHealth strategy includes the Open Data Strategic 
Programme whose stated aims are to facilitate transparency of the Public Sector while 
providing a valuable resource in the form of data that can drive innovation (Health Service 
Executive (HSE), 2016a, 2016b). The eHealth Ireland Open Data Portal (eHealth Ireland, 
2021), simplifies finding and accessing data from across the Irish Health Sector.   
 
In 2016 the Irish Health Research Board (HRB) launched an initiative to explore Ireland’s 
considerable but under-used resources of existing health datasets for research (Moran et al., 
2016). The recognised challenges include concerns around data protection and good 
governance, and poor skills in preparing data so that is suitable for sharing. ‘Proposals for an 
enabling data environment for health and health related research’  published in 2016  proposed 
a model  to link and  make available health and related data  in a safe, secure manner that 
protects the privacy and confidentiality of the data subjects with the aim of improving  people’s 
health and healthcare delivery. The DASSL (Data Access, Storage, Sharing and Linkage) 
model comprises seven main elements, designed to facilitate the conduct of research.  Five are 
related to infrastructure and services (a health research data hub,  trusted third party and data 
linkage service,  safe setting/safe haven, a research support unit and disclosure control) and 
two (governance and public engagement) are related to the broad legislative and socio-cultural 
context needed to facilitate implementation of the model. In 2019 the HRB announced funding 
for secondary data analysis projects and funded a pilot project to design and develop the 
infrastructure needed to share and link health data securely, a proof of concept of the proposed 
DASSL model  (Health Research Board, 2019). 
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The Sláintecare 10 year reform plan recognises the wealth of data within individual 
organisations and branches of the health system (Houses of the Oireachtas, 2017) and promises 
continued support for the eHealth strategy. In 2019, the Sláintecare report recommendation for   
a ‘common unit of geography’ for data collection and integration to increase capacity for cross-
organisational research (Information and Research, page 24) has been initiated with the 
announcement of the six integrated health regions (Health Regions, 2020).  
 
The increased regulations around data governance,  privacy and  sharing arising from the  
GDPR and the HRR Acts in 2018 against the  fragmented  landscape of the Irish health system 
adds further complexity to realising the potential of  Ireland’s national and social care data 
collections for PEoLC research. The use of health administrative data for PEoLC research are 
subject to appropriate ethical approval and compliance with GDPR and HRR requirements. Of 
particular relevance is the requirement for explicit consent of the data subject for data 
processing which is unique to Ireland.  Under HRR the use of personal data for health research 
that is of high public importance, and where obtaining consent from the data subject is not 
possible, is allowed in certain circumstances.  A health research declaration consent can be 
sought for specific research projects where a data controller determines this is required for a 
particular health research project. Guidance notes are available to assist the data controller 
organisation when making an application to the Health Research Consent Declaration 
Committee (HRCDC) for a consent declaration. A publically accessible log provides 
information on the decision process for existing applications that include the decision outcome, 
any specific conditions attached and/or additional recommendations (Health Research Consent 
Declaration Committee, 2020). These can inform the application process and highlight areas 
requiring further consideration.  
 
The Irish health system is in the middle of a major reform drive and a vision for a coordinated 
integrated health system, underpinned by a connected information systems infrastructure, is 
slowly emerging. The initiatives to improve the health information systems such as individual 
health identifiers, health service provider identifiers and the adoption and integration of 
postcodes across all data collection systems are a part of that vision. These reforms, combined 
with the requirements for improved data governance and data privacy arising from GDPR and 
the HRB initiatives to improve data sharing and linkage, will take time but should in due course 
provide a clearer roadmap for PEoLC research using linked administrative health data. This 
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thesis, exploring the potential of existing linked administrative health data created as part of 
cancer registration, is timely. It has demonstrated linked health data can be used for population 
based research, highlighted the challenges arising from the existing fragmented infrastructure 
and suggested how initiatives such as postcodes and health identifiers can be used to mitigate 
these challenges.  
 
 Guidelines for PEoLC research using health administrative data 
The overriding principle of using administrative health datasets for PEoLC research is to 
develop and evaluate a research question with a thorough advance understanding of the datasets 
to be used. Related to this is identifying which dataset forms the starting point from which the 
study population is to be identified and derived. These two considerations will inform most 
aspects of the study planning, design and implementation. In particular the recommendations 
of this thesis are to: 
o Examine the data dictionaries in detail to know what data items are available, 
any classification systems used including the versions used and the timeframes 
for each version across all datasets to be used in the study. 
o Examine the data model to understand how the data are organised and stored so 
that the levels at which data are stored is known in advance. This will allow a 
more accurate estimate of data linkage workload and evaluate potential 
challenges in advance e.g. identifying a cancer diagnosis episode from all HIPE 
episodes for a particular patient. 
o Anticipate and determine in advance what data are missing in any of the datasets 
to be used and the implications for the study. Examples include  
 The dataset only covers subsets of the population, for example PCRS 
records data for patients who have medical cards and eligibility to a 
medical card can vary over time. 
  Cancer registry data only has access to HIPE data that mentions a cancer 
diagnosis so that HIPE data prior to diagnosis or without mention of a 
cancer diagnosis are not available. This can include episodes post 
diagnosis for cancers with long survival times 
  Data may be missing within datasets over time for particular institutions 
for operational reasons 
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A second general principle arising from this work is that use of disease registries as a starting 
point and looking forward from an event (e.g. disease diagnosis) eliminates many of the biases 
associated with look back studies from death (Bach et al., 2004).  A desirable feature of any 
disease registry is that each subject is recorded only once, i.e. is uniquely identified within the 
register.  This simplifies the linkage process where a patient may be recorded many times in 
the dataset to be linked e.g.   HIPE and /or PCRS data.  For nearly all patient cohorts,  HIPE 
hospital episode data can provide comprehensive longitudinal morbidity data for the subset of 
patients seen in public acute hospitals while PCRS data is currently the only source of 
community based longitudinal  prescribing data for patients eligible for a medical card over the 
time frame of the study.   
Thirdly, it is important to design the study to minimise biases as far as possible with full 
knowledge of the underlying datasets and to look for opportunities to validate the data wherever 
possible. Because observational studies using administrative health data are non-randomised 
particular focus should be given to the potential for unobserved confounding and bias. 
Finally clear and detailed documentation is essential, listing the study strengths and weakness, 
including the types of bias and confounding that may be present. 
 
 Recommendations for future research 
 
A 2020 systematic review identified a number of  priorities for palliative care research 
internationally  that included service models (particularly out of hours (OOH)  and home care 
across all disease groups),  continuity of care (transition of services) and inequality in access 
to care (Hasson et al., 2020).  These are consistent with the research priorities for PEoLC on 
the island of Ireland reported in 2015 (McIlfatrick, 2015).  
 
 Service Models and continuity of care 
O’Leary et al describes the place of care for n=507 patients from the date of   SPC referral to 
death for a single regional specialist palliative care service in Ireland (O’Leary et al., 2017). 
Just over 84% had a cancer diagnosis, 55.5% received care in a single setting; 28.4% in 
hospital, 21.5% at home, 4.1% in a nursing home/community hospital and 1.4% in hospice. 
Late referral was associated with a single domain of care. Of the total, 39.3% died in hospital, 
25.8% in hospice, 25.8% at home and 9.1% in a nursing home/community hospital. Data for 
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the study was retrieved from electronic databases at the hospice and four local tertiary referral 
hospitals by the study authors who provided care directly to the individual patients.  
 
Information collected by specialist palliative care services include individual basic patient 
information, referral information, transfer and discharge information, activity in specialist 
palliative care in inpatient units (hospice), activity in specialist palliative day care/day hospice,  
activity in specialist palliative care in the community (home care),  activity in acute hospital 
specialist palliative care teams and activity in specialist palliative care bereavement support 
however  models of service provision vary greatly by CHO region  (Weafer & Toft, 2017). The 
study by O’Leary et al suggest much of the community based data are held by the hospice in 
that specialist palliative care region (O’Leary et al., 2017) and  illustrates the value of 
community based data for PEoLC research particularly around service models and continuity 
of care. The management and governance of the specialist palliative care services and the 
relationships between the different domains (hospice, homecare, day care and acute hospital) 
within a region are not clear. The data collected by the specialist palliative care services is not 
listed in the HIQA catalogue of national health and social care data collections (Health 
Information and Quality Authority, 2017).  A data dictionary, data model and clarification of 
the governance and access arrangements for the data collected by the regional SPC services is 
required. This would allow opportunities for future research of the role of service models on 
access to palliative care, on continuity of care and on community care. Additionally, the 
monthly aggregated data that make up the SPC-MDS is an indication of service levels by 
service providers and should be made publically available at regular intervals. Clarification of 
the overlap between specialist palliative care region and CHO area and/or the six newly created 
health regions is also warranted.  
 Inequality of access 
Currently HIPE is the only national data collection where information on palliative care receipt 
is captured. Using HIPE data we have shown that older cancer patients and patients from 
regions with fewer inpatient palliative care beds were less likely to be seen by the specialist 
palliative care team in the acute hospital setting (Kelly et al., 2020). The National Office for 
Clinical Audit use HIPE to develop hospital based standardised mortality ratios for six diseases 
(acute myocardial infarction, heart failure, ischaemic and haemorrhagic stroke, Chronic 
Obstructive Pulmonary Disease and pneumonia, (National Office of Clinical Audit, 2019). The 
2018 National Audit of Hospital Mortality Annual Report found evidence of variation in the 
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application of the palliative care code between hospitals. The mean rate of palliative care code 
use for all admissions has remained relatively static from 2.2% in 2014 to 2.8% in 2018 with a 
year on year increase in mean rate for all deaths from 37.4% to 48.4% over the same period. 
Tabulation of the use of palliative care code by primary diagnosis and hospital for all 
admissions and all deaths in hospital is a feasible first step to explore this further and investigate 
whether disease diagnosis affects access to palliative care. HIPE variables including admitting 
and discharge consultant, consultants associated with diagnosis and procedures together with 
the consultant speciality code which includes Palliative Medicine may be useful parameters for 
internal validation of the palliative care code.   
 
 Out of Hours service  
In the absence of community care data, HIPE remains the only data collection to investigate 
out of hour’s service.  Just over one fifth of n= 2558 patients who died in 2016, attended a 
cancer centre in 2016 and had an inpatient palliative care encounter were discharged to home 
and/or community setting excluding hospice (Kelly et al., 2020). This represents a transition in 
care. Investigation of readmission patterns for these patients in terms of type of admission 
(elective/emergency) and date and time of admission could identify week-end and/or OOH 
readmissions. The sampling frame could be broadened to all patients, with subgroup analysis 
by disease diagnosis, having a palliative care encounter in acute hospital and discharged home.  
 
 
 Prognostication and Machine Learning 
The use of machine learning (ML) to improve palliative and end of life care using health 
administrative data is an area of growing interest. In a rapid review of published studies that 
use ML to improve palliative care, one study found measures derived from health 
administrative data such as demographics, ICD codes, chronic conditions, functional status, 
durable medical equipment and prior healthcare utilization enhanced the performance of the 
ML models when used to capture trajectories (disease duration, onset of functional limitations, 
emergency department visits etc.)  (Storick et al., 2019). The reported studies found ML 
methods were superior to traditional logistic regression, but only when sufficient data were 
available, for example  physiologic and biochemical data. We did not have access to HIPE data 
before a cancer diagnosis so could not examine patterns of attendance before the diagnosis nor 
was information on functional status available. Studies comparing traditional logistic 
regression and ML methods using Irish data may be warranted while exploring access to other 
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sources, for example electronic pathology data. Machine/statistical learning approaches, e.g. 
random forests/support vector machines, should now be routinely considered as possible 
techniques to use, particularly where logistic regression is indicated. Getting indicators about 
the accuracy of the model and using test and training sets in this manner could be informative. 
 
The introduction of a national Electronic Health Record (EHR) in conjunction with IHI’s are a 
key part of the HSEs strategic e-Health Programme (Health Service Executive (HSE), 2013).  
EHRs are the means by which data can be recorded and shared across organisations and care 
settings (Electronic Health Record (EHR), 2020).  Internationally ML and secondary use of 
EHR data   are driving the development of predictive algorithms for   disease detection and 
real-time prognostication of patient outcomes (Xiao et al., 2018).  Avati et al describe a deep 
learning model that uses EHR data in California from approximately 2 million adult and 
paediatric patients to predict mortality within 3-12 months thus identifying patients who might 
benefit from palliative care (Avati et al., 2018).  
There are recognised limitations with machine learning that warrant careful consideration, 
particularly in the context of its role in the medical decision making process (Lindvall et al., 
2020). These include the potential of ML to exacerbate inequalities in access and delivery of 
care due to inaccurate predictions learned from historic data which is itself biased.  Because 
machine learning predictive models are often   inherently uninterpretable and complicated, (i.e. 
black box), the accuracy of the model cannot be adequately assessed (Rudin & Radin, 2019).  
Use of ML can lead to over confidence in automated results, so that careful comparison and 
evaluation with more interpretable traditional methods are warranted. As the health information 
infrastructure in Ireland develops, new opportunities for secondary use of health data will 
emerge.  
 Stakeholder involvement 
A key recommendation from the NACPC report published 2001 was that patients and their 
careers as  prime stakeholders should have input to the development of national and regional 
(Department of Health and Children, 2001b). Key stakeholders included service providers, 
service planners and service users (patients and carers). In light of this recommendation  the 
IHF 2006 baseline study on the provision of palliative care services in Ireland (Irish hospice 
Foundation, 2006) sought input from service providers. The recommendations for future 
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research described here were identified from an  international 2020 systematic review by 
Hasson el al,  (Hasson et al., 2020)  and  are  broadly consistent with the research priorities for 
PEoLC on the island of Ireland (McIlfatrick, 2015). The research priorities identified (OOH 
service, inequality of access, and continuity of care) are largely service orientated which 
Hasson et al suggest may be due to a dominant perspective from health care providers with less 
involvement from patients and caregivers (Hasson et al., 2020). 
Public involvement is recognised as necessary for high quality  research as it allows patient-
focused research questions to be identified and prioritised (Johnson, Ogden, et al., 2021).  
When dealing with populations with life-limiting illness, a more considered approach is 
required to cultivate patient and public involvement. A qualitative study of an the institutional 
level strategy to develop patient and public involvement in palliative care research found  
focussing  on building and carefully maintaining relationships, remaining flexible when dealing 
with individuals living in complex circumstances and involving the right people with 
appropriate experience to specific research projects were important, (Johnson, Ogden, et al., 
2021). The authors concluded a strategic approach to develop adequate infrastructure and 
networks can facilitate public involvement in palliative care research. 
 
Because a lot of palliative care research  is concerned with secondary analysis of existing 
administrative health and social care data collections Johnson et al  explored public views of  
palliative care research that uses  large datasets in a  one day workshop (Johnson et al., 2021).  
From this a number of opportunities to involve the public in ‘big data’ research were identified. 
These included raising public awareness of the existence of these data collections, education 
around key concepts such as data governance, data anonymisation, how data can be accessed 
and shared while maintaining patient confidentiality as well as seeking patient and public 
involvement in setting research priorities with the existing datasets. 
 
The realisation of the Sláintecare health care reform programme coupled with the increased 
clarity around data protection issues provide by GPPR and HRR should facilitate increased use 
of Ireland’s national and social data collection for PEoLC research. In that context a wider 
involvement of data controllers, data managers, researchers and data scientists is needed. These 
data can give a broad population based perspective on PEoLC in Ireland, however to fully 
understand the complexity of PEoLC, involvement of all the stakeholders including patients, 
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Appendix A - Grey literature sources 
All Ireland Institute of Hospice and Palliative care - https://aiihpc.org/ 
Australian Institute of Health and Welfare - https://www.aihw.gov.au/reports-data 
Cancer Research UK (CRUK) - https://www.cancerresearchuk.org/about-cancer 
Community Research and Development Information Service (CORDIS) - 
https://cordis.europa.eu/projects 
Irish Department of Health - https://www.gov.ie/en/organisation/department-of-health/ 
Health Information and Quality Authority - https://www.hiqa.ie/reports-and-publications 
Health Service Executive - https://www.hse.ie/eng/health/az/ 
Health Quality Ontario - https://www.hqontario.ca/ 
IC/ES https://www.ices.on.ca/ 
Irish Cancer Society - https://www.cancer.ie/ 
Irish Hospice foundation - https://hospicefoundation.ie/ 
National Cancer Registry Ireland - https://www.ncri.ie/ 
NHS Digital - https://digital.nhs.uk/ 
Public Health England - https://www.gov.uk/government/organisations/public-health-england 
Royal College of Physicians, London (https://www.rcplondon.ac.uk/) 
Surveillance, Epidemiology, and End Results (SEER) Program of the National Cancer 
Institute (NCI) - https://seer.cancer.gov/ 
The Irish Longitudinal Study on Ageing (TILDA) - https://tilda.tcd.ie/ 





Appendix B - Inpatient hospices in Ireland  
 
 
Name Location  Catchment area Funding Capacity Governance  
Our Lady’s Hospice  Harrold’s Cross Dublin Not stated  HSE and public 36 beds Registered charity 
Our Lady’s Hospice   Blackrock Dublin Not stated HSE and public 12 beds Registered charity 
St Francis Hospice Raheny Dublin North Dublin city and county HSE and public  19 beds Registered charity 
St Francis Hospice Blanchardstown Dublin Dublin north west HSE and public  24 beds Registered charity 
St Brigid’s Hospice Kildare Kildare and west Wicklow HSE and public 13 beds Registered charity 
Marymount Hospital & Hospice Cork Cork city and county HSE and public 44 beds Registered charity 
Milford Care Centre Limerick Limerick, Clare and North Tipperary HSE and public 30 beds Registered charity 
Galway Hospice Foundation Galway Not stated HSE and public 18 beds Registered charity 
North West Hospice Sligo Sligo, Leitrim, South Donegal, West Cavan HSE and public 8 beds Registered charity 
Donegal Hospice Donegal Donegal HSE and public 8 beds Registered charity 
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Appendix C - Data models and Data Dictionary 
 









NCRI principal data items: -   https://www.ncri.ie/data/data-we-
collect/data-fields 
NCRI data dictionary: - https://www.ncri.ie/contact available on 
request. 










Aut Even Hospital  Freshford Road, Co. Kilkenny 
UPMC Beacon Hospital Sandyford, Dublin 18 
Blackrock Clinic  Blackrock Co. Dublin 
Bon Secours Health System   
College Road, Cork, Co. Cork  
Strand Street, Tralee, Co. Kerry  
Renmore, Galway, Co. Galway  
Glasnein, Dublin 9 
 Barringtons Hospital, George’s Quay, Limerick 
Galway Clinic Doughiska, Co. Galway 
Hermitage Medical Centre  Old Lucan Road , Dublin 20 
Highfield Healthcare  Swords Road, Whitehall, Dublin 9 
UPMC Kildare Hospital  Prosperous Road, Clane, Co. Kildare 
Mount Carmel Hospital  Braemor Park, Churchtown, Dublin 14 
Mater Private Hospital   
Mater Private Dublin, Eccles Street, Dublin 7  
Mater Private Cork, City GateMahon, Cork 
St Francis Private Hospital Ballinderry,Mullingar, Co. Westmeath, N91 FE40 
St. Joseph’s Hospital Ray MacSharry Road , Garden Hill, Sligo              
St John of God Hospital Stillorgan,Co. Dublin 
St Patrick’s University Hospital  James’s Street, Dublin 8 
St Vincent’s Private Hospital  Elm Park, Dublin 4 
Sports Surgery Clinic Santry Demesne, Dublin 9 
Whitfield Clinic  Butlerstown North, Cork Road, Waterford 
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Appendix E - Project Approval   







Additional approval sought following introduction of GDPR 
Part 1 (Data Access Approval)  
Application under consideration: 
Cover page of application with contact details, date and reference number: 
 
National Cancer Registry Ireland 
APPLICATION FOR DATASET                                    
                                                                                             <<Above for office use only>> 
(1) CONTACT DETAILS  




Job Title PhD Student University of Limerick/Database Administrator, National Cancer R  
Organisation Name  
Organisation Type 
Please tick as appropriate and 
supply details 
X Government health dept/agency     Hospital/hospital group 
  Government department other        Local authority 
X Academic institution       Commercial         Charity 












Date of acknowledgement of complete application: 02/11/2018 
Date of research application committee meeting: 04/12/2018 
Request reviewed by: 
Reference No 2018-12-MK1 










CRITERIA CONSIDERED FOR APPROVAL 
 
(1) Summary information on the request 
 Aggregated data  
 X Anonymised dataset   
 Patient identifiable data 
 
(2) Has sufficient detail been provided to allow complete assessment of this request? 
 X Yes  
 No  
 
(3) Has all associated documentation been provided (ethical approval, CV of principal 
investigator(s))? 
 X Yes  
 No  
 
(4) Has full and complete justification been provided for all data items requested? 
 X Yes  
 No  
 





 Yes but only if data is grouped/converted to a lower level of specificity, which 
will suffice for this research  
 No 
 
(6) Is this project a collaboration, where NCRI will have control of/input to the analysis 
and interpretation of results as well future publications? 
 X Yes  
  No (NCRI facilitating the research only by providing data/dataset) 
 
(7) Is the quality of this research proposal sufficient to justify the resource requirements 
of the NCRI in providing the data/datasets as well as further collaborative involvement 
as appropriate? 
 X Yes  
 No  
 
 
(9) Estimated time line for preparation of data/dataset 
The data has already been matched and prepared for analysis (under existing 
permissions provided previously by Dr Harry Comber, former director) 
 
(10) For requests from commercial sources, cost of request 
N/A 
 
(11) NCRI staff member responsible for delivery and further contact with requester 
Sandra Deady 
 
RESULT OF REVIEW 
 X Accepted  
 Accepted with some changes 




The request has been approved by the committee.  The requester should sign the 
“Declaration by requester” form. 
As this work is internal and the data is not leaving the NCRI, there is no need for a Data 
Sharing Agreement to be drawn up for this request. 
It was noted by the committee that work on “place of death” could be of benefit to the 





Part 2 (Declaration by requester) 
National Cancer Registry Ireland 
APPLICATION FOR DATASET                                    
                                                                                             <<Above for office use only>> 
(1) CONTACT DETAILS  




Job Title PhD Student University of Limerick/Database Administrator, National Cancer R  
Organisation Name  
Organisation Type 
Please tick as appropriate and 
supply details 
X Government health dept/agency     Hospital/hospital group 
  Government department other        Local authority 
X Academic institution       Commercial         Charity 













Reference No 2018-12-MK1 
Date received 02/11/2018 
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National Cancer Registry Ireland 
APPLICATION FOR DATA/ DATASETS 
Declaration by requester/ supervisor of research 
I have read and understand the procedures and conditions of use of Cancer Registry data 
(https://www.ncri.ie/content/confidentiality) and am aware of the terms under which this 
information is being provided by the National Cancer Registry Ireland (NCRI). 
I undertake that (unless the National Cancer Registry has been specifically requested and has 
given permission) the data supplied (as referenced in the Data Request Form cover page 
above): 
1. Will be used only for the purposes specified in the completed Data Request form.  
Use of the information for a project or purposes other than that described in the 
completed Data Request form will not be undertaken without further NCRI approval. 
2. Will not be transmitted or made available in any format (other than those set out in the 
completed Data Request form) to anyone not named in this request. 
3. Will not be published in any format, prior to confirmation by the National Cancer 
Registry that the publication meets the criteria set out in this declaration.  The 
National Cancer Registry will be sent a final draft of any publication or report based 
on the data, and will have the right to have any analysis breaching these conditions 
removed or modified. 
4. Will ensure that, in complying with the conditions set out in this application, they also 
observe the relevant provisions of the Data Protection Acts, the EU General Data 
Protection Regulation and the Freedom of Information Act. 
5. Where research conducted on the data/datasets provided is independent of further 
NCRI involvement (i.e. non-collaborative studies), will ensure that publications (print 
or online, limited circulation or otherwise) will include the statement “data for this 
analysis was provided by the National Cancer Registry, interpretation of the results 
are the authors own”. 
6. If requested, the National Cancer Registry will archive the data/datasets provided for 
future availability in cases of peer reviewed public access requirements. 
Where individual record datasets are provided, I will ensure that the data supplied: 
7. Will not be used to identify or attempt to identify any individual, family, dwelling or 
institution and may not be published in a way which would allow any individual, 
family, dwelling or institution to be identified either directly or by linkage with other 
data. 
8. Will not be used to contact any individual patients or their family members. 
9. Will not be linked to any data not specified in the completed Data Request form. 
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10. Will not be transmitted outside the Republic of Ireland [if data is provided in response 
to a request from within Ireland]. 
11. Will be deleted or destroyed at the “End date of project” specified in the completed 
Data Request form.  The requester agrees to contact the National Cancer Registry to 
confirm that this has been carried out. 
 
Name:   MARIA KELLY       
  
(BLOCK CAPITALS) 
Signature:        Date: 11/12/2018  
 
 
FOR RESEARCH UNDER THE SUPERVISION OF A SENIOR 
RESEARCHER/CLINICIAN,  
PLEASE ENTER DETAILS AND SIGNATURE(S) 
 
 
Name:    AILISH HANNIGAN     
  
(BLOCK CAPITALS) 
Signature: Date: 10/12/18   
 
 














Appendix F - Project code 













Appendix G - Validation Study   
 
Table G.1 Counts of specialist palliative care referrals from the Palliative Care Minimum 






























count   
 1 496 471 19,(114) 490 99 
2 330 298 12,(40) 310 94 
3 408 339 1,(3) 340 83 
4 492 509 2, (18) 511 104 
5 570 376 45,(148) 421 74 
6 480 398 0,(1) 398 83 
7 564 528 12, (99) 540 96 
8 348 439 6, (82) 445 128 
